data_2g9l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2g9l _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.992 ' O ' ' HD2' ' A' ' 7' ' ' LYS . 82.6 mt . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -90.08 -26.76 20.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.2 m -68.78 -56.88 6.61 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.293 -172.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.5 mt -59.99 -36.55 77.42 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.106 0.562 . . . . 0.0 110.546 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.992 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 0.4 OUTLIER -62.61 -41.96 99.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.362 0.665 . . . . 0.0 110.286 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.16 -57.67 11.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.447 0.699 . . . . 0.0 110.387 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -65.16 -38.62 91.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.962 0.505 . . . . 0.0 111.174 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.44 96.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -81.25 47.55 1.04 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -166.15 -34.59 0.02 OUTLIER Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.1 t -87.6 46.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 154.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -154.08 -30.31 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 19' ' ' LYS . 48.1 tptt -74.79 -39.24 61.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 123.87 0.868 . . . . 0.0 109.061 170.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.41 -24.02 67.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.089 0.955 . . . . 0.0 110.834 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -89.98 -42.3 11.24 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.8 t -63.2 -31.58 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 170.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 15' ' ' LYS . 87.1 tttt -71.71 -36.2 70.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.891 0.476 . . . . 0.0 109.938 175.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.0 -40.75 56.42 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.59 88.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 170.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.284 0 C-N-CA 122.942 0.497 . . . . 0.0 111.485 -179.027 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 110.551 -0.166 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.564 ' O ' ' HB3' ' A' ' 30' ' ' SER . 86.0 mt -56.84 -33.42 66.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.839 0.855 . . . . 0.0 111.664 -175.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.873 ' O ' ' CB ' ' A' ' 31' ' ' CYS . 78.1 p -67.42 -40.33 85.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.788 0.435 . . . . 0.0 110.925 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 94.5 m -77.64 -51.88 9.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.352 0.661 . . . . 0.0 110.274 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.63 -49.07 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 123.388 0.675 . . . . 0.0 110.351 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.564 ' HB3' ' O ' ' A' ' 26' ' ' LEU . 34.8 t -66.38 -45.92 78.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.873 ' CB ' ' O ' ' A' ' 27' ' ' SER . 50.2 t -60.31 -15.61 26.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.7 0.8 . . . . 0.0 111.492 174.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 28' ' ' THR . 9.1 ttmm -80.43 56.96 2.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.191 0.52 . . . . 0.0 110.997 -171.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.3 mp -67.27 -57.11 7.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.09 43.13 2.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.057 0.943 . . . . 0.0 108.521 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.2 tptm 48.59 61.74 2.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.06 1.344 . . . . 0.0 110.901 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.453 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.092 172.756 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.657 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 81.4 mt . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -90.14 -23.52 21.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -69.86 -55.8 8.81 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 pp -63.31 -32.79 74.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.851 0.46 . . . . 0.0 110.576 174.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 1.5 tppp? -58.05 -47.46 83.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.263 1.025 . . . . 0.0 110.717 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -49.37 -54.02 19.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.782 1.233 . . . . 0.0 110.791 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -66.62 -42.64 86.47 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.071 0.549 . . . . 0.0 111.014 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.9 91.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.884 0.473 . . . . 0.0 110.978 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -69.26 -28.76 66.6 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.688 0.395 . . . . 0.0 110.505 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -74.52 -28.16 64.03 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.1 t -86.73 42.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 162.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -142.5 -32.19 0.11 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 172.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 7.2 mtpm? -77.31 -36.69 53.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.561 0.744 . . . . 0.0 109.3 172.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.55 -24.23 66.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.548 0.739 . . . . 0.0 110.371 173.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.1 mt -90.05 -45.74 8.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.002 0.921 . . . . 0.0 109.138 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.5 t -66.32 -27.89 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 65.2 tttm -74.51 -38.58 62.78 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.159 0.584 . . . . 0.0 110.186 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.79 -46.05 40.3 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.63 71.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 122.624 0.37 . . . . 0.0 110.039 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.876 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.448 -0.561 0 CA-C-O 120.38 0.134 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.41 -40.09 85.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.684 0.794 . . . . 0.0 111.364 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.6 p -67.41 -42.55 83.08 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.421 0.289 . . . . 0.0 111.393 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 1.078 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 66.1 m -54.31 -29.5 47.82 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.712 0.805 . . . . 0.0 111.341 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.51 -41.31 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 122.61 0.364 . . . . 0.0 110.056 176.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.0 t -76.24 -61.98 1.76 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.514 0.326 . . . . 0.0 110.319 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.6 p -77.61 31.13 0.16 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.314 0.246 . . . . 0.0 111.32 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 1.078 ' HB3' ' O ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -89.84 -25.65 20.93 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 117.658 0.208 . . . . 0.0 111.434 175.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.22 2.29 0.6 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.04 2.05 1.15 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.705 0.802 . . . . 0.0 111.007 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 48.4 33.49 3.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.055 1.342 . . . . 0.0 112.205 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 166.112 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -90.13 -17.81 26.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -69.76 -54.13 15.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -174.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 pp -59.63 -34.71 73.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.642 0.377 . . . . 0.0 110.852 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.23 -42.77 96.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.784 0.833 . . . . 0.0 110.832 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -56.73 -56.11 25.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.622 0.769 . . . . 0.0 110.458 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -69.15 -31.89 70.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.88 0.472 . . . . 0.0 111.462 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.56 86.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -83.76 54.21 2.81 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 169.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -166.42 -52.83 0.03 OUTLIER Glycine 0 C--N 1.337 0.616 0 C-N-CA 124.574 1.083 . . . . 0.0 113.058 -170.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.46 0.35 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 150.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -107.8 -18.2 10.29 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.919 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 35.4 mmtp -89.13 -19.95 24.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.403 1.081 . . . . 0.0 109.797 168.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.43 -30.55 61.95 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 167.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.22 -43.86 10.13 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.137 0.975 . . . . 0.0 108.614 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -67.81 -27.54 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.949 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.919 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 13.4 tmtt? -68.43 -39.98 81.34 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.065 0.546 . . . . 0.0 109.665 172.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.15 -40.99 60.93 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.91 73.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 122.742 0.417 . . . . 0.0 110.929 178.991 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.4 mt -56.47 -38.95 72.41 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.0 0.92 . . . . 0.0 110.828 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.8 p -68.97 -45.11 71.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.107 0.563 . . . . 0.0 110.662 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 89.7 m -54.82 -43.28 72.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.162 0.585 . . . . 0.0 111.139 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.29 -39.1 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.504 0.722 . . . . 0.0 110.798 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 t -72.54 -60.69 2.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.536 0.335 . . . . 0.0 110.484 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 6.0 p -78.46 29.18 0.19 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.897 0.479 . . . . 0.0 111.411 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.618 ' HB2' ' O ' ' A' ' 28' ' ' THR . 5.7 tmtt? -90.11 -52.43 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.38 1.072 . . . . 0.0 110.083 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.5 tp -50.2 -59.3 4.07 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.141 0.976 . . . . 0.0 110.926 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.09 -19.54 64.07 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 120.947 0.403 . . . . 0.0 111.55 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.6 tptm 56.64 55.51 6.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.53 1.932 . . . . 0.0 112.306 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 164.0 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -90.27 -21.31 22.16 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.6 m -72.03 -53.03 14.18 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.47 -32.09 73.44 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.917 0.487 . . . . 0.0 110.679 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -62.3 -46.47 88.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.77 0.828 . . . . 0.0 110.155 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -60.56 -50.79 72.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.01 0.924 . . . . 0.0 109.794 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -59.72 -49.47 77.62 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.991 0.516 . . . . 0.0 110.562 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.08 90.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.943 0.497 . . . . 0.0 110.456 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.99 -33.87 76.51 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.214 0.606 . . . . 0.0 110.466 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -77.38 -30.07 54.75 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.614 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 t -88.42 41.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 161.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -143.4 -29.15 0.12 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 176.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 19' ' ' LYS . 75.1 mmtt -85.75 -41.53 15.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.4 -18.17 64.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.645 0.778 . . . . 0.0 110.511 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.9 tp -87.68 -43.75 11.7 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.54 -32.85 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 15' ' ' LYS . 64.6 tttm -69.7 -32.11 70.52 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.76 0.424 . . . . 0.0 110.102 175.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.39 -47.2 29.77 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.96 -30.87 71.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.944 0.498 . . . . 0.0 110.917 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.142 0 C-N-CA 122.347 0.259 . . . . 0.0 111.366 -178.587 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 120.423 0.154 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.8 mt -59.08 -39.31 81.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.745 0.818 . . . . 0.0 110.371 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.9 t -67.87 -39.06 83.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.86 0.464 . . . . 0.0 110.733 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.765 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 39.0 m -65.48 -37.6 87.32 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.517 0.327 . . . . 0.0 110.746 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.53 -30.76 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.044 0.537 . . . . 0.0 110.405 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.9 t -81.67 -55.8 4.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.845 0.458 . . . . 0.0 109.896 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.2 t -57.65 -12.37 2.82 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.665 1.186 . . . . 0.0 111.647 175.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.765 ' HB2' ' O ' ' A' ' 28' ' ' THR . 11.9 tppt? -75.72 -42.73 49.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.13 0.972 . . . . 0.0 109.737 -175.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.7 mt -44.88 -55.15 5.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.415 1.086 . . . . 0.0 110.903 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.75 -28.41 36.51 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.276 0.56 . . . . 0.0 111.454 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 tptt 64.97 79.79 0.25 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.339 1.856 . . . . 0.0 111.104 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.452 -0.349 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.843 162.639 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -90.19 -12.68 37.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.684 0.793 . . . . 0.0 110.146 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 97.9 m -61.27 -52.95 62.57 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.5 -37.21 86.76 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.305 0.642 . . . . 0.0 110.651 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -60.36 -39.31 86.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.199 0.6 . . . . 0.0 110.568 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.08 -55.94 28.16 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.836 0.854 . . . . 0.0 110.259 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -68.41 -34.41 75.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.922 0.489 . . . . 0.0 111.378 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.69 98.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.85 53.39 2.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.61 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -170.95 -46.21 0.04 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 124.656 1.122 . . . . 0.0 113.02 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.4 t -78.99 28.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 143.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -126.26 -27.02 1.14 Allowed Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 167.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.709 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 45.5 mmtm -81.13 -29.85 34.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.08 0.952 . . . . 0.0 110.111 173.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.4 -27.29 63.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.17 -43.19 10.6 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.308 1.043 . . . . 0.0 108.264 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -66.36 -27.64 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 119.356 -0.938 . . . . 0.0 108.718 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.709 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 57.6 tptt -72.62 -36.85 68.15 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.11 0.564 . . . . 0.0 109.711 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.5 -41.93 56.82 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.55 80.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 122.875 0.47 . . . . 0.0 111.555 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 N--CA 1.455 -0.215 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.9 mt -54.7 -31.77 58.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.999 0.92 . . . . 0.0 111.115 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.2 t -82.19 -46.25 14.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.228 0.611 . . . . 0.0 110.476 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.1 m -63.53 -56.61 14.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.309 0.643 . . . . 0.0 110.57 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.6 p -49.66 -35.16 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.088 0.955 . . . . 0.0 111.876 -176.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.4 t -69.44 -60.91 2.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.116 0.567 . . . . 0.0 111.134 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 12.3 p -66.46 1.63 1.59 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 119.116 -0.469 . . . . 0.0 112.068 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 1.348 ' HD3' ' CD ' ' A' ' 35' ' ' LYS . 26.5 mmtm -90.04 52.46 2.28 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.642 0.655 . . . . 0.0 109.286 175.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.1 tp -76.44 -61.04 2.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.99 44.65 2.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 1.348 ' CD ' ' HD3' ' A' ' 32' ' ' LYS . 46.5 mmtm 49.28 61.15 3.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.968 1.307 . . . . 0.0 110.879 -171.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.055 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.15 -21.28 22.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.1 m -71.73 -45.04 63.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.08 -39.97 96.29 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.592 0.757 . . . . 0.0 110.038 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.644 ' HE3' ' HD2' ' A' ' 11' ' ' LYS . 56.7 tptt -59.01 -47.15 86.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.714 0.806 . . . . 0.0 110.559 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -61.12 -47.48 86.08 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.696 0.798 . . . . 0.0 110.022 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -62.5 -42.95 99.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.307 0.643 . . . . 0.0 110.586 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.02 96.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.666 0.386 . . . . 0.0 110.105 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.644 ' HD2' ' HE3' ' A' ' 7' ' ' LYS . 63.6 mtpt -81.71 43.36 0.75 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 171.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.21 -36.46 0.02 OUTLIER Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.98 41.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 153.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.24 -32.77 0.48 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.89 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 22.7 pttp -90.06 -25.17 20.92 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.363 0.665 . . . . 0.0 110.328 173.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.7 -26.42 63.41 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 167.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -89.98 -51.68 5.35 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.127 1.371 . . . . 0.0 108.223 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.6 t -65.42 -29.99 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.89 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 13.3 tmtt? -66.61 -39.66 88.44 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 173.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.32 -44.04 60.7 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.81 77.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 171.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.503 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.8 mt -56.97 -43.51 81.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.853 0.861 . . . . 0.0 110.473 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 m -65.3 -47.26 77.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.759 0.423 . . . . 0.0 110.075 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.834 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 2.3 m -82.49 36.26 0.47 Allowed 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.978 0.174 . . . . 0.0 110.804 178.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.55 -43.17 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 148.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.7 m -74.4 -58.79 3.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.469 0.708 . . . . 0.0 110.203 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.5 p -78.91 39.14 0.36 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.321 -0.371 . . . . 0.0 111.189 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.834 ' HD3' ' O ' ' A' ' 28' ' ' THR . 13.6 mmmm -81.37 -64.07 1.26 Allowed 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.268 0.486 . . . . 0.0 112.05 165.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 32.4 tp -29.89 71.45 0.0 OUTLIER 'General case' 0 C--N 1.339 0.148 0 C-N-CA 128.352 2.661 . . . . 0.0 113.306 -163.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 32' ' ' LYS . . . 67.62 57.54 0.54 Allowed 'General case' 0 C--O 1.23 0.055 0 C-N-CA 125.716 1.606 . . . . 0.0 110.087 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -144.31 -57.43 0.37 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.739 1.616 . . . . 0.0 109.605 -170.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 124.657 1.183 . . . . 0.0 109.914 -155.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -90.25 -18.82 24.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.489 0.716 . . . . 0.0 109.758 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -64.06 -47.46 80.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.3 -39.93 94.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.243 0.617 . . . . 0.0 110.532 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -63.04 -44.34 96.17 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.47 0.708 . . . . 0.0 110.377 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -56.84 -45.33 82.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.585 1.154 . . . . 0.0 110.222 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -76.98 -29.56 55.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.116 0.566 . . . . 0.0 111.282 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.68 94.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.745 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.58 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 9.1 ptpp? -83.72 44.33 0.98 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.936 0.494 . . . . 0.0 109.867 172.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -161.83 -49.12 0.02 OUTLIER Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.77 1.176 . . . . 0.0 112.862 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 91.9 t -68.34 4.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 148.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.578 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -112.72 -15.36 9.45 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.913 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 98.8 mttt -89.97 -29.76 18.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.803 0.841 . . . . 0.0 109.327 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.02 -26.94 64.29 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 167.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -89.45 -46.98 8.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.797 1.239 . . . . 0.0 108.591 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.6 t -65.83 -26.78 39.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.97 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.913 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 40.5 ttmt -71.84 -38.21 70.16 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.771 0.429 . . . . 0.0 109.848 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.82 -41.78 55.0 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.87 -33.63 75.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 170.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.271 0 C-N-CA 122.89 0.476 . . . . 0.0 111.638 -179.623 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.37 -32.98 70.62 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.76 0.824 . . . . 0.0 110.763 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 t -70.57 -39.33 73.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.75 0.42 . . . . 0.0 110.766 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.688 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 87.4 m -65.63 -35.12 79.88 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.678 0.217 . . . . 0.0 111.288 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.9 t -51.11 -30.8 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 122.788 0.435 . . . . 0.0 110.459 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.2 t -73.98 -62.1 1.62 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.928 0.491 . . . . 0.0 112.276 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 1.34 ' HB2' ' CD ' ' A' ' 35' ' ' LYS . 10.5 p -52.54 -27.29 15.98 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.688 ' HB2' ' O ' ' A' ' 28' ' ' THR . 62.2 tttp -79.06 65.78 4.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.666 1.222 . . . . 0.0 110.386 -158.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.3 mt -87.67 -53.15 4.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.078 -1.874 . . . . 0.0 108.495 166.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.09 0.19 0.32 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.594 0.757 . . . . 0.0 112.081 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 1.34 ' CD ' ' HB2' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -88.57 -46.64 8.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.886 1.274 . . . . 0.0 111.908 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 CA--C 1.535 0.395 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -159.761 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 1.169 ' O ' ' HD3' ' A' ' 7' ' ' LYS . 3.9 mm? . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 119.531 -0.271 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.17 -19.84 23.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.4 m -75.49 -45.41 38.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.5 -40.23 86.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.393 0.677 . . . . 0.0 110.092 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 1.169 ' HD3' ' O ' ' A' ' 3' ' ' LEU . 4.3 mptp? -64.87 -47.17 78.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.51 0.724 . . . . 0.0 109.955 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -61.83 -46.22 90.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.654 0.782 . . . . 0.0 110.152 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -60.86 -50.79 72.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.956 0.502 . . . . 0.0 110.221 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.79 -28.62 69.7 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.142 0.577 . . . . 0.0 111.291 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -72.09 -41.21 67.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.151 0.58 . . . . 0.0 110.26 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.85 -30.63 34.83 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.3 t -90.01 45.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 159.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.38 -30.16 0.13 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.912 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 20.5 ptmt -88.46 -20.12 25.6 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.741 0.416 . . . . 0.0 110.189 173.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.4 -27.64 61.57 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.01 -48.43 7.21 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.855 1.262 . . . . 0.0 108.314 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.1 t -67.16 -28.9 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.912 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 29.4 tptp -69.95 -34.06 72.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.4 -45.32 48.01 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.74 -30.2 70.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.708 0.403 . . . . 0.0 110.709 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.649 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.656 0.265 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.2 mt -56.67 -37.47 70.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.576 1.151 . . . . 0.0 111.512 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.2 p -90.12 -44.36 9.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.119 0.567 . . . . 0.0 111.255 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.445 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 99.1 m -49.2 -54.19 17.73 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.512 0.725 . . . . 0.0 110.889 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 p -48.86 -32.59 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.671 0.788 . . . . 0.0 111.131 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 t -87.44 -60.07 2.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.539 0.736 . . . . 0.0 111.288 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.787 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 35.2 m -59.36 -8.81 1.9 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.993 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -78.24 29.38 0.18 Allowed 'General case' 0 C--N 1.342 0.241 0 C-N-CA 118.61 -1.236 . . . . 0.0 113.023 -163.319 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 31' ' ' CYS . 87.5 mt -59.56 -41.3 89.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 166.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.56 44.99 1.62 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.875 0.87 . . . . 0.0 109.534 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? 48.91 46.06 22.24 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.847 1.259 . . . . 0.0 110.788 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.787 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 57.6 m . . . . . 0 N--CA 1.454 -0.24 0 C-N-CA 123.063 0.545 . . . . 0.0 112.146 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 70.8 mt . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.1 -11.49 41.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.803 0.841 . . . . 0.0 109.156 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 88.1 m -74.36 -59.32 2.78 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -172.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.0 mt -57.24 -40.0 76.71 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.714 0.405 . . . . 0.0 110.123 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -57.53 -45.47 85.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.227 1.011 . . . . 0.0 111.182 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -58.96 -51.57 69.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.165 0.586 . . . . 0.0 110.225 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -66.18 -39.66 89.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.894 0.478 . . . . 0.0 111.085 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.72 -37.52 84.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 175.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.0 mtpt -81.81 43.38 0.76 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 171.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -164.57 -36.86 0.02 OUTLIER Glycine 0 C--N 1.337 0.617 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.2 46.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 154.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -152.21 -29.34 0.04 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 19' ' ' LYS . 62.1 mtpt -79.85 -41.1 26.99 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.2 -22.49 66.9 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.033 0.933 . . . . 0.0 110.73 173.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.2 mt -90.09 -41.05 11.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.12 0.968 . . . . 0.0 108.586 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.5 -32.38 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 170.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 15' ' ' LYS . 23.4 tptm -70.21 -36.59 74.68 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.6 -41.56 50.5 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.05 82.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 170.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.345 0 C-N-CA 123.111 0.564 . . . . 0.0 111.047 179.487 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.456 -0.131 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.8 mt -53.57 -19.27 3.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.855 1.262 . . . . 0.0 112.575 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.9 m -87.75 -48.95 7.45 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.155 0.582 . . . . 0.0 110.749 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.571 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 94.1 m -48.21 -51.83 23.59 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.528 0.731 . . . . 0.0 111.229 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 m -49.48 -39.94 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 124.327 1.051 . . . . 0.0 112.263 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.5 p -72.6 -56.13 5.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.307 0.243 . . . . 0.0 110.661 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.7 p -81.91 27.16 0.47 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.516 0.726 . . . . 0.0 111.256 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 28' ' ' THR . 13.5 tmtt? -88.37 -41.7 12.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.978 0.511 . . . . 0.0 111.92 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 tp -48.53 -65.6 0.54 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.534 1.134 . . . . 0.0 111.528 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.22 -11.0 60.36 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.573 0.349 . . . . 0.0 111.524 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 16.4 tptm 48.49 51.74 14.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.824 2.049 . . . . 0.0 112.725 176.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 159.804 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.27 -28.98 18.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 168.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -74.86 -55.88 5.34 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.927 0.491 . . . . 0.0 111.646 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.42 -35.26 78.68 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.662 0.385 . . . . 0.0 110.091 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' N ' ' CD ' ' A' ' 7' ' ' LYS . 11.6 mptt -67.14 -39.76 86.63 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.776 1.23 . . . . 0.0 110.607 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -63.67 -47.5 80.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.551 0.741 . . . . 0.0 109.694 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -66.26 -45.49 80.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.045 0.538 . . . . 0.0 110.388 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 12' ' ' GLY . . . -61.32 -38.96 88.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 173.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -81.02 41.7 0.6 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.564 0.746 . . . . 0.0 109.245 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -162.88 -38.49 0.02 OUTLIER Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.68 45.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 155.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -146.56 -31.52 0.07 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 19' ' ' LYS . 97.2 mttt -79.6 -41.26 27.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 170.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -65.99 -17.53 64.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.087 0.955 . . . . 0.0 111.08 173.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 mt -90.1 -41.74 11.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -65.42 -32.31 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.4 tmtp? -69.28 -34.74 75.19 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.204 0.601 . . . . 0.0 109.874 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.02 -47.94 50.96 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.75 -30.17 70.78 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.078 0.551 . . . . 0.0 110.982 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.085 0 CA-C-N 117.493 0.133 . . . . 0.0 111.014 -179.238 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.38 -39.18 69.81 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.638 0.775 . . . . 0.0 110.661 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 t -63.96 -51.48 64.16 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.922 0.489 . . . . 0.0 110.432 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.862 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 62.4 m -60.72 -49.2 78.47 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.617 0.367 . . . . 0.0 110.246 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.87 -34.58 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.449 0.699 . . . . 0.0 110.607 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.2 t -72.37 -62.0 1.6 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.5 p -75.51 20.12 0.17 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.778 0.431 . . . . 0.0 111.55 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.862 ' HB2' ' O ' ' A' ' 28' ' ' THR . 41.1 ttmt -90.07 -34.17 16.03 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.605 0.762 . . . . 0.0 111.332 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.3 tp -57.15 -53.62 56.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.571 ' C ' ' H ' ' A' ' 36' ' ' THR . . . -80.69 78.58 7.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 160.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -63.39 22.75 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 126.561 1.944 . . . . 0.0 112.106 -171.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.571 ' H ' ' C ' ' A' ' 34' ' ' ALA . 15.2 t . . . . . 0 CA--C 1.532 0.281 0 O-C-N 121.947 -0.47 . . . . 0.0 109.82 169.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -90.21 -20.78 22.62 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.0 m -73.3 -50.61 21.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.52 -33.67 76.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 173.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.33 -45.03 96.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.963 0.905 . . . . 0.0 110.499 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -51.05 -52.21 45.49 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.453 1.101 . . . . 0.0 110.509 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -79.67 -30.54 41.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.563 0.745 . . . . 0.0 111.711 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.53 91.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.64 0.376 . . . . 0.0 110.82 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -64.86 -30.07 71.05 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.228 0.611 . . . . 0.0 110.654 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -76.24 -30.34 57.15 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 t -87.38 36.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 162.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -127.96 -33.77 0.58 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.245 -2.342 . . . . 0.0 107.245 170.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 19' ' ' LYS . 70.5 mmtt -73.97 -45.8 47.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.57 0.748 . . . . 0.0 109.421 172.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.19 -18.42 65.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.376 0.67 . . . . 0.0 110.472 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.99 -43.39 10.57 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.089 1.355 . . . . 0.0 107.897 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.0 t -63.3 -33.93 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -70.58 -32.49 69.89 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.753 0.421 . . . . 0.0 109.893 175.349 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.46 -45.85 44.23 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.02 -29.45 69.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.917 0.487 . . . . 0.0 110.921 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.13 0 CA-C-N 117.534 0.152 . . . . 0.0 111.005 -179.405 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -54.53 -36.8 64.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.065 0.946 . . . . 0.0 111.353 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 80.4 p -67.64 -48.47 66.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.414 0.285 . . . . 0.0 110.646 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.629 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 66.0 m -57.7 -46.87 83.76 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.068 0.547 . . . . 0.0 110.47 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.8 t -54.23 -31.78 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.573 0.749 . . . . 0.0 110.721 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.8 m -89.98 -48.37 7.25 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.995 0.518 . . . . 0.0 111.412 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.509 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 74.7 m -57.18 -19.07 18.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.65 0.38 . . . . 0.0 111.75 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.629 ' HB3' ' O ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -76.32 24.39 0.14 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -158.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.5 tp -60.33 -49.07 79.07 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.29 45.4 1.85 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.872 0.869 . . . . 0.0 108.9 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 45.52 57.94 4.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.3 1.44 . . . . 0.0 111.057 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 59.0 m . . . . . 0 N--CA 1.453 -0.321 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.057 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 1.128 ' O ' ' HD2' ' A' ' 7' ' ' LYS . 89.8 mt . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -90.1 -25.37 20.77 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.4 m -75.04 -48.59 23.26 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 123.375 0.422 . . . . 0.0 110.342 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.72 -38.52 91.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 1.128 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 0.6 OUTLIER -62.7 -41.07 98.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.92 0.888 . . . . 0.0 110.529 178.855 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -52.32 -43.41 64.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.93 0.892 . . . . 0.0 110.709 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -90.05 -39.36 12.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.605 0.762 . . . . 0.0 111.59 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.76 -38.88 76.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.204 0.602 . . . . 0.0 111.857 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -67.7 -35.16 78.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 119.473 -0.299 . . . . 0.0 110.748 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -71.53 -24.85 76.31 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.58 49.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 160.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -148.43 -33.97 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 174.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -72.29 -43.6 63.99 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.152 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.66 -23.48 67.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.514 0.726 . . . . 0.0 111.045 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.4 mt -88.46 -37.59 15.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 t -66.65 -29.94 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -79.89 1.69 26.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.127 0.571 . . . . 0.0 110.585 174.46 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.03 -68.38 0.35 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.42 -63.91 1.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.643 0.777 . . . . 0.0 110.891 177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.396 0 C-N-CA 123.803 0.841 . . . . 0.0 110.767 -177.763 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.8 mt -50.89 -39.44 54.23 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.486 1.114 . . . . 0.0 111.81 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.9 p -80.8 -42.05 22.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.761 0.424 . . . . 0.0 110.896 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.5 m -62.53 -52.35 63.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.302 0.641 . . . . 0.0 110.486 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.11 -36.75 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 122.946 0.499 . . . . 0.0 110.595 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.6 t -67.29 -55.53 13.52 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.511 0.725 . . . . 0.0 110.964 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.1 p -70.92 7.42 1.17 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.649 0.38 . . . . 0.0 111.837 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.699 ' HD2' ' HE3' ' A' ' 35' ' ' LYS . 22.9 ttpp -80.81 59.03 3.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.631 0.729 . . . . 0.0 109.871 -172.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.01 72.27 7.41 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 168.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.17 50.05 3.15 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.617 1.167 . . . . 0.0 110.189 -170.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.699 ' HE3' ' HD2' ' A' ' 32' ' ' LYS . 35.6 mmtp 53.79 67.7 0.96 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.024 1.33 . . . . 0.0 111.425 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.6 m . . . . . 0 N--CA 1.454 -0.255 0 C-N-CA 122.621 0.368 . . . . 0.0 110.206 176.533 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 111.422 0.156 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -90.01 -16.65 29.36 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.873 0.869 . . . . 0.0 108.967 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.0 m -73.26 -51.65 16.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.997 -173.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.3 mt -66.41 -36.29 82.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.946 0.499 . . . . 0.0 109.959 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -57.08 -46.94 82.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.905 0.882 . . . . 0.0 110.554 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -57.79 -49.32 77.0 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.127 0.971 . . . . 0.0 110.209 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 13' ' ' VAL . 88.7 t80 -65.99 -43.02 89.03 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.238 0.615 . . . . 0.0 110.927 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.54 95.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.074 0.55 . . . . 0.0 111.74 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -82.05 -18.62 42.56 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 117.923 0.328 . . . . 0.0 111.151 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.18 -28.85 47.84 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 170.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 9' ' ' PHE . 46.5 t -89.02 47.22 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 158.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.26 -28.35 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.884 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 3.0 pptp? -89.07 -22.66 22.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.895 0.478 . . . . 0.0 109.923 173.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.75 -27.0 62.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.147 0.579 . . . . 0.0 109.549 167.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.1 mt -90.16 -48.09 7.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.324 1.049 . . . . 0.0 108.964 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 t -65.96 -31.95 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.884 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 1.2 tmtp? -67.4 -39.63 85.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.195 0.598 . . . . 0.0 109.72 173.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.17 -41.87 59.19 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.42 -35.06 79.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 170.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.277 0 C-N-CA 122.821 0.449 . . . . 0.0 111.648 179.515 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.21 -36.05 82.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.56 0.744 . . . . 0.0 110.228 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.4 m -64.62 -47.1 79.8 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.118 0.567 . . . . 0.0 110.403 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.744 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 98.0 m -57.25 -50.38 73.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.076 0.55 . . . . 0.0 110.367 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.7 t -54.56 -33.22 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.815 0.846 . . . . 0.0 110.948 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.4 t -73.16 -62.63 1.4 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.192 0.197 . . . . 0.0 110.611 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -75.78 16.41 0.4 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.448 0.299 . . . . 0.0 111.621 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.744 ' HB2' ' O ' ' A' ' 28' ' ' THR . 68.5 tttt -90.2 -31.93 16.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.059 0.543 . . . . 0.0 111.49 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.2 tp -51.23 -64.13 0.91 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.794 0.838 . . . . 0.0 110.995 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.69 -7.47 59.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.811 0.444 . . . . 0.0 111.352 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.1 tptm 46.46 58.7 4.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.271 1.828 . . . . 0.0 112.167 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 161.352 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -90.23 -15.62 31.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.8 m -68.51 -47.0 68.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -59.58 -38.72 81.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.663 0.785 . . . . 0.0 110.567 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -63.83 -51.06 66.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -57.62 -48.9 78.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.086 0.955 . . . . 0.0 109.805 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -60.67 -44.72 96.14 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.412 0.685 . . . . 0.0 110.756 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.48 96.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.589 0.356 . . . . 0.0 110.238 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -82.83 42.71 0.8 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.573 ' O ' ' OD2' ' A' ' 16' ' ' ASP . . . -157.28 -37.74 0.02 OUTLIER Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 t -87.24 47.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 152.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -136.97 -36.32 0.18 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 174.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 19' ' ' LYS . 5.0 mmpt? -66.54 -39.85 88.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.705 0.802 . . . . 0.0 109.194 169.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.573 ' OD2' ' O ' ' A' ' 12' ' ' GLY . 3.5 m-20 -65.26 -25.98 67.9 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.431 1.093 . . . . 0.0 111.07 175.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.3 mt -90.1 -39.89 12.6 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.63 -30.84 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 15' ' ' LYS . 64.7 tttp -71.71 -36.87 70.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.052 0.541 . . . . 0.0 109.843 174.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.51 -41.93 56.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.58 80.88 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.309 0 C-N-CA 122.92 0.488 . . . . 0.0 111.633 -179.72 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.416 0.15 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.23 -37.66 72.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.25 1.02 . . . . 0.0 110.813 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -80.06 -41.64 25.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.135 0.574 . . . . 0.0 110.727 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 90.6 m -65.5 -50.35 65.63 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.27 0.628 . . . . 0.0 111.113 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.21 -41.25 86.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 122.784 0.433 . . . . 0.0 110.73 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.1 m -71.46 -46.82 58.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.197 0.599 . . . . 0.0 110.165 176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.2 t -65.35 -12.01 47.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.214 0.606 . . . . 0.0 111.199 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 1.292 ' CD ' ' HD3' ' A' ' 35' ' ' LYS . 19.7 ttpp -87.27 63.49 7.81 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.799 0.809 . . . . 0.0 109.452 -172.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.56 -57.99 4.51 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 168.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.02 47.92 1.71 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.991 0.917 . . . . 0.0 108.699 171.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 1.292 ' HD3' ' CD ' ' A' ' 32' ' ' LYS . 3.0 mmmp? 49.11 56.6 7.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.942 1.297 . . . . 0.0 111.016 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.891 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -90.12 -27.3 19.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 173.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.7 m -68.41 -44.41 75.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 123.346 0.404 . . . . 0.0 110.19 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.3 mt -58.11 -45.24 87.6 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.713 0.805 . . . . 0.0 110.322 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.83 -48.07 82.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.807 0.843 . . . . 0.0 110.71 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.46 -51.35 69.82 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.805 0.842 . . . . 0.0 109.762 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -57.91 -50.89 71.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.164 0.586 . . . . 0.0 110.51 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.75 -33.68 74.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.029 0.532 . . . . 0.0 110.744 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -73.99 -30.93 62.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.968 0.507 . . . . 0.0 110.16 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -76.19 -31.01 56.26 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 173.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -86.16 43.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 160.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -141.33 -32.69 0.13 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 107.343 -2.303 . . . . 0.0 107.343 172.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 19' ' ' LYS . 70.7 mmtt -68.73 -40.93 79.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.376 0.67 . . . . 0.0 109.416 169.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -64.05 -26.19 68.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.714 0.806 . . . . 0.0 110.664 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.4 mt -90.04 -41.34 11.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.237 1.015 . . . . 0.0 108.869 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.9 t -65.31 -29.02 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 171.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 15' ' ' LYS . 23.4 tptm -72.58 -37.06 68.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.869 0.467 . . . . 0.0 109.772 175.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.85 -42.55 52.8 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.85 80.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.287 0 C-N-CA 122.825 0.45 . . . . 0.0 111.645 179.579 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.8 mt -59.87 -40.42 88.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.047 0.939 . . . . 0.0 110.36 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.6 m -70.2 -40.84 74.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.988 0.515 . . . . 0.0 110.642 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.992 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 26.1 m -69.88 -7.09 37.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.13 -39.21 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 166.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -76.3 -64.17 1.16 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.057 0.543 . . . . 0.0 110.198 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 6.8 p -77.67 43.33 0.4 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 119.435 -0.317 . . . . 0.0 110.393 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.992 ' HB2' ' O ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -90.11 -56.13 3.34 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 178.147 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 tt -29.88 -75.0 0.03 OUTLIER 'General case' 0 C--N 1.343 0.29 0 C-N-CA 126.021 1.728 . . . . 0.0 113.264 -148.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.35 59.23 1.35 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -141.76 -65.52 0.42 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.032 0.933 . . . . 0.0 110.815 -162.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 123.63 0.772 . . . . 0.0 109.472 -159.369 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.038 0 N-CA-C 112.271 -0.332 . . . . 0.0 112.271 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -35.54 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 123.98 0.912 . . . . 0.0 110.867 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.992 ' O ' ' HD2' ' A' ' 7' ' ' LYS . 82.6 mt -72.48 -18.27 61.69 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.974 0.51 . . . . 0.0 112.186 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -90.08 -26.76 20.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.2 m -68.78 -56.88 6.61 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.293 -172.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.5 mt -59.99 -36.55 77.42 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.106 0.562 . . . . 0.0 110.546 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.992 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 0.4 OUTLIER -62.61 -41.96 99.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.362 0.665 . . . . 0.0 110.286 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.16 -57.67 11.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.447 0.699 . . . . 0.0 110.387 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -65.16 -38.62 91.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.962 0.505 . . . . 0.0 111.174 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.44 96.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -81.25 47.55 1.04 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -166.15 -34.59 0.02 OUTLIER Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.1 t -87.6 46.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 154.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -154.08 -30.31 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 19' ' ' LYS . 48.1 tptt -74.79 -39.24 61.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 123.87 0.868 . . . . 0.0 109.061 170.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.41 -24.02 67.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.089 0.955 . . . . 0.0 110.834 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -89.98 -42.3 11.24 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.8 t -63.2 -31.58 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 170.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 15' ' ' LYS . 87.1 tttt -71.71 -36.2 70.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.891 0.476 . . . . 0.0 109.938 175.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.0 -40.75 56.42 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.59 88.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 170.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.07 36.54 0.87 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.942 0.497 . . . . 0.0 111.485 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -90.03 -56.79 3.09 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.218 0.607 . . . . 0.0 111.262 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.72 -72.05 1.27 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -171.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.3 t -86.37 -53.12 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 126.857 2.063 . . . . 0.0 110.551 0.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.564 ' O ' ' HB3' ' A' ' 30' ' ' SER . 86.0 mt -56.84 -33.42 66.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.839 0.855 . . . . 0.0 111.664 -175.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.873 ' O ' ' CB ' ' A' ' 31' ' ' CYS . 78.1 p -67.42 -40.33 85.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.788 0.435 . . . . 0.0 110.925 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 94.5 m -77.64 -51.88 9.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.352 0.661 . . . . 0.0 110.274 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.63 -49.07 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 123.388 0.675 . . . . 0.0 110.351 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.564 ' HB3' ' O ' ' A' ' 26' ' ' LEU . 34.8 t -66.38 -45.92 78.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.873 ' CB ' ' O ' ' A' ' 27' ' ' SER . 50.2 t -60.31 -15.61 26.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.7 0.8 . . . . 0.0 111.492 174.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 28' ' ' THR . 9.1 ttmm -80.43 56.96 2.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.191 0.52 . . . . 0.0 110.997 -171.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.3 mp -67.27 -57.11 7.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.09 43.13 2.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.057 0.943 . . . . 0.0 108.521 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.784 ' HE2' ' O ' ' A' ' 37' ' ' CYS . 22.2 tptm 48.59 61.74 2.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.06 1.344 . . . . 0.0 110.901 -175.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.3 p -89.51 10.27 23.44 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.092 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.784 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 87.4 m . . . . . 0 C--N 1.342 0.253 0 C-N-CA 123.935 0.894 . . . . 0.0 109.289 169.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.039 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.5 tp -59.48 -31.0 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 123.839 0.856 . . . . 0.0 110.65 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.657 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 81.4 mt -74.28 -21.38 59.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.121 0.568 . . . . 0.0 111.842 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -90.14 -23.52 21.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -69.86 -55.8 8.81 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 pp -63.31 -32.79 74.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.851 0.46 . . . . 0.0 110.576 174.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 1.5 tppp? -58.05 -47.46 83.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.263 1.025 . . . . 0.0 110.717 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -49.37 -54.02 19.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.782 1.233 . . . . 0.0 110.791 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -66.62 -42.64 86.47 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.071 0.549 . . . . 0.0 111.014 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.9 91.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.884 0.473 . . . . 0.0 110.978 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -69.26 -28.76 66.6 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.688 0.395 . . . . 0.0 110.505 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -74.52 -28.16 64.03 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.1 t -86.73 42.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 162.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -142.5 -32.19 0.11 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 172.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 7.2 mtpm? -77.31 -36.69 53.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.561 0.744 . . . . 0.0 109.3 172.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.55 -24.23 66.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.548 0.739 . . . . 0.0 110.371 173.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.1 mt -90.05 -45.74 8.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.002 0.921 . . . . 0.0 109.138 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.5 t -66.32 -27.89 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 65.2 tttm -74.51 -38.58 62.78 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.159 0.584 . . . . 0.0 110.186 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.79 -46.05 40.3 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.63 71.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 122.624 0.37 . . . . 0.0 110.039 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.16 -17.24 40.67 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -76.39 -41.88 46.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.051 0.54 . . . . 0.0 111.018 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -129.95 72.03 0.49 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 t -60.15 -52.2 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 123.005 0.522 . . . . 0.0 110.698 -166.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.41 -40.09 85.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.684 0.794 . . . . 0.0 111.364 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.6 p -67.41 -42.55 83.08 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.421 0.289 . . . . 0.0 111.393 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 1.078 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 66.1 m -54.31 -29.5 47.82 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.712 0.805 . . . . 0.0 111.341 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.51 -41.31 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 122.61 0.364 . . . . 0.0 110.056 176.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.0 t -76.24 -61.98 1.76 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.514 0.326 . . . . 0.0 110.319 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.6 p -77.61 31.13 0.16 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.314 0.246 . . . . 0.0 111.32 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 1.078 ' HB3' ' O ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -89.84 -25.65 20.93 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 117.658 0.208 . . . . 0.0 111.434 175.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.22 2.29 0.6 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.04 2.05 1.15 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.705 0.802 . . . . 0.0 111.007 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 48.4 33.49 3.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.055 1.342 . . . . 0.0 112.205 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.5 p -69.1 -27.8 65.92 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 166.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.9 m . . . . . 0 N--CA 1.45 -0.444 0 C-N-CA 124.719 1.208 . . . . 0.0 109.272 178.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.052 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -84.29 37.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.634 0.774 . . . . 0.0 110.652 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.24 -34.27 25.88 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.007 0.923 . . . . 0.0 111.594 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -90.13 -17.81 26.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -69.76 -54.13 15.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -174.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 pp -59.63 -34.71 73.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.642 0.377 . . . . 0.0 110.852 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.23 -42.77 96.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.784 0.833 . . . . 0.0 110.832 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -56.73 -56.11 25.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.622 0.769 . . . . 0.0 110.458 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -69.15 -31.89 70.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.88 0.472 . . . . 0.0 111.462 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.56 86.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -83.76 54.21 2.81 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 169.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -166.42 -52.83 0.03 OUTLIER Glycine 0 C--N 1.337 0.616 0 C-N-CA 124.574 1.083 . . . . 0.0 113.058 -170.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.46 0.35 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 150.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -107.8 -18.2 10.29 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.919 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 35.4 mmtp -89.13 -19.95 24.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.403 1.081 . . . . 0.0 109.797 168.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.43 -30.55 61.95 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 167.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.22 -43.86 10.13 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.137 0.975 . . . . 0.0 108.614 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -67.81 -27.54 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.949 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.919 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 13.4 tmtt? -68.43 -39.98 81.34 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.065 0.546 . . . . 0.0 109.665 172.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.15 -40.99 60.93 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.91 73.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.03 37.45 0.89 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.742 0.417 . . . . 0.0 110.929 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -90.05 -59.95 2.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.389 0.675 . . . . 0.0 109.482 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -171.29 56.46 0.18 Allowed Glycine 0 C--N 1.338 0.658 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 p -85.56 -42.99 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 123.113 0.565 . . . . 0.0 110.49 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.4 mt -56.47 -38.95 72.41 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.0 0.92 . . . . 0.0 110.828 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.8 p -68.97 -45.11 71.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.107 0.563 . . . . 0.0 110.662 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 89.7 m -54.82 -43.28 72.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.162 0.585 . . . . 0.0 111.139 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.29 -39.1 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.504 0.722 . . . . 0.0 110.798 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 t -72.54 -60.69 2.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.536 0.335 . . . . 0.0 110.484 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 6.0 p -78.46 29.18 0.19 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.897 0.479 . . . . 0.0 111.411 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.618 ' HB2' ' O ' ' A' ' 28' ' ' THR . 5.7 tmtt? -90.11 -52.43 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.38 1.072 . . . . 0.0 110.083 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.5 tp -50.2 -59.3 4.07 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.141 0.976 . . . . 0.0 110.926 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.09 -19.54 64.07 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 120.947 0.403 . . . . 0.0 111.55 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.6 tptm 56.64 55.51 6.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.53 1.932 . . . . 0.0 112.306 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.3 p -97.51 14.06 27.78 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 164.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 77.6 m . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 123.827 0.851 . . . . 0.0 109.969 -178.709 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.016 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.34 -34.95 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.692 0.797 . . . . 0.0 109.866 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.67 -22.91 63.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.098 0.559 . . . . 0.0 111.876 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -90.27 -21.31 22.16 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.6 m -72.03 -53.03 14.18 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.47 -32.09 73.44 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.917 0.487 . . . . 0.0 110.679 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -62.3 -46.47 88.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.77 0.828 . . . . 0.0 110.155 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -60.56 -50.79 72.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.01 0.924 . . . . 0.0 109.794 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -59.72 -49.47 77.62 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.991 0.516 . . . . 0.0 110.562 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.08 90.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.943 0.497 . . . . 0.0 110.456 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.99 -33.87 76.51 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.214 0.606 . . . . 0.0 110.466 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -77.38 -30.07 54.75 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.614 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 t -88.42 41.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 161.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -143.4 -29.15 0.12 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 176.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 19' ' ' LYS . 75.1 mmtt -85.75 -41.53 15.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.4 -18.17 64.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.645 0.778 . . . . 0.0 110.511 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.9 tp -87.68 -43.75 11.7 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.54 -32.85 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 15' ' ' LYS . 64.6 tttm -69.7 -32.11 70.52 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.76 0.424 . . . . 0.0 110.102 175.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.39 -47.2 29.77 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.96 -30.87 71.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.944 0.498 . . . . 0.0 110.917 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.13 -29.25 67.26 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.347 0.259 . . . . 0.0 111.366 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -55.71 -37.88 68.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.767 0.827 . . . . 0.0 111.071 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.22 80.72 0.11 Allowed Glycine 0 C--N 1.339 0.716 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.2 m -60.45 -47.51 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 122.991 0.517 . . . . 0.0 110.629 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.8 mt -59.08 -39.31 81.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.745 0.818 . . . . 0.0 110.371 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.9 t -67.87 -39.06 83.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.86 0.464 . . . . 0.0 110.733 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.765 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 39.0 m -65.48 -37.6 87.32 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.517 0.327 . . . . 0.0 110.746 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.53 -30.76 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.044 0.537 . . . . 0.0 110.405 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.9 t -81.67 -55.8 4.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.845 0.458 . . . . 0.0 109.896 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.2 t -57.65 -12.37 2.82 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.665 1.186 . . . . 0.0 111.647 175.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.765 ' HB2' ' O ' ' A' ' 28' ' ' THR . 11.9 tppt? -75.72 -42.73 49.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.13 0.972 . . . . 0.0 109.737 -175.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.7 mt -44.88 -55.15 5.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.415 1.086 . . . . 0.0 110.903 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.75 -28.41 36.51 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.276 0.56 . . . . 0.0 111.454 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 tptt 64.97 79.79 0.25 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.339 1.856 . . . . 0.0 111.104 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.3 t -129.65 16.12 5.9 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.843 162.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 56.6 m . . . . . 0 C--N 1.344 0.329 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 172.602 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.056 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.29 -26.4 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.733 1.613 . . . . 0.0 110.156 -0.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.23 -28.15 69.16 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.827 0.851 . . . . 0.0 112.378 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -90.19 -12.68 37.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.684 0.793 . . . . 0.0 110.146 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 97.9 m -61.27 -52.95 62.57 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.5 -37.21 86.76 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.305 0.642 . . . . 0.0 110.651 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -60.36 -39.31 86.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.199 0.6 . . . . 0.0 110.568 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.08 -55.94 28.16 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.836 0.854 . . . . 0.0 110.259 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -68.41 -34.41 75.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.922 0.489 . . . . 0.0 111.378 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.69 98.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.85 53.39 2.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.61 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -170.95 -46.21 0.04 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 124.656 1.122 . . . . 0.0 113.02 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.4 t -78.99 28.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 143.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.61 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -126.26 -27.02 1.14 Allowed Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 167.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.709 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 45.5 mmtm -81.13 -29.85 34.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.08 0.952 . . . . 0.0 110.111 173.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.4 -27.29 63.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.17 -43.19 10.6 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.308 1.043 . . . . 0.0 108.264 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -66.36 -27.64 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 119.356 -0.938 . . . . 0.0 108.718 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.709 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 57.6 tptt -72.62 -36.85 68.15 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.11 0.564 . . . . 0.0 109.711 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.5 -41.93 56.82 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.55 80.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.05 28.48 1.38 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.875 0.47 . . . . 0.0 111.555 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -88.6 -60.58 1.92 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.108 0.563 . . . . 0.0 109.617 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.45 81.25 0.08 OUTLIER Glycine 0 C--N 1.337 0.603 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.95 -52.09 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.564 0.746 . . . . 0.0 110.236 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.9 mt -54.7 -31.77 58.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.999 0.92 . . . . 0.0 111.115 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.2 t -82.19 -46.25 14.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.228 0.611 . . . . 0.0 110.476 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.1 m -63.53 -56.61 14.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.309 0.643 . . . . 0.0 110.57 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.6 p -49.66 -35.16 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.088 0.955 . . . . 0.0 111.876 -176.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.4 t -69.44 -60.91 2.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.116 0.567 . . . . 0.0 111.134 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 12.3 p -66.46 1.63 1.59 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 119.116 -0.469 . . . . 0.0 112.068 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 1.348 ' HD3' ' CD ' ' A' ' 35' ' ' LYS . 26.5 mmtm -90.04 52.46 2.28 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.642 0.655 . . . . 0.0 109.286 175.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.1 tp -76.44 -61.04 2.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.99 44.65 2.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 1.348 ' CD ' ' HD3' ' A' ' 32' ' ' LYS . 46.5 mmtm 49.28 61.15 3.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.968 1.307 . . . . 0.0 110.879 -171.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.7 m -61.28 -41.68 97.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 169.678 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.067 0 N-CA-C 112.391 -0.284 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.8 -34.46 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.696 0.799 . . . . 0.0 109.914 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.52 -23.59 62.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.388 0.675 . . . . 0.0 112.01 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.15 -21.28 22.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.1 m -71.73 -45.04 63.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.08 -39.97 96.29 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.592 0.757 . . . . 0.0 110.038 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.644 ' HE3' ' HD2' ' A' ' 11' ' ' LYS . 56.7 tptt -59.01 -47.15 86.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.714 0.806 . . . . 0.0 110.559 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -61.12 -47.48 86.08 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.696 0.798 . . . . 0.0 110.022 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -62.5 -42.95 99.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.307 0.643 . . . . 0.0 110.586 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.02 96.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.666 0.386 . . . . 0.0 110.105 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.644 ' HD2' ' HE3' ' A' ' 7' ' ' LYS . 63.6 mtpt -81.71 43.36 0.75 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 171.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.21 -36.46 0.02 OUTLIER Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.98 41.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 153.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.24 -32.77 0.48 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.89 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 22.7 pttp -90.06 -25.17 20.92 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.363 0.665 . . . . 0.0 110.328 173.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.7 -26.42 63.41 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 167.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -89.98 -51.68 5.35 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.127 1.371 . . . . 0.0 108.223 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.6 t -65.42 -29.99 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.89 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 13.3 tmtt? -66.61 -39.66 88.44 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 173.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.32 -44.04 60.7 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.81 77.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 171.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.47 -18.69 44.35 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -58.76 -42.63 89.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.294 0.638 . . . . 0.0 110.715 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -157.46 79.17 0.18 Allowed Glycine 0 C--N 1.338 0.641 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.95 -51.27 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 122.973 0.509 . . . . 0.0 109.82 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.8 mt -56.97 -43.51 81.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.853 0.861 . . . . 0.0 110.473 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 m -65.3 -47.26 77.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.759 0.423 . . . . 0.0 110.075 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.834 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 2.3 m -82.49 36.26 0.47 Allowed 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.978 0.174 . . . . 0.0 110.804 178.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.55 -43.17 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 148.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.7 m -74.4 -58.79 3.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.469 0.708 . . . . 0.0 110.203 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.5 p -78.91 39.14 0.36 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.321 -0.371 . . . . 0.0 111.189 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.834 ' HD3' ' O ' ' A' ' 28' ' ' THR . 13.6 mmmm -81.37 -64.07 1.26 Allowed 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.268 0.486 . . . . 0.0 112.05 165.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 32.4 tp -29.89 71.45 0.0 OUTLIER 'General case' 0 C--N 1.339 0.148 0 C-N-CA 128.352 2.661 . . . . 0.0 113.306 -163.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 32' ' ' LYS . . . 67.62 57.54 0.54 Allowed 'General case' 0 C--O 1.23 0.055 0 C-N-CA 125.716 1.606 . . . . 0.0 110.087 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.48 ' CB ' ' H ' ' A' ' 37' ' ' CYS . 82.2 mttt -144.31 -57.43 0.37 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.739 1.616 . . . . 0.0 109.605 -170.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.3 p 56.49 16.89 2.7 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.657 1.183 . . . . 0.0 109.914 -155.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.48 ' H ' ' CB ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 C-N-CA 125.021 1.328 . . . . 0.0 111.189 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.083 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.8 tp -83.17 -27.42 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 125.607 1.563 . . . . 0.0 110.636 -1.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.1 mt -67.34 -20.87 65.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.176 0.59 . . . . 0.0 112.443 -176.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -90.25 -18.82 24.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.489 0.716 . . . . 0.0 109.758 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -64.06 -47.46 80.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.3 -39.93 94.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.243 0.617 . . . . 0.0 110.532 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -63.04 -44.34 96.17 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.47 0.708 . . . . 0.0 110.377 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -56.84 -45.33 82.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.585 1.154 . . . . 0.0 110.222 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -76.98 -29.56 55.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.116 0.566 . . . . 0.0 111.282 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.68 94.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.745 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.58 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 9.1 ptpp? -83.72 44.33 0.98 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.936 0.494 . . . . 0.0 109.867 172.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -161.83 -49.12 0.02 OUTLIER Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.77 1.176 . . . . 0.0 112.862 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 91.9 t -68.34 4.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 148.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.578 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -112.72 -15.36 9.45 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.913 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 98.8 mttt -89.97 -29.76 18.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.803 0.841 . . . . 0.0 109.327 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.02 -26.94 64.29 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 167.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -89.45 -46.98 8.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.797 1.239 . . . . 0.0 108.591 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.6 t -65.83 -26.78 39.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.97 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.913 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 40.5 ttmt -71.84 -38.21 70.16 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.771 0.429 . . . . 0.0 109.848 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.82 -41.78 55.0 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.87 -33.63 75.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 170.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.07 26.03 1.98 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.89 0.476 . . . . 0.0 111.638 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -79.47 -53.25 7.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.93 78.4 0.13 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.58 -57.69 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 123.199 0.599 . . . . 0.0 109.945 -175.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.37 -32.98 70.62 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.76 0.824 . . . . 0.0 110.763 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 t -70.57 -39.33 73.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.75 0.42 . . . . 0.0 110.766 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.688 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 87.4 m -65.63 -35.12 79.88 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.678 0.217 . . . . 0.0 111.288 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.9 t -51.11 -30.8 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 122.788 0.435 . . . . 0.0 110.459 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.2 t -73.98 -62.1 1.62 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.928 0.491 . . . . 0.0 112.276 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 1.34 ' HB2' ' CD ' ' A' ' 35' ' ' LYS . 10.5 p -52.54 -27.29 15.98 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.688 ' HB2' ' O ' ' A' ' 28' ' ' THR . 62.2 tttp -79.06 65.78 4.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.666 1.222 . . . . 0.0 110.386 -158.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.3 mt -87.67 -53.15 4.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.078 -1.874 . . . . 0.0 108.495 166.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.09 0.19 0.32 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.594 0.757 . . . . 0.0 112.081 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 1.34 ' CD ' ' HB2' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -88.57 -46.64 8.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.886 1.274 . . . . 0.0 111.908 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.5 ' O ' ' HB2' ' A' ' 37' ' ' CYS . 4.8 m 61.7 13.26 5.19 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -159.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 36' ' ' THR . 1.7 m . . . . . 0 C--N 1.345 0.385 0 C-N-CA 123.928 0.891 . . . . 0.0 110.131 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.047 0 N-CA-C 112.385 -0.286 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.86 -30.01 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.168 0.587 . . . . 0.0 109.738 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 1.169 ' O ' ' HD3' ' A' ' 7' ' ' LYS . 3.9 mm? -64.51 -26.54 68.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.266 0.626 . . . . 0.0 111.662 174.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.17 -19.84 23.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.4 m -75.49 -45.41 38.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.5 -40.23 86.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.393 0.677 . . . . 0.0 110.092 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 1.169 ' HD3' ' O ' ' A' ' 3' ' ' LEU . 4.3 mptp? -64.87 -47.17 78.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.51 0.724 . . . . 0.0 109.955 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -61.83 -46.22 90.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.654 0.782 . . . . 0.0 110.152 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -60.86 -50.79 72.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.956 0.502 . . . . 0.0 110.221 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.79 -28.62 69.7 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.142 0.577 . . . . 0.0 111.291 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -72.09 -41.21 67.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.151 0.58 . . . . 0.0 110.26 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.85 -30.63 34.83 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.3 t -90.01 45.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 159.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.38 -30.16 0.13 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.912 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 20.5 ptmt -88.46 -20.12 25.6 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.741 0.416 . . . . 0.0 110.189 173.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.4 -27.64 61.57 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.01 -48.43 7.21 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.855 1.262 . . . . 0.0 108.314 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.1 t -67.16 -28.9 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.912 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 29.4 tptp -69.95 -34.06 72.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.4 -45.32 48.01 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.74 -30.2 70.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.708 0.403 . . . . 0.0 110.709 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.98 -17.48 64.7 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -55.57 -41.3 73.1 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.617 0.767 . . . . 0.0 110.937 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.84 77.61 0.1 Allowed Glycine 0 C--N 1.337 0.631 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -53.82 -42.41 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 123.468 0.707 . . . . 0.0 111.057 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.2 mt -56.67 -37.47 70.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.576 1.151 . . . . 0.0 111.512 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.2 p -90.12 -44.36 9.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.119 0.567 . . . . 0.0 111.255 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.445 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 99.1 m -49.2 -54.19 17.73 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.512 0.725 . . . . 0.0 110.889 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 p -48.86 -32.59 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.671 0.788 . . . . 0.0 111.131 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 t -87.44 -60.07 2.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.539 0.736 . . . . 0.0 111.288 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.787 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 35.2 m -59.36 -8.81 1.9 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.993 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -78.24 29.38 0.18 Allowed 'General case' 0 C--N 1.342 0.241 0 C-N-CA 118.61 -1.236 . . . . 0.0 113.023 -163.319 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 31' ' ' CYS . 87.5 mt -59.56 -41.3 89.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 166.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.56 44.99 1.62 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.875 0.87 . . . . 0.0 109.534 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? 48.91 46.06 22.24 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.847 1.259 . . . . 0.0 110.788 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.787 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 57.6 m -73.06 -18.42 61.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.063 0.545 . . . . 0.0 112.146 -169.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 C--N 1.341 0.212 0 C-N-CA 122.779 0.432 . . . . 0.0 110.074 177.036 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.079 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.0 pt -80.5 53.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.73 0.812 . . . . 0.0 110.278 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 70.8 mt -84.13 -46.13 12.26 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.655 0.782 . . . . 0.0 111.416 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.1 -11.49 41.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.803 0.841 . . . . 0.0 109.156 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 88.1 m -74.36 -59.32 2.78 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -172.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.0 mt -57.24 -40.0 76.71 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.714 0.405 . . . . 0.0 110.123 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -57.53 -45.47 85.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.227 1.011 . . . . 0.0 111.182 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -58.96 -51.57 69.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.165 0.586 . . . . 0.0 110.225 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -66.18 -39.66 89.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.894 0.478 . . . . 0.0 111.085 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.72 -37.52 84.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 175.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.0 mtpt -81.81 43.38 0.76 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 171.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -164.57 -36.86 0.02 OUTLIER Glycine 0 C--N 1.337 0.617 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.2 46.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 154.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -152.21 -29.34 0.04 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 19' ' ' LYS . 62.1 mtpt -79.85 -41.1 26.99 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.2 -22.49 66.9 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.033 0.933 . . . . 0.0 110.73 173.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.2 mt -90.09 -41.05 11.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.12 0.968 . . . . 0.0 108.586 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.5 -32.38 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 170.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 15' ' ' LYS . 23.4 tptm -70.21 -36.59 74.68 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.6 -41.56 50.5 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.05 82.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 170.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.06 41.54 1.05 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.111 0.564 . . . . 0.0 111.047 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -90.01 -58.86 2.36 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.375 0.67 . . . . 0.0 110.196 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.58 -79.23 1.21 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t -84.29 -44.19 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 126.132 1.773 . . . . 0.0 109.76 -1.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.8 mt -53.57 -19.27 3.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.855 1.262 . . . . 0.0 112.575 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.9 m -87.75 -48.95 7.45 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.155 0.582 . . . . 0.0 110.749 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.571 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 94.1 m -48.21 -51.83 23.59 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.528 0.731 . . . . 0.0 111.229 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 m -49.48 -39.94 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 124.327 1.051 . . . . 0.0 112.263 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.5 p -72.6 -56.13 5.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.307 0.243 . . . . 0.0 110.661 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.7 p -81.91 27.16 0.47 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.516 0.726 . . . . 0.0 111.256 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 28' ' ' THR . 13.5 tmtt? -88.37 -41.7 12.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.978 0.511 . . . . 0.0 111.92 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 tp -48.53 -65.6 0.54 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.534 1.134 . . . . 0.0 111.528 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.22 -11.0 60.36 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.573 0.349 . . . . 0.0 111.524 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 16.4 tptm 48.49 51.74 14.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.824 2.049 . . . . 0.0 112.725 176.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.3 t -72.97 -16.04 61.53 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 159.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.451 -0.4 0 C-N-CA 124.576 1.15 . . . . 0.0 108.74 177.511 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 N-CA-C 112.308 -0.317 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -90.05 15.32 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.368 1.467 . . . . 0.0 111.732 -1.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.9 mt -78.49 -17.38 56.35 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.206 0.602 . . . . 0.0 111.8 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.27 -28.98 18.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 168.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -74.86 -55.88 5.34 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.927 0.491 . . . . 0.0 111.646 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.42 -35.26 78.68 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.662 0.385 . . . . 0.0 110.091 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' N ' ' CD ' ' A' ' 7' ' ' LYS . 11.6 mptt -67.14 -39.76 86.63 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.776 1.23 . . . . 0.0 110.607 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -63.67 -47.5 80.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.551 0.741 . . . . 0.0 109.694 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -66.26 -45.49 80.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.045 0.538 . . . . 0.0 110.388 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 12' ' ' GLY . . . -61.32 -38.96 88.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 173.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -81.02 41.7 0.6 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.564 0.746 . . . . 0.0 109.245 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -162.88 -38.49 0.02 OUTLIER Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.68 45.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 155.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -146.56 -31.52 0.07 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 19' ' ' LYS . 97.2 mttt -79.6 -41.26 27.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 170.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -65.99 -17.53 64.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.087 0.955 . . . . 0.0 111.08 173.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 mt -90.1 -41.74 11.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -65.42 -32.31 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 15' ' ' LYS . 1.4 tmtp? -69.28 -34.74 75.19 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.204 0.601 . . . . 0.0 109.874 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.02 -47.94 50.96 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.75 -30.17 70.78 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.078 0.551 . . . . 0.0 110.982 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.81 -33.18 73.67 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 117.493 0.133 . . . . 0.0 111.014 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -59.76 -47.49 85.48 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.538 0.735 . . . . 0.0 110.479 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.52 99.01 0.13 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.8 t -58.67 -60.13 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -171.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.38 -39.18 69.81 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.638 0.775 . . . . 0.0 110.661 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 t -63.96 -51.48 64.16 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.922 0.489 . . . . 0.0 110.432 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.862 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 62.4 m -60.72 -49.2 78.47 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.617 0.367 . . . . 0.0 110.246 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.87 -34.58 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.449 0.699 . . . . 0.0 110.607 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.2 t -72.37 -62.0 1.6 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.5 p -75.51 20.12 0.17 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.778 0.431 . . . . 0.0 111.55 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.862 ' HB2' ' O ' ' A' ' 28' ' ' THR . 41.1 ttmt -90.07 -34.17 16.03 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.605 0.762 . . . . 0.0 111.332 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.3 tp -57.15 -53.62 56.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.571 ' C ' ' H ' ' A' ' 36' ' ' THR . . . -80.69 78.58 7.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 160.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -63.39 22.75 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 126.561 1.944 . . . . 0.0 112.106 -171.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.571 ' H ' ' C ' ' A' ' 34' ' ' ALA . 15.2 t -81.05 18.59 1.01 Allowed 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.947 -0.47 . . . . 0.0 109.82 169.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 119.123 -0.465 . . . . 0.0 110.091 -172.244 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.019 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -33.76 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.795 0.838 . . . . 0.0 109.999 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.11 -25.55 64.46 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.54 0.736 . . . . 0.0 112.065 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -90.21 -20.78 22.62 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.0 m -73.3 -50.61 21.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.52 -33.67 76.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 173.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.33 -45.03 96.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.963 0.905 . . . . 0.0 110.499 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -51.05 -52.21 45.49 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.453 1.101 . . . . 0.0 110.509 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -79.67 -30.54 41.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.563 0.745 . . . . 0.0 111.711 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.53 91.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.64 0.376 . . . . 0.0 110.82 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -64.86 -30.07 71.05 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.228 0.611 . . . . 0.0 110.654 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -76.24 -30.34 57.15 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 t -87.38 36.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 162.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -127.96 -33.77 0.58 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.245 -2.342 . . . . 0.0 107.245 170.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 19' ' ' LYS . 70.5 mmtt -73.97 -45.8 47.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.57 0.748 . . . . 0.0 109.421 172.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.19 -18.42 65.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.376 0.67 . . . . 0.0 110.472 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.99 -43.39 10.57 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.089 1.355 . . . . 0.0 107.897 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.0 t -63.3 -33.93 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -70.58 -32.49 69.89 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.753 0.421 . . . . 0.0 109.893 175.349 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.46 -45.85 44.23 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.02 -29.45 69.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.917 0.487 . . . . 0.0 110.921 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.53 -34.95 76.43 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 117.534 0.152 . . . . 0.0 111.005 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -60.54 -30.67 69.91 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.742 0.817 . . . . 0.0 111.227 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -161.41 85.89 0.11 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.16 -61.55 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -172.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -54.53 -36.8 64.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.065 0.946 . . . . 0.0 111.353 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 80.4 p -67.64 -48.47 66.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.414 0.285 . . . . 0.0 110.646 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.629 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 66.0 m -57.7 -46.87 83.76 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.068 0.547 . . . . 0.0 110.47 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.8 t -54.23 -31.78 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.573 0.749 . . . . 0.0 110.721 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.8 m -89.98 -48.37 7.25 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.995 0.518 . . . . 0.0 111.412 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.509 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 74.7 m -57.18 -19.07 18.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.65 0.38 . . . . 0.0 111.75 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.629 ' HB3' ' O ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -76.32 24.39 0.14 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -158.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.5 tp -60.33 -49.07 79.07 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.29 45.4 1.85 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.872 0.869 . . . . 0.0 108.9 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 45.52 57.94 4.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.3 1.44 . . . . 0.0 111.057 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 59.0 m -69.35 -21.08 63.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.057 176.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.452 -0.365 0 C-N-CA 122.552 0.341 . . . . 0.0 110.665 175.522 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.019 0 N-CA-C 112.272 -0.331 . . . . 0.0 112.272 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.8 tp -58.22 -31.69 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 123.717 0.807 . . . . 0.0 110.617 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 1.128 ' O ' ' HD2' ' A' ' 7' ' ' LYS . 89.8 mt -72.15 -21.59 61.43 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.55 0.74 . . . . 0.0 112.2 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -90.1 -25.37 20.77 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.4 m -75.04 -48.59 23.26 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 123.375 0.422 . . . . 0.0 110.342 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.72 -38.52 91.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 1.128 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 0.6 OUTLIER -62.7 -41.07 98.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.92 0.888 . . . . 0.0 110.529 178.855 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -52.32 -43.41 64.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.93 0.892 . . . . 0.0 110.709 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -90.05 -39.36 12.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.605 0.762 . . . . 0.0 111.59 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.76 -38.88 76.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.204 0.602 . . . . 0.0 111.857 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -67.7 -35.16 78.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 119.473 -0.299 . . . . 0.0 110.748 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -71.53 -24.85 76.31 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.58 49.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 160.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -148.43 -33.97 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 174.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -72.29 -43.6 63.99 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.152 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.66 -23.48 67.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.514 0.726 . . . . 0.0 111.045 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.4 mt -88.46 -37.59 15.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 t -66.65 -29.94 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -79.89 1.69 26.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.127 0.571 . . . . 0.0 110.585 174.46 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.03 -68.38 0.35 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.42 -63.91 1.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.643 0.777 . . . . 0.0 110.891 177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.02 40.81 1.02 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.803 0.841 . . . . 0.0 110.767 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.94 -60.04 2.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.58 74.47 0.16 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.06 -49.97 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.295 0.638 . . . . 0.0 110.175 -175.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.8 mt -50.89 -39.44 54.23 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.486 1.114 . . . . 0.0 111.81 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.9 p -80.8 -42.05 22.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.761 0.424 . . . . 0.0 110.896 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.5 m -62.53 -52.35 63.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.302 0.641 . . . . 0.0 110.486 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.11 -36.75 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 122.946 0.499 . . . . 0.0 110.595 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.6 t -67.29 -55.53 13.52 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.511 0.725 . . . . 0.0 110.964 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.1 p -70.92 7.42 1.17 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.649 0.38 . . . . 0.0 111.837 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.699 ' HD2' ' HE3' ' A' ' 35' ' ' LYS . 22.9 ttpp -80.81 59.03 3.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.631 0.729 . . . . 0.0 109.871 -172.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.01 72.27 7.41 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 168.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.17 50.05 3.15 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.617 1.167 . . . . 0.0 110.189 -170.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.699 ' HE3' ' HD2' ' A' ' 32' ' ' LYS . 35.6 mmtp 53.79 67.7 0.96 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.024 1.33 . . . . 0.0 111.425 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.6 m -76.7 -37.63 55.79 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.621 0.368 . . . . 0.0 110.206 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.341 0.206 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.987 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.037 0 N-CA-C 112.32 -0.312 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.5 pp -82.29 38.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.678 0.791 . . . . 0.0 110.638 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.4 mt -82.23 -37.09 26.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.89 0.876 . . . . 0.0 111.422 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -90.01 -16.65 29.36 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.873 0.869 . . . . 0.0 108.967 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.0 m -73.26 -51.65 16.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.997 -173.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.3 mt -66.41 -36.29 82.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.946 0.499 . . . . 0.0 109.959 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -57.08 -46.94 82.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.905 0.882 . . . . 0.0 110.554 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -57.79 -49.32 77.0 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.127 0.971 . . . . 0.0 110.209 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.404 ' O ' ' N ' ' A' ' 13' ' ' VAL . 88.7 t80 -65.99 -43.02 89.03 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.238 0.615 . . . . 0.0 110.927 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.54 95.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.074 0.55 . . . . 0.0 111.74 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -82.05 -18.62 42.56 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 117.923 0.328 . . . . 0.0 111.151 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.18 -28.85 47.84 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 170.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 9' ' ' PHE . 46.5 t -89.02 47.22 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 158.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.26 -28.35 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.884 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 3.0 pptp? -89.07 -22.66 22.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.895 0.478 . . . . 0.0 109.923 173.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.75 -27.0 62.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.147 0.579 . . . . 0.0 109.549 167.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.1 mt -90.16 -48.09 7.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.324 1.049 . . . . 0.0 108.964 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 t -65.96 -31.95 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.884 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 1.2 tmtp? -67.4 -39.63 85.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.195 0.598 . . . . 0.0 109.72 173.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.17 -41.87 59.19 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.42 -35.06 79.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 170.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.1 27.02 1.71 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.821 0.449 . . . . 0.0 111.648 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -78.87 -62.01 1.83 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.94 52.39 0.16 Allowed Glycine 0 C--N 1.336 0.557 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 p -73.55 -46.02 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.21 -36.05 82.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.56 0.744 . . . . 0.0 110.228 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.4 m -64.62 -47.1 79.8 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.118 0.567 . . . . 0.0 110.403 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.744 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 98.0 m -57.25 -50.38 73.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.076 0.55 . . . . 0.0 110.367 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.7 t -54.56 -33.22 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.815 0.846 . . . . 0.0 110.948 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.4 t -73.16 -62.63 1.4 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.192 0.197 . . . . 0.0 110.611 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -75.78 16.41 0.4 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.448 0.299 . . . . 0.0 111.621 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.744 ' HB2' ' O ' ' A' ' 28' ' ' THR . 68.5 tttt -90.2 -31.93 16.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.059 0.543 . . . . 0.0 111.49 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.2 tp -51.23 -64.13 0.91 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.794 0.838 . . . . 0.0 110.995 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.69 -7.47 59.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.811 0.444 . . . . 0.0 111.352 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.626 ' HE2' ' O ' ' A' ' 37' ' ' CYS . 19.1 tptm 46.46 58.7 4.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.271 1.828 . . . . 0.0 112.167 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.3 t -76.22 -18.24 59.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 161.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.626 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 63.1 m . . . . . 0 N--CA 1.452 -0.333 0 C-N-CA 124.015 0.926 . . . . 0.0 109.875 176.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.005 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -82.4 39.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.626 0.77 . . . . 0.0 110.522 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.3 mt -82.81 -35.68 26.21 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.505 0.722 . . . . 0.0 111.577 -172.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -90.23 -15.62 31.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.8 m -68.51 -47.0 68.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -59.58 -38.72 81.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.663 0.785 . . . . 0.0 110.567 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -63.83 -51.06 66.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -57.62 -48.9 78.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.086 0.955 . . . . 0.0 109.805 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -60.67 -44.72 96.14 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.412 0.685 . . . . 0.0 110.756 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.48 96.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.589 0.356 . . . . 0.0 110.238 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -82.83 42.71 0.8 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.573 ' O ' ' OD2' ' A' ' 16' ' ' ASP . . . -157.28 -37.74 0.02 OUTLIER Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 t -87.24 47.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 152.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -136.97 -36.32 0.18 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 174.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 19' ' ' LYS . 5.0 mmpt? -66.54 -39.85 88.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.705 0.802 . . . . 0.0 109.194 169.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.573 ' OD2' ' O ' ' A' ' 12' ' ' GLY . 3.5 m-20 -65.26 -25.98 67.9 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.431 1.093 . . . . 0.0 111.07 175.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.3 mt -90.1 -39.89 12.6 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.63 -30.84 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 15' ' ' LYS . 64.7 tttp -71.71 -36.87 70.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.052 0.541 . . . . 0.0 109.843 174.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.51 -41.93 56.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.58 80.88 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.01 28.77 1.31 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.92 0.488 . . . . 0.0 111.633 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? -78.81 -55.23 5.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.94 76.3 0.11 Allowed Glycine 0 C--N 1.337 0.596 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m -56.41 -44.67 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.592 0.757 . . . . 0.0 110.843 -176.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.23 -37.66 72.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.25 1.02 . . . . 0.0 110.813 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -80.06 -41.64 25.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.135 0.574 . . . . 0.0 110.727 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 90.6 m -65.5 -50.35 65.63 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.27 0.628 . . . . 0.0 111.113 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.21 -41.25 86.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 122.784 0.433 . . . . 0.0 110.73 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.1 m -71.46 -46.82 58.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.197 0.599 . . . . 0.0 110.165 176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.2 t -65.35 -12.01 47.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.214 0.606 . . . . 0.0 111.199 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 1.292 ' CD ' ' HD3' ' A' ' 35' ' ' LYS . 19.7 ttpp -87.27 63.49 7.81 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.799 0.809 . . . . 0.0 109.452 -172.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.56 -57.99 4.51 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 168.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.02 47.92 1.71 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.991 0.917 . . . . 0.0 108.699 171.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 1.292 ' HD3' ' CD ' ' A' ' 32' ' ' LYS . 3.0 mmmp? 49.11 56.6 7.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.942 1.297 . . . . 0.0 111.016 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -71.61 -35.76 70.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 91.5 m . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 170.444 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.002 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.61 -36.52 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.384 0.674 . . . . 0.0 109.599 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.9 mt -73.65 -15.44 61.25 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.907 0.483 . . . . 0.0 112.104 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -90.12 -27.3 19.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 173.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.7 m -68.41 -44.41 75.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 123.346 0.404 . . . . 0.0 110.19 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.3 mt -58.11 -45.24 87.6 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.713 0.805 . . . . 0.0 110.322 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.83 -48.07 82.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.807 0.843 . . . . 0.0 110.71 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.46 -51.35 69.82 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.805 0.842 . . . . 0.0 109.762 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -57.91 -50.89 71.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.164 0.586 . . . . 0.0 110.51 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.75 -33.68 74.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.029 0.532 . . . . 0.0 110.744 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -73.99 -30.93 62.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.968 0.507 . . . . 0.0 110.16 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -76.19 -31.01 56.26 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 173.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -86.16 43.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 160.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -141.33 -32.69 0.13 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 107.343 -2.303 . . . . 0.0 107.343 172.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 19' ' ' LYS . 70.7 mmtt -68.73 -40.93 79.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.376 0.67 . . . . 0.0 109.416 169.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -64.05 -26.19 68.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.714 0.806 . . . . 0.0 110.664 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.4 mt -90.04 -41.34 11.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.237 1.015 . . . . 0.0 108.869 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.9 t -65.31 -29.02 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 171.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 15' ' ' LYS . 23.4 tptm -72.58 -37.06 68.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.869 0.467 . . . . 0.0 109.772 175.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.85 -42.55 52.8 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.85 80.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.08 27.38 1.63 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.825 0.45 . . . . 0.0 111.645 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -78.65 -62.55 1.65 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.35 46.7 0.17 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 177.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.0 p -64.0 -41.91 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 122.916 0.486 . . . . 0.0 110.061 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.8 mt -59.87 -40.42 88.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.047 0.939 . . . . 0.0 110.36 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.6 m -70.2 -40.84 74.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.988 0.515 . . . . 0.0 110.642 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.992 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 26.1 m -69.88 -7.09 37.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.13 -39.21 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 166.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -76.3 -64.17 1.16 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.057 0.543 . . . . 0.0 110.198 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 6.8 p -77.67 43.33 0.4 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 119.435 -0.317 . . . . 0.0 110.393 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.992 ' HB2' ' O ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -90.11 -56.13 3.34 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 178.147 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 tt -29.88 -75.0 0.03 OUTLIER 'General case' 0 C--N 1.343 0.29 0 C-N-CA 126.021 1.728 . . . . 0.0 113.264 -148.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.35 59.23 1.35 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -141.76 -65.52 0.42 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.032 0.933 . . . . 0.0 110.815 -162.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m 63.37 11.92 5.86 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.63 0.772 . . . . 0.0 109.472 -159.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.452 -0.373 0 C-N-CA 124.642 1.177 . . . . 0.0 111.569 177.339 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.964 ' O ' ' HD2' ' A' ' 7' ' ' LYS . 82.6 mt . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -90.08 -26.76 20.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.2 m -68.78 -56.88 6.61 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.293 -172.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.5 mt -59.99 -36.55 77.42 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.106 0.562 . . . . 0.0 110.546 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.964 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 0.4 OUTLIER -62.61 -41.96 99.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.362 0.665 . . . . 0.0 110.286 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.16 -57.67 11.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.447 0.699 . . . . 0.0 110.387 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -65.16 -38.62 91.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.962 0.505 . . . . 0.0 111.174 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.44 96.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -81.25 47.55 1.04 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -166.15 -34.59 0.02 OUTLIER Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.1 t -87.6 46.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 154.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -154.08 -30.31 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 19' ' ' LYS . 48.1 tptt -74.79 -39.24 61.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 123.87 0.868 . . . . 0.0 109.061 170.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.41 -24.02 67.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.089 0.955 . . . . 0.0 110.834 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -89.98 -42.3 11.24 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.8 t -63.2 -31.58 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 170.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 15' ' ' LYS . 87.1 tttt -71.71 -36.2 70.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.891 0.476 . . . . 0.0 109.938 175.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.0 -40.75 56.42 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.59 88.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 170.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.284 0 C-N-CA 122.942 0.497 . . . . 0.0 111.485 -179.027 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 110.551 -0.166 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.579 ' O ' ' HB3' ' A' ' 30' ' ' SER . 86.0 mt -56.84 -33.42 66.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.839 0.855 . . . . 0.0 111.664 -175.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.873 ' O ' ' CB ' ' A' ' 31' ' ' CYS . 78.1 p -67.42 -40.33 85.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.788 0.435 . . . . 0.0 110.925 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.578 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 94.5 m -77.64 -51.88 9.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.352 0.661 . . . . 0.0 110.274 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.63 -49.07 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 123.388 0.675 . . . . 0.0 110.351 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 26' ' ' LEU . 34.8 t -66.38 -45.92 78.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.873 ' CB ' ' O ' ' A' ' 27' ' ' SER . 50.2 t -60.31 -15.61 26.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.7 0.8 . . . . 0.0 111.492 174.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 28' ' ' THR . 9.1 ttmm -80.43 56.96 2.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.191 0.52 . . . . 0.0 110.997 -171.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.3 mp -67.27 -57.11 7.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.09 43.13 2.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.057 0.943 . . . . 0.0 108.521 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.2 tptm 48.59 61.74 2.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.06 1.344 . . . . 0.0 110.901 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.453 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.092 172.756 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.659 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 81.4 mt . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -90.14 -23.52 21.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -69.86 -55.8 8.81 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 pp -63.31 -32.79 74.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.851 0.46 . . . . 0.0 110.576 174.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 1.5 tppp? -58.05 -47.46 83.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.263 1.025 . . . . 0.0 110.717 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -49.37 -54.02 19.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.782 1.233 . . . . 0.0 110.791 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -66.62 -42.64 86.47 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.071 0.549 . . . . 0.0 111.014 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.9 91.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.884 0.473 . . . . 0.0 110.978 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -69.26 -28.76 66.6 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.688 0.395 . . . . 0.0 110.505 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -74.52 -28.16 64.03 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.1 t -86.73 42.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 162.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -142.5 -32.19 0.11 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 172.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 7.2 mtpm? -77.31 -36.69 53.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.561 0.744 . . . . 0.0 109.3 172.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.55 -24.23 66.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.548 0.739 . . . . 0.0 110.371 173.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.1 mt -90.05 -45.74 8.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.002 0.921 . . . . 0.0 109.138 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.5 t -66.32 -27.89 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 65.2 tttm -74.51 -38.58 62.78 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.159 0.584 . . . . 0.0 110.186 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.79 -46.05 40.3 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.63 71.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 122.624 0.37 . . . . 0.0 110.039 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.876 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.448 -0.561 0 CA-C-O 120.38 0.134 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.41 -40.09 85.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.684 0.794 . . . . 0.0 111.364 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.6 p -67.41 -42.55 83.08 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.421 0.289 . . . . 0.0 111.393 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 1.075 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 66.1 m -54.31 -29.5 47.82 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.712 0.805 . . . . 0.0 111.341 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.51 -41.31 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 122.61 0.364 . . . . 0.0 110.056 176.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.0 t -76.24 -61.98 1.76 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.514 0.326 . . . . 0.0 110.319 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.6 p -77.61 31.13 0.16 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.314 0.246 . . . . 0.0 111.32 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 1.075 ' HB3' ' O ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -89.84 -25.65 20.93 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 117.658 0.208 . . . . 0.0 111.434 175.304 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.22 2.29 0.6 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.04 2.05 1.15 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.705 0.802 . . . . 0.0 111.007 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 48.4 33.49 3.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.055 1.342 . . . . 0.0 112.205 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 166.112 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -90.13 -17.81 26.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -69.76 -54.13 15.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -174.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 pp -59.63 -34.71 73.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.642 0.377 . . . . 0.0 110.852 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.23 -42.77 96.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.784 0.833 . . . . 0.0 110.832 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -56.73 -56.11 25.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.622 0.769 . . . . 0.0 110.458 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -69.15 -31.89 70.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.88 0.472 . . . . 0.0 111.462 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.56 86.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -83.76 54.21 2.81 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 169.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.696 ' H ' ' H ' ' A' ' 14' ' ' GLY . . . -166.42 -52.83 0.03 OUTLIER Glycine 0 C--N 1.337 0.616 0 C-N-CA 124.574 1.083 . . . . 0.0 113.058 -170.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.46 0.35 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 150.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.696 ' H ' ' H ' ' A' ' 12' ' ' GLY . . . -107.8 -18.2 10.29 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.944 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 35.4 mmtp -89.13 -19.95 24.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.403 1.081 . . . . 0.0 109.797 168.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.43 -30.55 61.95 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 167.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.22 -43.86 10.13 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.137 0.975 . . . . 0.0 108.614 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -67.81 -27.54 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.949 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.944 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 13.4 tmtt? -68.43 -39.98 81.34 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.065 0.546 . . . . 0.0 109.665 172.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.15 -40.99 60.93 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.91 73.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 122.742 0.417 . . . . 0.0 110.929 178.991 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.4 mt -56.47 -38.95 72.41 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.0 0.92 . . . . 0.0 110.828 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.8 p -68.97 -45.11 71.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.107 0.563 . . . . 0.0 110.662 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.61 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 89.7 m -54.82 -43.28 72.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.162 0.585 . . . . 0.0 111.139 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.29 -39.1 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.504 0.722 . . . . 0.0 110.798 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 t -72.54 -60.69 2.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.536 0.335 . . . . 0.0 110.484 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 6.0 p -78.46 29.18 0.19 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.897 0.479 . . . . 0.0 111.411 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 28' ' ' THR . 5.7 tmtt? -90.11 -52.43 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.38 1.072 . . . . 0.0 110.083 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.5 tp -50.2 -59.3 4.07 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.141 0.976 . . . . 0.0 110.926 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.09 -19.54 64.07 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 120.947 0.403 . . . . 0.0 111.55 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.6 tptm 56.64 55.51 6.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.53 1.932 . . . . 0.0 112.306 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 164.0 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -90.27 -21.31 22.16 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.6 m -72.03 -53.03 14.18 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.47 -32.09 73.44 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.917 0.487 . . . . 0.0 110.679 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -62.3 -46.47 88.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.77 0.828 . . . . 0.0 110.155 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -60.56 -50.79 72.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.01 0.924 . . . . 0.0 109.794 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -59.72 -49.47 77.62 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.991 0.516 . . . . 0.0 110.562 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.08 90.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.943 0.497 . . . . 0.0 110.456 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.99 -33.87 76.51 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.214 0.606 . . . . 0.0 110.466 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -77.38 -30.07 54.75 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.614 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 t -88.42 41.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 161.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -143.4 -29.15 0.12 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 176.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 19' ' ' LYS . 75.1 mmtt -85.75 -41.53 15.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.4 -18.17 64.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.645 0.778 . . . . 0.0 110.511 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.9 tp -87.68 -43.75 11.7 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.54 -32.85 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 15' ' ' LYS . 64.6 tttm -69.7 -32.11 70.52 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.76 0.424 . . . . 0.0 110.102 175.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.39 -47.2 29.77 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.96 -30.87 71.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.944 0.498 . . . . 0.0 110.917 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.142 0 C-N-CA 122.347 0.259 . . . . 0.0 111.366 -178.587 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 120.423 0.154 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.8 mt -59.08 -39.31 81.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.745 0.818 . . . . 0.0 110.371 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.9 t -67.87 -39.06 83.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.86 0.464 . . . . 0.0 110.733 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.745 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 39.0 m -65.48 -37.6 87.32 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.517 0.327 . . . . 0.0 110.746 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.53 -30.76 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.044 0.537 . . . . 0.0 110.405 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.9 t -81.67 -55.8 4.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.845 0.458 . . . . 0.0 109.896 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.2 t -57.65 -12.37 2.82 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.665 1.186 . . . . 0.0 111.647 175.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.745 ' HB2' ' O ' ' A' ' 28' ' ' THR . 11.9 tppt? -75.72 -42.73 49.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.13 0.972 . . . . 0.0 109.737 -175.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.7 mt -44.88 -55.15 5.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.415 1.086 . . . . 0.0 110.903 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.75 -28.41 36.51 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.276 0.56 . . . . 0.0 111.454 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 tptt 64.97 79.79 0.25 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.339 1.856 . . . . 0.0 111.104 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.452 -0.349 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.843 162.639 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -90.19 -12.68 37.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.684 0.793 . . . . 0.0 110.146 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 97.9 m -61.27 -52.95 62.57 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.5 -37.21 86.76 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.305 0.642 . . . . 0.0 110.651 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -60.36 -39.31 86.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.199 0.6 . . . . 0.0 110.568 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.08 -55.94 28.16 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.836 0.854 . . . . 0.0 110.259 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -68.41 -34.41 75.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.922 0.489 . . . . 0.0 111.378 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.69 98.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.85 53.39 2.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.55 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -170.95 -46.21 0.04 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 124.656 1.122 . . . . 0.0 113.02 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.4 t -78.99 28.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 143.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -126.26 -27.02 1.14 Allowed Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 167.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.721 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 45.5 mmtm -81.13 -29.85 34.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.08 0.952 . . . . 0.0 110.111 173.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.4 -27.29 63.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.17 -43.19 10.6 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.308 1.043 . . . . 0.0 108.264 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -66.36 -27.64 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 119.356 -0.938 . . . . 0.0 108.718 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.721 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 57.6 tptt -72.62 -36.85 68.15 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.11 0.564 . . . . 0.0 109.711 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.5 -41.93 56.82 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.55 80.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 122.875 0.47 . . . . 0.0 111.555 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 N--CA 1.455 -0.215 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.9 mt -54.7 -31.77 58.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.999 0.92 . . . . 0.0 111.115 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.2 t -82.19 -46.25 14.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.228 0.611 . . . . 0.0 110.476 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.1 m -63.53 -56.61 14.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.309 0.643 . . . . 0.0 110.57 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.6 p -49.66 -35.16 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.088 0.955 . . . . 0.0 111.876 -176.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.4 t -69.44 -60.91 2.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.116 0.567 . . . . 0.0 111.134 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 12.3 p -66.46 1.63 1.59 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 119.116 -0.469 . . . . 0.0 112.068 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 1.35 ' HD3' ' CD ' ' A' ' 35' ' ' LYS . 26.5 mmtm -90.04 52.46 2.28 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.642 0.655 . . . . 0.0 109.286 175.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.1 tp -76.44 -61.04 2.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.99 44.65 2.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 1.35 ' CD ' ' HD3' ' A' ' 32' ' ' LYS . 46.5 mmtm 49.28 61.15 3.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.968 1.307 . . . . 0.0 110.879 -171.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.055 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.15 -21.28 22.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.1 m -71.73 -45.04 63.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.08 -39.97 96.29 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.592 0.757 . . . . 0.0 110.038 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.662 ' HE3' ' HD2' ' A' ' 11' ' ' LYS . 56.7 tptt -59.01 -47.15 86.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.714 0.806 . . . . 0.0 110.559 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -61.12 -47.48 86.08 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.696 0.798 . . . . 0.0 110.022 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -62.5 -42.95 99.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.307 0.643 . . . . 0.0 110.586 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.02 96.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.666 0.386 . . . . 0.0 110.105 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.662 ' HD2' ' HE3' ' A' ' 7' ' ' LYS . 63.6 mtpt -81.71 43.36 0.75 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 171.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.21 -36.46 0.02 OUTLIER Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.98 41.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 153.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.24 -32.77 0.48 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.929 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 22.7 pttp -90.06 -25.17 20.92 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.363 0.665 . . . . 0.0 110.328 173.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.7 -26.42 63.41 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 167.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -89.98 -51.68 5.35 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.127 1.371 . . . . 0.0 108.223 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.6 t -65.42 -29.99 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.929 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 13.3 tmtt? -66.61 -39.66 88.44 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 173.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.32 -44.04 60.7 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.81 77.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 171.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.503 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.8 mt -56.97 -43.51 81.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.853 0.861 . . . . 0.0 110.473 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 m -65.3 -47.26 77.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.759 0.423 . . . . 0.0 110.075 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.847 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 2.3 m -82.49 36.26 0.47 Allowed 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.978 0.174 . . . . 0.0 110.804 178.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.55 -43.17 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 148.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.7 m -74.4 -58.79 3.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.469 0.708 . . . . 0.0 110.203 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.5 p -78.91 39.14 0.36 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.321 -0.371 . . . . 0.0 111.189 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.847 ' HD3' ' O ' ' A' ' 28' ' ' THR . 13.6 mmmm -81.37 -64.07 1.26 Allowed 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.268 0.486 . . . . 0.0 112.05 165.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 32.4 tp -29.89 71.45 0.0 OUTLIER 'General case' 0 C--N 1.339 0.148 0 C-N-CA 128.352 2.661 . . . . 0.0 113.306 -163.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 32' ' ' LYS . . . 67.62 57.54 0.54 Allowed 'General case' 0 C--O 1.23 0.055 0 C-N-CA 125.716 1.606 . . . . 0.0 110.087 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -144.31 -57.43 0.37 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.739 1.616 . . . . 0.0 109.605 -170.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 124.657 1.183 . . . . 0.0 109.914 -155.951 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -90.25 -18.82 24.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.489 0.716 . . . . 0.0 109.758 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -64.06 -47.46 80.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.3 -39.93 94.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.243 0.617 . . . . 0.0 110.532 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -63.04 -44.34 96.17 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.47 0.708 . . . . 0.0 110.377 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -56.84 -45.33 82.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.585 1.154 . . . . 0.0 110.222 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -76.98 -29.56 55.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.116 0.566 . . . . 0.0 111.282 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.68 94.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.745 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.576 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 9.1 ptpp? -83.72 44.33 0.98 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.936 0.494 . . . . 0.0 109.867 172.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.588 ' N ' ' H ' ' A' ' 14' ' ' GLY . . . -161.83 -49.12 0.02 OUTLIER Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.77 1.176 . . . . 0.0 112.862 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 91.9 t -68.34 4.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 148.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' N ' ' A' ' 12' ' ' GLY . . . -112.72 -15.36 9.45 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.935 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 98.8 mttt -89.97 -29.76 18.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.803 0.841 . . . . 0.0 109.327 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.02 -26.94 64.29 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 167.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -89.45 -46.98 8.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.797 1.239 . . . . 0.0 108.591 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.6 t -65.83 -26.78 39.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.97 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.935 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 40.5 ttmt -71.84 -38.21 70.16 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.771 0.429 . . . . 0.0 109.848 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.82 -41.78 55.0 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.87 -33.63 75.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 170.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.271 0 C-N-CA 122.89 0.476 . . . . 0.0 111.638 -179.623 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.37 -32.98 70.62 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.76 0.824 . . . . 0.0 110.763 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 t -70.57 -39.33 73.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.75 0.42 . . . . 0.0 110.766 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.731 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 87.4 m -65.63 -35.12 79.88 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.678 0.217 . . . . 0.0 111.288 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.9 t -51.11 -30.8 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 122.788 0.435 . . . . 0.0 110.459 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.2 t -73.98 -62.1 1.62 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.928 0.491 . . . . 0.0 112.276 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 1.349 ' HB2' ' CD ' ' A' ' 35' ' ' LYS . 10.5 p -52.54 -27.29 15.98 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.731 ' HB2' ' O ' ' A' ' 28' ' ' THR . 62.2 tttp -79.06 65.78 4.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.666 1.222 . . . . 0.0 110.386 -158.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.3 mt -87.67 -53.15 4.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.078 -1.874 . . . . 0.0 108.495 166.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.09 0.19 0.32 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.594 0.757 . . . . 0.0 112.081 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 1.349 ' CD ' ' HB2' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -88.57 -46.64 8.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.886 1.274 . . . . 0.0 111.908 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 CA--C 1.535 0.395 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -159.761 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.158 ' O ' ' HD3' ' A' ' 7' ' ' LYS . 3.9 mm? . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 119.531 -0.271 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.17 -19.84 23.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.4 m -75.49 -45.41 38.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.5 -40.23 86.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.393 0.677 . . . . 0.0 110.092 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 1.158 ' HD3' ' O ' ' A' ' 3' ' ' LEU . 4.3 mptp? -64.87 -47.17 78.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.51 0.724 . . . . 0.0 109.955 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -61.83 -46.22 90.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.654 0.782 . . . . 0.0 110.152 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -60.86 -50.79 72.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.956 0.502 . . . . 0.0 110.221 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.79 -28.62 69.7 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.142 0.577 . . . . 0.0 111.291 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -72.09 -41.21 67.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.151 0.58 . . . . 0.0 110.26 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.85 -30.63 34.83 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.3 t -90.01 45.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 159.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.38 -30.16 0.13 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.92 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 20.5 ptmt -88.46 -20.12 25.6 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.741 0.416 . . . . 0.0 110.189 173.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.4 -27.64 61.57 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.01 -48.43 7.21 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.855 1.262 . . . . 0.0 108.314 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.1 t -67.16 -28.9 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.92 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 29.4 tptp -69.95 -34.06 72.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.4 -45.32 48.01 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.74 -30.2 70.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.708 0.403 . . . . 0.0 110.709 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.649 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.656 0.265 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.2 mt -56.67 -37.47 70.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.576 1.151 . . . . 0.0 111.512 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.2 p -90.12 -44.36 9.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.119 0.567 . . . . 0.0 111.255 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.437 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 99.1 m -49.2 -54.19 17.73 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.512 0.725 . . . . 0.0 110.889 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 p -48.86 -32.59 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.671 0.788 . . . . 0.0 111.131 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 t -87.44 -60.07 2.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.539 0.736 . . . . 0.0 111.288 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.826 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 35.2 m -59.36 -8.81 1.9 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.993 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -78.24 29.38 0.18 Allowed 'General case' 0 C--N 1.342 0.241 0 C-N-CA 118.61 -1.236 . . . . 0.0 113.023 -163.319 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.56 -41.3 89.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 166.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.56 44.99 1.62 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.875 0.87 . . . . 0.0 109.534 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? 48.91 46.06 22.24 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.847 1.259 . . . . 0.0 110.788 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.826 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 57.6 m . . . . . 0 N--CA 1.454 -0.24 0 C-N-CA 123.063 0.545 . . . . 0.0 112.146 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 70.8 mt . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.1 -11.49 41.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.803 0.841 . . . . 0.0 109.156 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 88.1 m -74.36 -59.32 2.78 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -172.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.0 mt -57.24 -40.0 76.71 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.714 0.405 . . . . 0.0 110.123 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -57.53 -45.47 85.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.227 1.011 . . . . 0.0 111.182 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -58.96 -51.57 69.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.165 0.586 . . . . 0.0 110.225 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -66.18 -39.66 89.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.894 0.478 . . . . 0.0 111.085 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.72 -37.52 84.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 175.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.0 mtpt -81.81 43.38 0.76 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 171.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -164.57 -36.86 0.02 OUTLIER Glycine 0 C--N 1.337 0.617 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.2 46.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 154.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -152.21 -29.34 0.04 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 19' ' ' LYS . 62.1 mtpt -79.85 -41.1 26.99 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.2 -22.49 66.9 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.033 0.933 . . . . 0.0 110.73 173.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.2 mt -90.09 -41.05 11.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.12 0.968 . . . . 0.0 108.586 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.5 -32.38 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 170.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 15' ' ' LYS . 23.4 tptm -70.21 -36.59 74.68 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.6 -41.56 50.5 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.05 82.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 170.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.345 0 C-N-CA 123.111 0.564 . . . . 0.0 111.047 179.487 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.456 -0.131 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.8 mt -53.57 -19.27 3.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.855 1.262 . . . . 0.0 112.575 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.9 m -87.75 -48.95 7.45 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.155 0.582 . . . . 0.0 110.749 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.562 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 94.1 m -48.21 -51.83 23.59 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.528 0.731 . . . . 0.0 111.229 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 m -49.48 -39.94 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 124.327 1.051 . . . . 0.0 112.263 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.5 p -72.6 -56.13 5.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.307 0.243 . . . . 0.0 110.661 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.7 p -81.91 27.16 0.47 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.516 0.726 . . . . 0.0 111.256 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 28' ' ' THR . 13.5 tmtt? -88.37 -41.7 12.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.978 0.511 . . . . 0.0 111.92 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 tp -48.53 -65.6 0.54 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.534 1.134 . . . . 0.0 111.528 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.22 -11.0 60.36 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.573 0.349 . . . . 0.0 111.524 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 16.4 tptm 48.49 51.74 14.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.824 2.049 . . . . 0.0 112.725 176.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 159.804 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.27 -28.98 18.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 168.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -74.86 -55.88 5.34 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.927 0.491 . . . . 0.0 111.646 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.42 -35.26 78.68 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.662 0.385 . . . . 0.0 110.091 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' N ' ' CD ' ' A' ' 7' ' ' LYS . 11.6 mptt -67.14 -39.76 86.63 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.776 1.23 . . . . 0.0 110.607 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -63.67 -47.5 80.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.551 0.741 . . . . 0.0 109.694 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -66.26 -45.49 80.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.045 0.538 . . . . 0.0 110.388 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.96 88.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 173.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -81.02 41.7 0.6 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.564 0.746 . . . . 0.0 109.245 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -162.88 -38.49 0.02 OUTLIER Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.68 45.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 155.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -146.56 -31.52 0.07 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.6 -41.26 27.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 170.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -65.99 -17.53 64.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.087 0.955 . . . . 0.0 111.08 173.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 mt -90.1 -41.74 11.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -65.42 -32.31 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' C ' ' HD3' ' A' ' 19' ' ' LYS . 1.4 tmtp? -69.28 -34.74 75.19 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.204 0.601 . . . . 0.0 109.874 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.02 -47.94 50.96 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.75 -30.17 70.78 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.078 0.551 . . . . 0.0 110.982 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.085 0 CA-C-N 117.493 0.133 . . . . 0.0 111.014 -179.238 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.38 -39.18 69.81 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.638 0.775 . . . . 0.0 110.661 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 t -63.96 -51.48 64.16 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.922 0.489 . . . . 0.0 110.432 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.854 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 62.4 m -60.72 -49.2 78.47 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.617 0.367 . . . . 0.0 110.246 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.87 -34.58 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.449 0.699 . . . . 0.0 110.607 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.2 t -72.37 -62.0 1.6 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.5 p -75.51 20.12 0.17 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.778 0.431 . . . . 0.0 111.55 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.854 ' HB2' ' O ' ' A' ' 28' ' ' THR . 41.1 ttmt -90.07 -34.17 16.03 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.605 0.762 . . . . 0.0 111.332 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.3 tp -57.15 -53.62 56.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 36' ' ' THR . . . -80.69 78.58 7.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 160.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -63.39 22.75 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 126.561 1.944 . . . . 0.0 112.106 -171.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 34' ' ' ALA . 15.2 t . . . . . 0 CA--C 1.532 0.281 0 O-C-N 121.947 -0.47 . . . . 0.0 109.82 169.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -90.21 -20.78 22.62 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.0 m -73.3 -50.61 21.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.52 -33.67 76.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 173.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.33 -45.03 96.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.963 0.905 . . . . 0.0 110.499 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -51.05 -52.21 45.49 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.453 1.101 . . . . 0.0 110.509 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -79.67 -30.54 41.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.563 0.745 . . . . 0.0 111.711 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.53 91.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.64 0.376 . . . . 0.0 110.82 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -64.86 -30.07 71.05 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.228 0.611 . . . . 0.0 110.654 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -76.24 -30.34 57.15 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 t -87.38 36.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 162.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -127.96 -33.77 0.58 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.245 -2.342 . . . . 0.0 107.245 170.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 19' ' ' LYS . 70.5 mmtt -73.97 -45.8 47.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.57 0.748 . . . . 0.0 109.421 172.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.19 -18.42 65.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.376 0.67 . . . . 0.0 110.472 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.99 -43.39 10.57 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.089 1.355 . . . . 0.0 107.897 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.0 t -63.3 -33.93 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -70.58 -32.49 69.89 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.753 0.421 . . . . 0.0 109.893 175.349 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.46 -45.85 44.23 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.02 -29.45 69.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.917 0.487 . . . . 0.0 110.921 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.13 0 CA-C-N 117.534 0.152 . . . . 0.0 111.005 -179.405 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -54.53 -36.8 64.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.065 0.946 . . . . 0.0 111.353 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 80.4 p -67.64 -48.47 66.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.414 0.285 . . . . 0.0 110.646 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.61 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 66.0 m -57.7 -46.87 83.76 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.068 0.547 . . . . 0.0 110.47 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.8 t -54.23 -31.78 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.573 0.749 . . . . 0.0 110.721 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.8 m -89.98 -48.37 7.25 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.995 0.518 . . . . 0.0 111.412 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 74.7 m -57.18 -19.07 18.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.65 0.38 . . . . 0.0 111.75 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.612 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -76.32 24.39 0.14 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -158.772 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.5 tp -60.33 -49.07 79.07 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.29 45.4 1.85 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.872 0.869 . . . . 0.0 108.9 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 45.52 57.94 4.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.3 1.44 . . . . 0.0 111.057 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 59.0 m . . . . . 0 N--CA 1.453 -0.321 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.057 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.105 ' O ' ' HD2' ' A' ' 7' ' ' LYS . 89.8 mt . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -90.1 -25.37 20.77 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.4 m -75.04 -48.59 23.26 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 123.375 0.422 . . . . 0.0 110.342 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.72 -38.52 91.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 1.105 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 0.6 OUTLIER -62.7 -41.07 98.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.92 0.888 . . . . 0.0 110.529 178.855 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -52.32 -43.41 64.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.93 0.892 . . . . 0.0 110.709 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -90.05 -39.36 12.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.605 0.762 . . . . 0.0 111.59 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.76 -38.88 76.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.204 0.602 . . . . 0.0 111.857 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -67.7 -35.16 78.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 119.473 -0.299 . . . . 0.0 110.748 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -71.53 -24.85 76.31 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.58 49.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 160.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -148.43 -33.97 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 174.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -72.29 -43.6 63.99 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.152 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.66 -23.48 67.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.514 0.726 . . . . 0.0 111.045 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.4 mt -88.46 -37.59 15.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 t -66.65 -29.94 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -79.89 1.69 26.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.127 0.571 . . . . 0.0 110.585 174.46 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.03 -68.38 0.35 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.42 -63.91 1.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.643 0.777 . . . . 0.0 110.891 177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.396 0 C-N-CA 123.803 0.841 . . . . 0.0 110.767 -177.763 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 30' ' ' SER . 87.8 mt -50.89 -39.44 54.23 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.486 1.114 . . . . 0.0 111.81 -177.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.9 p -80.8 -42.05 22.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.761 0.424 . . . . 0.0 110.896 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.5 m -62.53 -52.35 63.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.302 0.641 . . . . 0.0 110.486 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.11 -36.75 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 122.946 0.499 . . . . 0.0 110.595 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 35.6 t -67.29 -55.53 13.52 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.511 0.725 . . . . 0.0 110.964 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.1 p -70.92 7.42 1.17 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.649 0.38 . . . . 0.0 111.837 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.705 ' HD2' ' HE3' ' A' ' 35' ' ' LYS . 22.9 ttpp -80.81 59.03 3.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.631 0.729 . . . . 0.0 109.871 -172.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.01 72.27 7.41 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 168.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.17 50.05 3.15 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.617 1.167 . . . . 0.0 110.189 -170.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.705 ' HE3' ' HD2' ' A' ' 32' ' ' LYS . 35.6 mmtp 53.79 67.7 0.96 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.024 1.33 . . . . 0.0 111.425 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.6 m . . . . . 0 N--CA 1.454 -0.255 0 C-N-CA 122.621 0.368 . . . . 0.0 110.206 176.533 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 111.422 0.156 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -90.01 -16.65 29.36 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.873 0.869 . . . . 0.0 108.967 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.0 m -73.26 -51.65 16.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.997 -173.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.3 mt -66.41 -36.29 82.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.946 0.499 . . . . 0.0 109.959 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -57.08 -46.94 82.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.905 0.882 . . . . 0.0 110.554 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -57.79 -49.32 77.0 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.127 0.971 . . . . 0.0 110.209 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -65.99 -43.02 89.03 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.238 0.615 . . . . 0.0 110.927 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.54 95.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.074 0.55 . . . . 0.0 111.74 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -82.05 -18.62 42.56 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 117.923 0.328 . . . . 0.0 111.151 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.18 -28.85 47.84 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 170.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.02 47.22 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 158.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.26 -28.35 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.926 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 3.0 pptp? -89.07 -22.66 22.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.895 0.478 . . . . 0.0 109.923 173.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.75 -27.0 62.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.147 0.579 . . . . 0.0 109.549 167.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.1 mt -90.16 -48.09 7.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.324 1.049 . . . . 0.0 108.964 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 t -65.96 -31.95 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.926 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 1.2 tmtp? -67.4 -39.63 85.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.195 0.598 . . . . 0.0 109.72 173.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.17 -41.87 59.19 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.42 -35.06 79.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 170.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.277 0 C-N-CA 122.821 0.449 . . . . 0.0 111.648 179.515 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.21 -36.05 82.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.56 0.744 . . . . 0.0 110.228 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.4 m -64.62 -47.1 79.8 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.118 0.567 . . . . 0.0 110.403 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.756 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 98.0 m -57.25 -50.38 73.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.076 0.55 . . . . 0.0 110.367 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.7 t -54.56 -33.22 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.815 0.846 . . . . 0.0 110.948 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.4 t -73.16 -62.63 1.4 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.192 0.197 . . . . 0.0 110.611 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -75.78 16.41 0.4 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.448 0.299 . . . . 0.0 111.621 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.756 ' HB2' ' O ' ' A' ' 28' ' ' THR . 68.5 tttt -90.2 -31.93 16.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.059 0.543 . . . . 0.0 111.49 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.2 tp -51.23 -64.13 0.91 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.794 0.838 . . . . 0.0 110.995 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.69 -7.47 59.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.811 0.444 . . . . 0.0 111.352 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 19.1 tptm 46.46 58.7 4.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.271 1.828 . . . . 0.0 112.167 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 161.352 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -90.23 -15.62 31.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.8 m -68.51 -47.0 68.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -59.58 -38.72 81.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.663 0.785 . . . . 0.0 110.567 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -63.83 -51.06 66.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -57.62 -48.9 78.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.086 0.955 . . . . 0.0 109.805 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -60.67 -44.72 96.14 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.412 0.685 . . . . 0.0 110.756 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.48 96.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.589 0.356 . . . . 0.0 110.238 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -82.83 42.71 0.8 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.573 ' O ' ' OD2' ' A' ' 16' ' ' ASP . . . -157.28 -37.74 0.02 OUTLIER Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 t -87.24 47.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 152.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -136.97 -36.32 0.18 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 174.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 19' ' ' LYS . 5.0 mmpt? -66.54 -39.85 88.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.705 0.802 . . . . 0.0 109.194 169.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.573 ' OD2' ' O ' ' A' ' 12' ' ' GLY . 3.5 m-20 -65.26 -25.98 67.9 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.431 1.093 . . . . 0.0 111.07 175.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.3 mt -90.1 -39.89 12.6 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.63 -30.84 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 15' ' ' LYS . 64.7 tttp -71.71 -36.87 70.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.052 0.541 . . . . 0.0 109.843 174.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.51 -41.93 56.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.58 80.88 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.309 0 C-N-CA 122.92 0.488 . . . . 0.0 111.633 -179.72 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.416 0.15 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.23 -37.66 72.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.25 1.02 . . . . 0.0 110.813 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -80.06 -41.64 25.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.135 0.574 . . . . 0.0 110.727 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 90.6 m -65.5 -50.35 65.63 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.27 0.628 . . . . 0.0 111.113 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.21 -41.25 86.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 122.784 0.433 . . . . 0.0 110.73 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.1 m -71.46 -46.82 58.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.197 0.599 . . . . 0.0 110.165 176.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.2 t -65.35 -12.01 47.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.214 0.606 . . . . 0.0 111.199 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 1.364 ' CD ' ' HD3' ' A' ' 35' ' ' LYS . 19.7 ttpp -87.27 63.49 7.81 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.799 0.809 . . . . 0.0 109.452 -172.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.56 -57.99 4.51 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 168.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.02 47.92 1.71 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.991 0.917 . . . . 0.0 108.699 171.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 1.364 ' HD3' ' CD ' ' A' ' 32' ' ' LYS . 3.0 mmmp? 49.11 56.6 7.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.942 1.297 . . . . 0.0 111.016 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.891 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -90.12 -27.3 19.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 173.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.7 m -68.41 -44.41 75.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 123.346 0.404 . . . . 0.0 110.19 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.3 mt -58.11 -45.24 87.6 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.713 0.805 . . . . 0.0 110.322 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.83 -48.07 82.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.807 0.843 . . . . 0.0 110.71 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.46 -51.35 69.82 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.805 0.842 . . . . 0.0 109.762 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -57.91 -50.89 71.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.164 0.586 . . . . 0.0 110.51 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.75 -33.68 74.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.029 0.532 . . . . 0.0 110.744 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -73.99 -30.93 62.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.968 0.507 . . . . 0.0 110.16 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -76.19 -31.01 56.26 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 173.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -86.16 43.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 160.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -141.33 -32.69 0.13 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 107.343 -2.303 . . . . 0.0 107.343 172.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 19' ' ' LYS . 70.7 mmtt -68.73 -40.93 79.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.376 0.67 . . . . 0.0 109.416 169.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -64.05 -26.19 68.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.714 0.806 . . . . 0.0 110.664 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.4 mt -90.04 -41.34 11.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.237 1.015 . . . . 0.0 108.869 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.9 t -65.31 -29.02 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 171.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 15' ' ' LYS . 23.4 tptm -72.58 -37.06 68.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.869 0.467 . . . . 0.0 109.772 175.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.85 -42.55 52.8 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.85 80.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.287 0 C-N-CA 122.825 0.45 . . . . 0.0 111.645 179.579 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.8 mt -59.87 -40.42 88.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.047 0.939 . . . . 0.0 110.36 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.6 m -70.2 -40.84 74.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.988 0.515 . . . . 0.0 110.642 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.982 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 26.1 m -69.88 -7.09 37.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.13 -39.21 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 166.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -76.3 -64.17 1.16 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.057 0.543 . . . . 0.0 110.198 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 6.8 p -77.67 43.33 0.4 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 119.435 -0.317 . . . . 0.0 110.393 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.982 ' HB2' ' O ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -90.11 -56.13 3.34 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 178.147 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 tt -29.88 -75.0 0.03 OUTLIER 'General case' 0 C--N 1.343 0.29 0 C-N-CA 126.021 1.728 . . . . 0.0 113.264 -148.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.35 59.23 1.35 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -141.76 -65.52 0.42 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.032 0.933 . . . . 0.0 110.815 -162.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 123.63 0.772 . . . . 0.0 109.472 -159.369 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.038 0 N-CA-C 112.271 -0.332 . . . . 0.0 112.271 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -35.54 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 123.98 0.912 . . . . 0.0 110.867 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.964 ' O ' ' HD2' ' A' ' 7' ' ' LYS . 82.6 mt -72.48 -18.27 61.69 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.974 0.51 . . . . 0.0 112.186 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -90.08 -26.76 20.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.2 m -68.78 -56.88 6.61 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.293 -172.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.5 mt -59.99 -36.55 77.42 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.106 0.562 . . . . 0.0 110.546 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.964 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 0.4 OUTLIER -62.61 -41.96 99.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.362 0.665 . . . . 0.0 110.286 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.16 -57.67 11.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.447 0.699 . . . . 0.0 110.387 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -65.16 -38.62 91.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.962 0.505 . . . . 0.0 111.174 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.44 96.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -81.25 47.55 1.04 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -166.15 -34.59 0.02 OUTLIER Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.1 t -87.6 46.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 154.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -154.08 -30.31 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 19' ' ' LYS . 48.1 tptt -74.79 -39.24 61.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 123.87 0.868 . . . . 0.0 109.061 170.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.41 -24.02 67.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.089 0.955 . . . . 0.0 110.834 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -89.98 -42.3 11.24 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.8 t -63.2 -31.58 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 170.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 15' ' ' LYS . 87.1 tttt -71.71 -36.2 70.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.891 0.476 . . . . 0.0 109.938 175.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.0 -40.75 56.42 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.59 88.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 170.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.07 36.54 0.87 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.942 0.497 . . . . 0.0 111.485 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -90.03 -56.79 3.09 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.218 0.607 . . . . 0.0 111.262 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.72 -72.05 1.27 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -171.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.3 t -86.37 -53.12 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 126.857 2.063 . . . . 0.0 110.551 0.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.579 ' O ' ' HB3' ' A' ' 30' ' ' SER . 86.0 mt -56.84 -33.42 66.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.839 0.855 . . . . 0.0 111.664 -175.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.873 ' O ' ' CB ' ' A' ' 31' ' ' CYS . 78.1 p -67.42 -40.33 85.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.788 0.435 . . . . 0.0 110.925 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.578 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 94.5 m -77.64 -51.88 9.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.352 0.661 . . . . 0.0 110.274 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.63 -49.07 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 123.388 0.675 . . . . 0.0 110.351 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 26' ' ' LEU . 34.8 t -66.38 -45.92 78.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.873 ' CB ' ' O ' ' A' ' 27' ' ' SER . 50.2 t -60.31 -15.61 26.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.7 0.8 . . . . 0.0 111.492 174.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 28' ' ' THR . 9.1 ttmm -80.43 56.96 2.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.191 0.52 . . . . 0.0 110.997 -171.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.3 mp -67.27 -57.11 7.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.09 43.13 2.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.057 0.943 . . . . 0.0 108.521 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.787 ' HE2' ' O ' ' A' ' 37' ' ' CYS . 22.2 tptm 48.59 61.74 2.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.06 1.344 . . . . 0.0 110.901 -175.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.3 p -89.51 10.27 23.44 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.092 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.787 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 87.4 m . . . . . 0 C--N 1.342 0.253 0 C-N-CA 123.935 0.894 . . . . 0.0 109.289 169.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.039 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.5 tp -59.48 -31.0 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 123.839 0.856 . . . . 0.0 110.65 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.659 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 81.4 mt -74.28 -21.38 59.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.121 0.568 . . . . 0.0 111.842 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -90.14 -23.52 21.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -69.86 -55.8 8.81 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 pp -63.31 -32.79 74.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.851 0.46 . . . . 0.0 110.576 174.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 1.5 tppp? -58.05 -47.46 83.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.263 1.025 . . . . 0.0 110.717 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -49.37 -54.02 19.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.782 1.233 . . . . 0.0 110.791 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -66.62 -42.64 86.47 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.071 0.549 . . . . 0.0 111.014 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.9 91.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.884 0.473 . . . . 0.0 110.978 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -69.26 -28.76 66.6 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.688 0.395 . . . . 0.0 110.505 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -74.52 -28.16 64.03 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.1 t -86.73 42.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 162.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -142.5 -32.19 0.11 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 172.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 7.2 mtpm? -77.31 -36.69 53.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.561 0.744 . . . . 0.0 109.3 172.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.55 -24.23 66.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.548 0.739 . . . . 0.0 110.371 173.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.1 mt -90.05 -45.74 8.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.002 0.921 . . . . 0.0 109.138 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.5 t -66.32 -27.89 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 65.2 tttm -74.51 -38.58 62.78 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.159 0.584 . . . . 0.0 110.186 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.79 -46.05 40.3 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.63 71.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 122.624 0.37 . . . . 0.0 110.039 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.16 -17.24 40.67 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -76.39 -41.88 46.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.051 0.54 . . . . 0.0 111.018 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -129.95 72.03 0.49 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 t -60.15 -52.2 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 123.005 0.522 . . . . 0.0 110.698 -166.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.41 -40.09 85.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.684 0.794 . . . . 0.0 111.364 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.6 p -67.41 -42.55 83.08 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.421 0.289 . . . . 0.0 111.393 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 1.075 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 66.1 m -54.31 -29.5 47.82 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.712 0.805 . . . . 0.0 111.341 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.51 -41.31 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 122.61 0.364 . . . . 0.0 110.056 176.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.0 t -76.24 -61.98 1.76 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.514 0.326 . . . . 0.0 110.319 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.6 p -77.61 31.13 0.16 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.314 0.246 . . . . 0.0 111.32 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 1.075 ' HB3' ' O ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -89.84 -25.65 20.93 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 117.658 0.208 . . . . 0.0 111.434 175.304 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.22 2.29 0.6 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.04 2.05 1.15 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.705 0.802 . . . . 0.0 111.007 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 48.4 33.49 3.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.055 1.342 . . . . 0.0 112.205 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.5 p -69.1 -27.8 65.92 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 166.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.9 m . . . . . 0 N--CA 1.45 -0.444 0 C-N-CA 124.719 1.208 . . . . 0.0 109.272 178.979 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.052 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -84.29 37.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.634 0.774 . . . . 0.0 110.652 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.24 -34.27 25.88 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.007 0.923 . . . . 0.0 111.594 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -90.13 -17.81 26.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -69.76 -54.13 15.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -174.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 pp -59.63 -34.71 73.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.642 0.377 . . . . 0.0 110.852 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.23 -42.77 96.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.784 0.833 . . . . 0.0 110.832 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -56.73 -56.11 25.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.622 0.769 . . . . 0.0 110.458 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -69.15 -31.89 70.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.88 0.472 . . . . 0.0 111.462 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.56 86.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -83.76 54.21 2.81 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 169.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.696 ' H ' ' H ' ' A' ' 14' ' ' GLY . . . -166.42 -52.83 0.03 OUTLIER Glycine 0 C--N 1.337 0.616 0 C-N-CA 124.574 1.083 . . . . 0.0 113.058 -170.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.46 0.35 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 150.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.696 ' H ' ' H ' ' A' ' 12' ' ' GLY . . . -107.8 -18.2 10.29 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.944 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 35.4 mmtp -89.13 -19.95 24.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.403 1.081 . . . . 0.0 109.797 168.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.43 -30.55 61.95 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 167.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.22 -43.86 10.13 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.137 0.975 . . . . 0.0 108.614 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -67.81 -27.54 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.949 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.944 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 13.4 tmtt? -68.43 -39.98 81.34 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.065 0.546 . . . . 0.0 109.665 172.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.15 -40.99 60.93 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.91 73.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.03 37.45 0.89 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.742 0.417 . . . . 0.0 110.929 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -90.05 -59.95 2.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.389 0.675 . . . . 0.0 109.482 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -171.29 56.46 0.18 Allowed Glycine 0 C--N 1.338 0.658 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 p -85.56 -42.99 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 123.113 0.565 . . . . 0.0 110.49 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.4 mt -56.47 -38.95 72.41 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.0 0.92 . . . . 0.0 110.828 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.8 p -68.97 -45.11 71.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.107 0.563 . . . . 0.0 110.662 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.61 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 89.7 m -54.82 -43.28 72.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.162 0.585 . . . . 0.0 111.139 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.29 -39.1 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.504 0.722 . . . . 0.0 110.798 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 t -72.54 -60.69 2.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.536 0.335 . . . . 0.0 110.484 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 6.0 p -78.46 29.18 0.19 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.897 0.479 . . . . 0.0 111.411 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 28' ' ' THR . 5.7 tmtt? -90.11 -52.43 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.38 1.072 . . . . 0.0 110.083 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.5 tp -50.2 -59.3 4.07 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.141 0.976 . . . . 0.0 110.926 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.09 -19.54 64.07 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 120.947 0.403 . . . . 0.0 111.55 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.6 tptm 56.64 55.51 6.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.53 1.932 . . . . 0.0 112.306 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.3 p -97.51 14.06 27.78 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 164.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 77.6 m . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 123.827 0.851 . . . . 0.0 109.969 -178.709 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.016 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.34 -34.95 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.692 0.797 . . . . 0.0 109.866 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.67 -22.91 63.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.098 0.559 . . . . 0.0 111.876 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -90.27 -21.31 22.16 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.6 m -72.03 -53.03 14.18 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.47 -32.09 73.44 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.917 0.487 . . . . 0.0 110.679 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -62.3 -46.47 88.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.77 0.828 . . . . 0.0 110.155 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -60.56 -50.79 72.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.01 0.924 . . . . 0.0 109.794 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -59.72 -49.47 77.62 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.991 0.516 . . . . 0.0 110.562 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.08 90.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.943 0.497 . . . . 0.0 110.456 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.99 -33.87 76.51 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.214 0.606 . . . . 0.0 110.466 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -77.38 -30.07 54.75 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.614 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 t -88.42 41.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 161.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -143.4 -29.15 0.12 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 176.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 19' ' ' LYS . 75.1 mmtt -85.75 -41.53 15.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.4 -18.17 64.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.645 0.778 . . . . 0.0 110.511 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.9 tp -87.68 -43.75 11.7 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.54 -32.85 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 15' ' ' LYS . 64.6 tttm -69.7 -32.11 70.52 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.76 0.424 . . . . 0.0 110.102 175.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.39 -47.2 29.77 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.96 -30.87 71.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.944 0.498 . . . . 0.0 110.917 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.13 -29.25 67.26 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.347 0.259 . . . . 0.0 111.366 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -55.71 -37.88 68.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.767 0.827 . . . . 0.0 111.071 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.22 80.72 0.11 Allowed Glycine 0 C--N 1.339 0.716 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.2 m -60.45 -47.51 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 122.991 0.517 . . . . 0.0 110.629 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.8 mt -59.08 -39.31 81.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.745 0.818 . . . . 0.0 110.371 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.9 t -67.87 -39.06 83.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.86 0.464 . . . . 0.0 110.733 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.745 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 39.0 m -65.48 -37.6 87.32 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.517 0.327 . . . . 0.0 110.746 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.53 -30.76 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.044 0.537 . . . . 0.0 110.405 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.9 t -81.67 -55.8 4.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.845 0.458 . . . . 0.0 109.896 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.2 t -57.65 -12.37 2.82 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.665 1.186 . . . . 0.0 111.647 175.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.745 ' HB2' ' O ' ' A' ' 28' ' ' THR . 11.9 tppt? -75.72 -42.73 49.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.13 0.972 . . . . 0.0 109.737 -175.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.7 mt -44.88 -55.15 5.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.415 1.086 . . . . 0.0 110.903 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.75 -28.41 36.51 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.276 0.56 . . . . 0.0 111.454 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 tptt 64.97 79.79 0.25 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.339 1.856 . . . . 0.0 111.104 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.3 t -129.65 16.12 5.9 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.843 162.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 56.6 m . . . . . 0 C--N 1.344 0.329 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 172.602 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.056 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.29 -26.4 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.733 1.613 . . . . 0.0 110.156 -0.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.23 -28.15 69.16 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.827 0.851 . . . . 0.0 112.378 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -90.19 -12.68 37.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.684 0.793 . . . . 0.0 110.146 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 97.9 m -61.27 -52.95 62.57 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.5 -37.21 86.76 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.305 0.642 . . . . 0.0 110.651 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -60.36 -39.31 86.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.199 0.6 . . . . 0.0 110.568 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.08 -55.94 28.16 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.836 0.854 . . . . 0.0 110.259 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -68.41 -34.41 75.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.922 0.489 . . . . 0.0 111.378 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.69 98.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.85 53.39 2.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.55 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -170.95 -46.21 0.04 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 124.656 1.122 . . . . 0.0 113.02 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.4 t -78.99 28.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 143.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -126.26 -27.02 1.14 Allowed Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 167.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.721 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 45.5 mmtm -81.13 -29.85 34.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.08 0.952 . . . . 0.0 110.111 173.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.4 -27.29 63.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.17 -43.19 10.6 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.308 1.043 . . . . 0.0 108.264 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -66.36 -27.64 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 119.356 -0.938 . . . . 0.0 108.718 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.721 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 57.6 tptt -72.62 -36.85 68.15 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.11 0.564 . . . . 0.0 109.711 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.5 -41.93 56.82 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.55 80.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.05 28.48 1.38 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.875 0.47 . . . . 0.0 111.555 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -88.6 -60.58 1.92 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.108 0.563 . . . . 0.0 109.617 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.45 81.25 0.08 OUTLIER Glycine 0 C--N 1.337 0.603 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.95 -52.09 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.564 0.746 . . . . 0.0 110.236 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.9 mt -54.7 -31.77 58.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.999 0.92 . . . . 0.0 111.115 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.2 t -82.19 -46.25 14.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.228 0.611 . . . . 0.0 110.476 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.1 m -63.53 -56.61 14.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.309 0.643 . . . . 0.0 110.57 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.6 p -49.66 -35.16 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.088 0.955 . . . . 0.0 111.876 -176.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.4 t -69.44 -60.91 2.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.116 0.567 . . . . 0.0 111.134 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 12.3 p -66.46 1.63 1.59 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 119.116 -0.469 . . . . 0.0 112.068 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 1.35 ' HD3' ' CD ' ' A' ' 35' ' ' LYS . 26.5 mmtm -90.04 52.46 2.28 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.642 0.655 . . . . 0.0 109.286 175.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.1 tp -76.44 -61.04 2.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.99 44.65 2.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 1.35 ' CD ' ' HD3' ' A' ' 32' ' ' LYS . 46.5 mmtm 49.28 61.15 3.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.968 1.307 . . . . 0.0 110.879 -171.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.7 m -61.28 -41.68 97.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 169.678 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.067 0 N-CA-C 112.391 -0.284 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.8 -34.46 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.696 0.799 . . . . 0.0 109.914 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.52 -23.59 62.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.388 0.675 . . . . 0.0 112.01 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.15 -21.28 22.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.1 m -71.73 -45.04 63.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.08 -39.97 96.29 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.592 0.757 . . . . 0.0 110.038 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.662 ' HE3' ' HD2' ' A' ' 11' ' ' LYS . 56.7 tptt -59.01 -47.15 86.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.714 0.806 . . . . 0.0 110.559 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -61.12 -47.48 86.08 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.696 0.798 . . . . 0.0 110.022 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -62.5 -42.95 99.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.307 0.643 . . . . 0.0 110.586 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.02 96.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.666 0.386 . . . . 0.0 110.105 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.662 ' HD2' ' HE3' ' A' ' 7' ' ' LYS . 63.6 mtpt -81.71 43.36 0.75 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 171.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.21 -36.46 0.02 OUTLIER Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.98 41.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 153.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.24 -32.77 0.48 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.929 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 22.7 pttp -90.06 -25.17 20.92 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.363 0.665 . . . . 0.0 110.328 173.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.7 -26.42 63.41 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 167.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -89.98 -51.68 5.35 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.127 1.371 . . . . 0.0 108.223 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.6 t -65.42 -29.99 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.929 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 13.3 tmtt? -66.61 -39.66 88.44 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 173.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.32 -44.04 60.7 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.81 77.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 171.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.47 -18.69 44.35 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -58.76 -42.63 89.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.294 0.638 . . . . 0.0 110.715 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -157.46 79.17 0.18 Allowed Glycine 0 C--N 1.338 0.641 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.95 -51.27 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 122.973 0.509 . . . . 0.0 109.82 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.8 mt -56.97 -43.51 81.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.853 0.861 . . . . 0.0 110.473 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 m -65.3 -47.26 77.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.759 0.423 . . . . 0.0 110.075 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.847 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 2.3 m -82.49 36.26 0.47 Allowed 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.978 0.174 . . . . 0.0 110.804 178.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.55 -43.17 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 148.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.7 m -74.4 -58.79 3.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.469 0.708 . . . . 0.0 110.203 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.5 p -78.91 39.14 0.36 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.321 -0.371 . . . . 0.0 111.189 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.847 ' HD3' ' O ' ' A' ' 28' ' ' THR . 13.6 mmmm -81.37 -64.07 1.26 Allowed 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.268 0.486 . . . . 0.0 112.05 165.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 32.4 tp -29.89 71.45 0.0 OUTLIER 'General case' 0 C--N 1.339 0.148 0 C-N-CA 128.352 2.661 . . . . 0.0 113.306 -163.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 32' ' ' LYS . . . 67.62 57.54 0.54 Allowed 'General case' 0 C--O 1.23 0.055 0 C-N-CA 125.716 1.606 . . . . 0.0 110.087 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.506 ' CB ' ' H ' ' A' ' 37' ' ' CYS . 82.2 mttt -144.31 -57.43 0.37 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.739 1.616 . . . . 0.0 109.605 -170.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.3 p 56.49 16.89 2.7 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.657 1.183 . . . . 0.0 109.914 -155.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.506 ' H ' ' CB ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 C-N-CA 125.021 1.328 . . . . 0.0 111.189 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.083 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.8 tp -83.17 -27.42 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 125.607 1.563 . . . . 0.0 110.636 -1.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.1 mt -67.34 -20.87 65.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.176 0.59 . . . . 0.0 112.443 -176.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -90.25 -18.82 24.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.489 0.716 . . . . 0.0 109.758 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -64.06 -47.46 80.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.3 -39.93 94.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.243 0.617 . . . . 0.0 110.532 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -63.04 -44.34 96.17 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.47 0.708 . . . . 0.0 110.377 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -56.84 -45.33 82.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.585 1.154 . . . . 0.0 110.222 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -76.98 -29.56 55.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.116 0.566 . . . . 0.0 111.282 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.68 94.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.745 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.576 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 9.1 ptpp? -83.72 44.33 0.98 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.936 0.494 . . . . 0.0 109.867 172.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.588 ' N ' ' H ' ' A' ' 14' ' ' GLY . . . -161.83 -49.12 0.02 OUTLIER Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.77 1.176 . . . . 0.0 112.862 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 91.9 t -68.34 4.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 148.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' N ' ' A' ' 12' ' ' GLY . . . -112.72 -15.36 9.45 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.935 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 98.8 mttt -89.97 -29.76 18.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.803 0.841 . . . . 0.0 109.327 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.02 -26.94 64.29 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 167.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -89.45 -46.98 8.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.797 1.239 . . . . 0.0 108.591 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.6 t -65.83 -26.78 39.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.97 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.935 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 40.5 ttmt -71.84 -38.21 70.16 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.771 0.429 . . . . 0.0 109.848 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.82 -41.78 55.0 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.87 -33.63 75.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 170.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.07 26.03 1.98 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.89 0.476 . . . . 0.0 111.638 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -79.47 -53.25 7.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.93 78.4 0.13 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.58 -57.69 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 123.199 0.599 . . . . 0.0 109.945 -175.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.37 -32.98 70.62 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.76 0.824 . . . . 0.0 110.763 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 t -70.57 -39.33 73.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.75 0.42 . . . . 0.0 110.766 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.731 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 87.4 m -65.63 -35.12 79.88 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.678 0.217 . . . . 0.0 111.288 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.9 t -51.11 -30.8 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 122.788 0.435 . . . . 0.0 110.459 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.2 t -73.98 -62.1 1.62 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.928 0.491 . . . . 0.0 112.276 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 1.349 ' HB2' ' CD ' ' A' ' 35' ' ' LYS . 10.5 p -52.54 -27.29 15.98 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.731 ' HB2' ' O ' ' A' ' 28' ' ' THR . 62.2 tttp -79.06 65.78 4.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.666 1.222 . . . . 0.0 110.386 -158.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.3 mt -87.67 -53.15 4.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.078 -1.874 . . . . 0.0 108.495 166.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.09 0.19 0.32 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.594 0.757 . . . . 0.0 112.081 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 1.349 ' CD ' ' HB2' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -88.57 -46.64 8.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.886 1.274 . . . . 0.0 111.908 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 37' ' ' CYS . 4.8 m 61.7 13.26 5.19 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -159.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 36' ' ' THR . 1.7 m . . . . . 0 C--N 1.345 0.385 0 C-N-CA 123.928 0.891 . . . . 0.0 110.131 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.047 0 N-CA-C 112.385 -0.286 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.86 -30.01 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.168 0.587 . . . . 0.0 109.738 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.158 ' O ' ' HD3' ' A' ' 7' ' ' LYS . 3.9 mm? -64.51 -26.54 68.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.266 0.626 . . . . 0.0 111.662 174.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.17 -19.84 23.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.4 m -75.49 -45.41 38.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.5 -40.23 86.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.393 0.677 . . . . 0.0 110.092 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 1.158 ' HD3' ' O ' ' A' ' 3' ' ' LEU . 4.3 mptp? -64.87 -47.17 78.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.51 0.724 . . . . 0.0 109.955 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -61.83 -46.22 90.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.654 0.782 . . . . 0.0 110.152 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -60.86 -50.79 72.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.956 0.502 . . . . 0.0 110.221 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.79 -28.62 69.7 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.142 0.577 . . . . 0.0 111.291 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -72.09 -41.21 67.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.151 0.58 . . . . 0.0 110.26 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.85 -30.63 34.83 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.3 t -90.01 45.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 159.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.38 -30.16 0.13 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.92 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 20.5 ptmt -88.46 -20.12 25.6 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.741 0.416 . . . . 0.0 110.189 173.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.4 -27.64 61.57 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.01 -48.43 7.21 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.855 1.262 . . . . 0.0 108.314 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.1 t -67.16 -28.9 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.92 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 29.4 tptp -69.95 -34.06 72.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.4 -45.32 48.01 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.74 -30.2 70.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.708 0.403 . . . . 0.0 110.709 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.98 -17.48 64.7 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -55.57 -41.3 73.1 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.617 0.767 . . . . 0.0 110.937 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.84 77.61 0.1 Allowed Glycine 0 C--N 1.337 0.631 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -53.82 -42.41 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 123.468 0.707 . . . . 0.0 111.057 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.2 mt -56.67 -37.47 70.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.576 1.151 . . . . 0.0 111.512 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.2 p -90.12 -44.36 9.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.119 0.567 . . . . 0.0 111.255 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.437 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 99.1 m -49.2 -54.19 17.73 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.512 0.725 . . . . 0.0 110.889 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 p -48.86 -32.59 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.671 0.788 . . . . 0.0 111.131 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 t -87.44 -60.07 2.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.539 0.736 . . . . 0.0 111.288 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.826 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 35.2 m -59.36 -8.81 1.9 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.993 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -78.24 29.38 0.18 Allowed 'General case' 0 C--N 1.342 0.241 0 C-N-CA 118.61 -1.236 . . . . 0.0 113.023 -163.319 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.56 -41.3 89.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 166.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.56 44.99 1.62 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.875 0.87 . . . . 0.0 109.534 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? 48.91 46.06 22.24 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.847 1.259 . . . . 0.0 110.788 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.826 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 57.6 m -73.06 -18.42 61.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.063 0.545 . . . . 0.0 112.146 -169.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 C--N 1.341 0.212 0 C-N-CA 122.779 0.432 . . . . 0.0 110.074 177.036 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.079 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.0 pt -80.5 53.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.73 0.812 . . . . 0.0 110.278 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 70.8 mt -84.13 -46.13 12.26 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.655 0.782 . . . . 0.0 111.416 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.1 -11.49 41.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.803 0.841 . . . . 0.0 109.156 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 88.1 m -74.36 -59.32 2.78 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -172.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.0 mt -57.24 -40.0 76.71 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.714 0.405 . . . . 0.0 110.123 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -57.53 -45.47 85.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.227 1.011 . . . . 0.0 111.182 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -58.96 -51.57 69.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.165 0.586 . . . . 0.0 110.225 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -66.18 -39.66 89.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.894 0.478 . . . . 0.0 111.085 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.72 -37.52 84.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 175.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.0 mtpt -81.81 43.38 0.76 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 171.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -164.57 -36.86 0.02 OUTLIER Glycine 0 C--N 1.337 0.617 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.2 46.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 154.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -152.21 -29.34 0.04 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 19' ' ' LYS . 62.1 mtpt -79.85 -41.1 26.99 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.2 -22.49 66.9 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.033 0.933 . . . . 0.0 110.73 173.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.2 mt -90.09 -41.05 11.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.12 0.968 . . . . 0.0 108.586 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.5 -32.38 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 170.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 15' ' ' LYS . 23.4 tptm -70.21 -36.59 74.68 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.6 -41.56 50.5 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.05 82.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 170.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.06 41.54 1.05 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.111 0.564 . . . . 0.0 111.047 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -90.01 -58.86 2.36 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.375 0.67 . . . . 0.0 110.196 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.58 -79.23 1.21 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t -84.29 -44.19 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 126.132 1.773 . . . . 0.0 109.76 -1.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.8 mt -53.57 -19.27 3.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.855 1.262 . . . . 0.0 112.575 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.9 m -87.75 -48.95 7.45 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.155 0.582 . . . . 0.0 110.749 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.562 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 94.1 m -48.21 -51.83 23.59 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.528 0.731 . . . . 0.0 111.229 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 m -49.48 -39.94 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 124.327 1.051 . . . . 0.0 112.263 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.5 p -72.6 -56.13 5.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.307 0.243 . . . . 0.0 110.661 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.7 p -81.91 27.16 0.47 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.516 0.726 . . . . 0.0 111.256 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 28' ' ' THR . 13.5 tmtt? -88.37 -41.7 12.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.978 0.511 . . . . 0.0 111.92 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 tp -48.53 -65.6 0.54 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.534 1.134 . . . . 0.0 111.528 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.22 -11.0 60.36 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.573 0.349 . . . . 0.0 111.524 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 16.4 tptm 48.49 51.74 14.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.824 2.049 . . . . 0.0 112.725 176.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.3 t -72.97 -16.04 61.53 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 159.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.451 -0.4 0 C-N-CA 124.576 1.15 . . . . 0.0 108.74 177.511 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 N-CA-C 112.308 -0.317 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -90.05 15.32 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.368 1.467 . . . . 0.0 111.732 -1.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.9 mt -78.49 -17.38 56.35 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.206 0.602 . . . . 0.0 111.8 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.27 -28.98 18.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 168.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -74.86 -55.88 5.34 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.927 0.491 . . . . 0.0 111.646 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.42 -35.26 78.68 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.662 0.385 . . . . 0.0 110.091 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' N ' ' CD ' ' A' ' 7' ' ' LYS . 11.6 mptt -67.14 -39.76 86.63 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.776 1.23 . . . . 0.0 110.607 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -63.67 -47.5 80.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.551 0.741 . . . . 0.0 109.694 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -66.26 -45.49 80.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.045 0.538 . . . . 0.0 110.388 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.96 88.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 173.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -81.02 41.7 0.6 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.564 0.746 . . . . 0.0 109.245 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -162.88 -38.49 0.02 OUTLIER Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.68 45.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 155.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -146.56 -31.52 0.07 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.6 -41.26 27.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 170.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -65.99 -17.53 64.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.087 0.955 . . . . 0.0 111.08 173.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 mt -90.1 -41.74 11.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -65.42 -32.31 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' C ' ' HD3' ' A' ' 19' ' ' LYS . 1.4 tmtp? -69.28 -34.74 75.19 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.204 0.601 . . . . 0.0 109.874 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.02 -47.94 50.96 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.75 -30.17 70.78 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.078 0.551 . . . . 0.0 110.982 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.81 -33.18 73.67 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 117.493 0.133 . . . . 0.0 111.014 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -59.76 -47.49 85.48 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.538 0.735 . . . . 0.0 110.479 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.52 99.01 0.13 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.8 t -58.67 -60.13 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -171.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.38 -39.18 69.81 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.638 0.775 . . . . 0.0 110.661 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 t -63.96 -51.48 64.16 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.922 0.489 . . . . 0.0 110.432 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.854 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 62.4 m -60.72 -49.2 78.47 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.617 0.367 . . . . 0.0 110.246 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.87 -34.58 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.449 0.699 . . . . 0.0 110.607 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.2 t -72.37 -62.0 1.6 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.5 p -75.51 20.12 0.17 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.778 0.431 . . . . 0.0 111.55 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.854 ' HB2' ' O ' ' A' ' 28' ' ' THR . 41.1 ttmt -90.07 -34.17 16.03 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.605 0.762 . . . . 0.0 111.332 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.3 tp -57.15 -53.62 56.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 36' ' ' THR . . . -80.69 78.58 7.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 160.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -63.39 22.75 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 126.561 1.944 . . . . 0.0 112.106 -171.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 34' ' ' ALA . 15.2 t -81.05 18.59 1.01 Allowed 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.947 -0.47 . . . . 0.0 109.82 169.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 119.123 -0.465 . . . . 0.0 110.091 -172.244 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.019 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -33.76 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.795 0.838 . . . . 0.0 109.999 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.11 -25.55 64.46 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.54 0.736 . . . . 0.0 112.065 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -90.21 -20.78 22.62 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.0 m -73.3 -50.61 21.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.52 -33.67 76.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 173.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.33 -45.03 96.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.963 0.905 . . . . 0.0 110.499 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -51.05 -52.21 45.49 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.453 1.101 . . . . 0.0 110.509 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -79.67 -30.54 41.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.563 0.745 . . . . 0.0 111.711 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.53 91.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.64 0.376 . . . . 0.0 110.82 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -64.86 -30.07 71.05 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.228 0.611 . . . . 0.0 110.654 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -76.24 -30.34 57.15 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 t -87.38 36.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 162.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -127.96 -33.77 0.58 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.245 -2.342 . . . . 0.0 107.245 170.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 19' ' ' LYS . 70.5 mmtt -73.97 -45.8 47.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.57 0.748 . . . . 0.0 109.421 172.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.19 -18.42 65.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.376 0.67 . . . . 0.0 110.472 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.99 -43.39 10.57 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.089 1.355 . . . . 0.0 107.897 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.0 t -63.3 -33.93 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -70.58 -32.49 69.89 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.753 0.421 . . . . 0.0 109.893 175.349 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.46 -45.85 44.23 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.02 -29.45 69.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.917 0.487 . . . . 0.0 110.921 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.53 -34.95 76.43 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 117.534 0.152 . . . . 0.0 111.005 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -60.54 -30.67 69.91 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.742 0.817 . . . . 0.0 111.227 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -161.41 85.89 0.11 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.16 -61.55 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -172.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -54.53 -36.8 64.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.065 0.946 . . . . 0.0 111.353 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 80.4 p -67.64 -48.47 66.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.414 0.285 . . . . 0.0 110.646 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.61 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 66.0 m -57.7 -46.87 83.76 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.068 0.547 . . . . 0.0 110.47 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.8 t -54.23 -31.78 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.573 0.749 . . . . 0.0 110.721 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.8 m -89.98 -48.37 7.25 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.995 0.518 . . . . 0.0 111.412 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 74.7 m -57.18 -19.07 18.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.65 0.38 . . . . 0.0 111.75 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.612 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -76.32 24.39 0.14 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -158.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.5 tp -60.33 -49.07 79.07 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.29 45.4 1.85 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.872 0.869 . . . . 0.0 108.9 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 45.52 57.94 4.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.3 1.44 . . . . 0.0 111.057 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 59.0 m -69.35 -21.08 63.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.057 176.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.452 -0.365 0 C-N-CA 122.552 0.341 . . . . 0.0 110.665 175.522 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.019 0 N-CA-C 112.272 -0.331 . . . . 0.0 112.272 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.8 tp -58.22 -31.69 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 123.717 0.807 . . . . 0.0 110.617 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.105 ' O ' ' HD2' ' A' ' 7' ' ' LYS . 89.8 mt -72.15 -21.59 61.43 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.55 0.74 . . . . 0.0 112.2 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -90.1 -25.37 20.77 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.4 m -75.04 -48.59 23.26 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 123.375 0.422 . . . . 0.0 110.342 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.72 -38.52 91.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 1.105 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 0.6 OUTLIER -62.7 -41.07 98.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.92 0.888 . . . . 0.0 110.529 178.855 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -52.32 -43.41 64.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.93 0.892 . . . . 0.0 110.709 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -90.05 -39.36 12.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.605 0.762 . . . . 0.0 111.59 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.76 -38.88 76.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.204 0.602 . . . . 0.0 111.857 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -67.7 -35.16 78.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 119.473 -0.299 . . . . 0.0 110.748 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -71.53 -24.85 76.31 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.58 49.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 160.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -148.43 -33.97 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 174.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -72.29 -43.6 63.99 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.152 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.66 -23.48 67.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.514 0.726 . . . . 0.0 111.045 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.4 mt -88.46 -37.59 15.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 t -66.65 -29.94 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -79.89 1.69 26.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.127 0.571 . . . . 0.0 110.585 174.46 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.03 -68.38 0.35 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.42 -63.91 1.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.643 0.777 . . . . 0.0 110.891 177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.02 40.81 1.02 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.803 0.841 . . . . 0.0 110.767 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.94 -60.04 2.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.58 74.47 0.16 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.06 -49.97 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.295 0.638 . . . . 0.0 110.175 -175.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 30' ' ' SER . 87.8 mt -50.89 -39.44 54.23 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.486 1.114 . . . . 0.0 111.81 -177.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.9 p -80.8 -42.05 22.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.761 0.424 . . . . 0.0 110.896 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.5 m -62.53 -52.35 63.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.302 0.641 . . . . 0.0 110.486 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.11 -36.75 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 122.946 0.499 . . . . 0.0 110.595 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 35.6 t -67.29 -55.53 13.52 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.511 0.725 . . . . 0.0 110.964 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.1 p -70.92 7.42 1.17 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.649 0.38 . . . . 0.0 111.837 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.705 ' HD2' ' HE3' ' A' ' 35' ' ' LYS . 22.9 ttpp -80.81 59.03 3.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.631 0.729 . . . . 0.0 109.871 -172.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.01 72.27 7.41 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 168.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.17 50.05 3.15 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.617 1.167 . . . . 0.0 110.189 -170.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.705 ' HE3' ' HD2' ' A' ' 32' ' ' LYS . 35.6 mmtp 53.79 67.7 0.96 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.024 1.33 . . . . 0.0 111.425 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.6 m -76.7 -37.63 55.79 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.621 0.368 . . . . 0.0 110.206 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.341 0.206 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.987 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.037 0 N-CA-C 112.32 -0.312 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.5 pp -82.29 38.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.678 0.791 . . . . 0.0 110.638 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.4 mt -82.23 -37.09 26.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.89 0.876 . . . . 0.0 111.422 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -90.01 -16.65 29.36 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.873 0.869 . . . . 0.0 108.967 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.0 m -73.26 -51.65 16.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.997 -173.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.3 mt -66.41 -36.29 82.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.946 0.499 . . . . 0.0 109.959 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -57.08 -46.94 82.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.905 0.882 . . . . 0.0 110.554 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -57.79 -49.32 77.0 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.127 0.971 . . . . 0.0 110.209 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -65.99 -43.02 89.03 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.238 0.615 . . . . 0.0 110.927 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.54 95.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.074 0.55 . . . . 0.0 111.74 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -82.05 -18.62 42.56 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 117.923 0.328 . . . . 0.0 111.151 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.18 -28.85 47.84 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 170.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.02 47.22 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 158.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.26 -28.35 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.926 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 3.0 pptp? -89.07 -22.66 22.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.895 0.478 . . . . 0.0 109.923 173.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.75 -27.0 62.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.147 0.579 . . . . 0.0 109.549 167.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.1 mt -90.16 -48.09 7.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.324 1.049 . . . . 0.0 108.964 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 t -65.96 -31.95 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.926 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 1.2 tmtp? -67.4 -39.63 85.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.195 0.598 . . . . 0.0 109.72 173.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.17 -41.87 59.19 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.42 -35.06 79.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 170.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.1 27.02 1.71 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.821 0.449 . . . . 0.0 111.648 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -78.87 -62.01 1.83 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.94 52.39 0.16 Allowed Glycine 0 C--N 1.336 0.557 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 p -73.55 -46.02 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.21 -36.05 82.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.56 0.744 . . . . 0.0 110.228 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.4 m -64.62 -47.1 79.8 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.118 0.567 . . . . 0.0 110.403 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.756 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 98.0 m -57.25 -50.38 73.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.076 0.55 . . . . 0.0 110.367 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.7 t -54.56 -33.22 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.815 0.846 . . . . 0.0 110.948 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.4 t -73.16 -62.63 1.4 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.192 0.197 . . . . 0.0 110.611 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -75.78 16.41 0.4 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.448 0.299 . . . . 0.0 111.621 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.756 ' HB2' ' O ' ' A' ' 28' ' ' THR . 68.5 tttt -90.2 -31.93 16.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.059 0.543 . . . . 0.0 111.49 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.2 tp -51.23 -64.13 0.91 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.794 0.838 . . . . 0.0 110.995 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.69 -7.47 59.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.811 0.444 . . . . 0.0 111.352 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.627 ' HE2' ' O ' ' A' ' 37' ' ' CYS . 19.1 tptm 46.46 58.7 4.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.271 1.828 . . . . 0.0 112.167 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.3 t -76.22 -18.24 59.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 161.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.627 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 63.1 m . . . . . 0 N--CA 1.452 -0.333 0 C-N-CA 124.015 0.926 . . . . 0.0 109.875 176.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.005 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -82.4 39.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.626 0.77 . . . . 0.0 110.522 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.3 mt -82.81 -35.68 26.21 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.505 0.722 . . . . 0.0 111.577 -172.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -90.23 -15.62 31.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.8 m -68.51 -47.0 68.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -59.58 -38.72 81.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.663 0.785 . . . . 0.0 110.567 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -63.83 -51.06 66.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -57.62 -48.9 78.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.086 0.955 . . . . 0.0 109.805 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -60.67 -44.72 96.14 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.412 0.685 . . . . 0.0 110.756 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.48 96.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.589 0.356 . . . . 0.0 110.238 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -82.83 42.71 0.8 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.573 ' O ' ' OD2' ' A' ' 16' ' ' ASP . . . -157.28 -37.74 0.02 OUTLIER Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 t -87.24 47.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 152.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -136.97 -36.32 0.18 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 174.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 19' ' ' LYS . 5.0 mmpt? -66.54 -39.85 88.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.705 0.802 . . . . 0.0 109.194 169.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.573 ' OD2' ' O ' ' A' ' 12' ' ' GLY . 3.5 m-20 -65.26 -25.98 67.9 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.431 1.093 . . . . 0.0 111.07 175.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.3 mt -90.1 -39.89 12.6 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.63 -30.84 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 15' ' ' LYS . 64.7 tttp -71.71 -36.87 70.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.052 0.541 . . . . 0.0 109.843 174.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.51 -41.93 56.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.58 80.88 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.01 28.77 1.31 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.92 0.488 . . . . 0.0 111.633 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? -78.81 -55.23 5.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.94 76.3 0.11 Allowed Glycine 0 C--N 1.337 0.596 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m -56.41 -44.67 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.592 0.757 . . . . 0.0 110.843 -176.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.23 -37.66 72.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.25 1.02 . . . . 0.0 110.813 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -80.06 -41.64 25.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.135 0.574 . . . . 0.0 110.727 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 90.6 m -65.5 -50.35 65.63 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.27 0.628 . . . . 0.0 111.113 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.21 -41.25 86.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 122.784 0.433 . . . . 0.0 110.73 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.1 m -71.46 -46.82 58.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.197 0.599 . . . . 0.0 110.165 176.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.2 t -65.35 -12.01 47.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.214 0.606 . . . . 0.0 111.199 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 1.364 ' CD ' ' HD3' ' A' ' 35' ' ' LYS . 19.7 ttpp -87.27 63.49 7.81 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.799 0.809 . . . . 0.0 109.452 -172.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.56 -57.99 4.51 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 168.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.02 47.92 1.71 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.991 0.917 . . . . 0.0 108.699 171.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 1.364 ' HD3' ' CD ' ' A' ' 32' ' ' LYS . 3.0 mmmp? 49.11 56.6 7.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.942 1.297 . . . . 0.0 111.016 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -71.61 -35.76 70.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 91.5 m . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 170.444 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.002 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.61 -36.52 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.384 0.674 . . . . 0.0 109.599 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.9 mt -73.65 -15.44 61.25 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.907 0.483 . . . . 0.0 112.104 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -90.12 -27.3 19.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 173.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.7 m -68.41 -44.41 75.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 123.346 0.404 . . . . 0.0 110.19 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.3 mt -58.11 -45.24 87.6 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.713 0.805 . . . . 0.0 110.322 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.83 -48.07 82.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.807 0.843 . . . . 0.0 110.71 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.46 -51.35 69.82 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.805 0.842 . . . . 0.0 109.762 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -57.91 -50.89 71.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.164 0.586 . . . . 0.0 110.51 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.75 -33.68 74.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.029 0.532 . . . . 0.0 110.744 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -73.99 -30.93 62.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.968 0.507 . . . . 0.0 110.16 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -76.19 -31.01 56.26 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 173.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -86.16 43.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 160.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -141.33 -32.69 0.13 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 107.343 -2.303 . . . . 0.0 107.343 172.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 19' ' ' LYS . 70.7 mmtt -68.73 -40.93 79.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.376 0.67 . . . . 0.0 109.416 169.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -64.05 -26.19 68.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.714 0.806 . . . . 0.0 110.664 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.4 mt -90.04 -41.34 11.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.237 1.015 . . . . 0.0 108.869 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.9 t -65.31 -29.02 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 171.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 15' ' ' LYS . 23.4 tptm -72.58 -37.06 68.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.869 0.467 . . . . 0.0 109.772 175.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.85 -42.55 52.8 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.85 80.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.08 27.38 1.63 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.825 0.45 . . . . 0.0 111.645 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -78.65 -62.55 1.65 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.35 46.7 0.17 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 177.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.0 p -64.0 -41.91 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 122.916 0.486 . . . . 0.0 110.061 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.8 mt -59.87 -40.42 88.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.047 0.939 . . . . 0.0 110.36 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.6 m -70.2 -40.84 74.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.988 0.515 . . . . 0.0 110.642 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.982 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 26.1 m -69.88 -7.09 37.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.13 -39.21 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 166.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -76.3 -64.17 1.16 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.057 0.543 . . . . 0.0 110.198 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 6.8 p -77.67 43.33 0.4 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 119.435 -0.317 . . . . 0.0 110.393 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.982 ' HB2' ' O ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -90.11 -56.13 3.34 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 178.147 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 tt -29.88 -75.0 0.03 OUTLIER 'General case' 0 C--N 1.343 0.29 0 C-N-CA 126.021 1.728 . . . . 0.0 113.264 -148.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.35 59.23 1.35 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.411 ' CB ' ' H ' ' A' ' 37' ' ' CYS . 45.2 mtpt -141.76 -65.52 0.42 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.032 0.933 . . . . 0.0 110.815 -162.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m 63.37 11.92 5.86 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.63 0.772 . . . . 0.0 109.472 -159.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.411 ' H ' ' CB ' ' A' ' 35' ' ' LYS . 1.2 t . . . . . 0 N--CA 1.452 -0.373 0 C-N-CA 124.642 1.177 . . . . 0.0 111.569 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.964 ' O ' ' HD2' ' A' ' 7' ' ' LYS . 82.6 mt . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -90.08 -26.76 20.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.2 m -68.78 -56.88 6.61 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.293 -172.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.5 mt -59.99 -36.55 77.42 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.106 0.562 . . . . 0.0 110.546 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.964 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 0.4 OUTLIER -62.61 -41.96 99.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.362 0.665 . . . . 0.0 110.286 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.16 -57.67 11.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.447 0.699 . . . . 0.0 110.387 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -65.16 -38.62 91.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.962 0.505 . . . . 0.0 111.174 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.44 96.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -81.25 47.55 1.04 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -166.15 -34.59 0.02 OUTLIER Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.1 t -87.6 46.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 154.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -154.08 -30.31 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 19' ' ' LYS . 48.1 tptt -74.79 -39.24 61.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 123.87 0.868 . . . . 0.0 109.061 170.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.41 -24.02 67.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.089 0.955 . . . . 0.0 110.834 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -89.98 -42.3 11.24 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.8 t -63.2 -31.58 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 170.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 15' ' ' LYS . 87.1 tttt -71.71 -36.2 70.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.891 0.476 . . . . 0.0 109.938 175.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.0 -40.75 56.42 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.59 88.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 170.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.284 0 C-N-CA 122.942 0.497 . . . . 0.0 111.485 -179.027 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 110.551 -0.166 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.579 ' O ' ' HB3' ' A' ' 30' ' ' SER . 86.0 mt -56.84 -33.42 66.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.839 0.855 . . . . 0.0 111.664 -175.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.873 ' O ' ' CB ' ' A' ' 31' ' ' CYS . 78.1 p -67.42 -40.33 85.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.788 0.435 . . . . 0.0 110.925 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.578 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 94.5 m -77.64 -51.88 9.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.352 0.661 . . . . 0.0 110.274 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.63 -49.07 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 123.388 0.675 . . . . 0.0 110.351 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 26' ' ' LEU . 34.8 t -66.38 -45.92 78.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.873 ' CB ' ' O ' ' A' ' 27' ' ' SER . 50.2 t -60.31 -15.61 26.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.7 0.8 . . . . 0.0 111.492 174.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 28' ' ' THR . 9.1 ttmm -80.43 56.96 2.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.191 0.52 . . . . 0.0 110.997 -171.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.3 mp -67.27 -57.11 7.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.09 43.13 2.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.057 0.943 . . . . 0.0 108.521 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.2 tptm 48.59 61.74 2.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.06 1.344 . . . . 0.0 110.901 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.453 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.092 172.756 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.659 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 81.4 mt . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -90.14 -23.52 21.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -69.86 -55.8 8.81 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 pp -63.31 -32.79 74.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.851 0.46 . . . . 0.0 110.576 174.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 1.5 tppp? -58.05 -47.46 83.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.263 1.025 . . . . 0.0 110.717 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -49.37 -54.02 19.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.782 1.233 . . . . 0.0 110.791 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -66.62 -42.64 86.47 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.071 0.549 . . . . 0.0 111.014 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.9 91.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.884 0.473 . . . . 0.0 110.978 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -69.26 -28.76 66.6 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.688 0.395 . . . . 0.0 110.505 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -74.52 -28.16 64.03 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.1 t -86.73 42.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 162.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -142.5 -32.19 0.11 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 172.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 7.2 mtpm? -77.31 -36.69 53.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.561 0.744 . . . . 0.0 109.3 172.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.55 -24.23 66.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.548 0.739 . . . . 0.0 110.371 173.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.1 mt -90.05 -45.74 8.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.002 0.921 . . . . 0.0 109.138 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.5 t -66.32 -27.89 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 65.2 tttm -74.51 -38.58 62.78 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.159 0.584 . . . . 0.0 110.186 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.79 -46.05 40.3 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.63 71.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 122.624 0.37 . . . . 0.0 110.039 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.876 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.448 -0.561 0 CA-C-O 120.38 0.134 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.41 -40.09 85.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.684 0.794 . . . . 0.0 111.364 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.6 p -67.41 -42.55 83.08 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.421 0.289 . . . . 0.0 111.393 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 1.075 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 66.1 m -54.31 -29.5 47.82 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.712 0.805 . . . . 0.0 111.341 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.51 -41.31 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 122.61 0.364 . . . . 0.0 110.056 176.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.0 t -76.24 -61.98 1.76 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.514 0.326 . . . . 0.0 110.319 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.6 p -77.61 31.13 0.16 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.314 0.246 . . . . 0.0 111.32 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 1.075 ' HB3' ' O ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -89.84 -25.65 20.93 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 117.658 0.208 . . . . 0.0 111.434 175.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.22 2.29 0.6 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.04 2.05 1.15 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.705 0.802 . . . . 0.0 111.007 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 48.4 33.49 3.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.055 1.342 . . . . 0.0 112.205 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 166.112 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -90.13 -17.81 26.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -69.76 -54.13 15.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -174.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 pp -59.63 -34.71 73.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.642 0.377 . . . . 0.0 110.852 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.23 -42.77 96.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.784 0.833 . . . . 0.0 110.832 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -56.73 -56.11 25.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.622 0.769 . . . . 0.0 110.458 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -69.15 -31.89 70.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.88 0.472 . . . . 0.0 111.462 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.56 86.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -83.76 54.21 2.81 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 169.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.696 ' H ' ' H ' ' A' ' 14' ' ' GLY . . . -166.42 -52.83 0.03 OUTLIER Glycine 0 C--N 1.337 0.616 0 C-N-CA 124.574 1.083 . . . . 0.0 113.058 -170.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.46 0.35 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 150.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.696 ' H ' ' H ' ' A' ' 12' ' ' GLY . . . -107.8 -18.2 10.29 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.944 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 35.4 mmtp -89.13 -19.95 24.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.403 1.081 . . . . 0.0 109.797 168.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.43 -30.55 61.95 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 167.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.22 -43.86 10.13 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.137 0.975 . . . . 0.0 108.614 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -67.81 -27.54 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.949 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.944 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 13.4 tmtt? -68.43 -39.98 81.34 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.065 0.546 . . . . 0.0 109.665 172.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.15 -40.99 60.93 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.91 73.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 122.742 0.417 . . . . 0.0 110.929 178.991 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.4 mt -56.47 -38.95 72.41 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.0 0.92 . . . . 0.0 110.828 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.8 p -68.97 -45.11 71.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.107 0.563 . . . . 0.0 110.662 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.61 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 89.7 m -54.82 -43.28 72.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.162 0.585 . . . . 0.0 111.139 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.29 -39.1 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.504 0.722 . . . . 0.0 110.798 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 t -72.54 -60.69 2.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.536 0.335 . . . . 0.0 110.484 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 6.0 p -78.46 29.18 0.19 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.897 0.479 . . . . 0.0 111.411 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 28' ' ' THR . 5.7 tmtt? -90.11 -52.43 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.38 1.072 . . . . 0.0 110.083 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.5 tp -50.2 -59.3 4.07 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.141 0.976 . . . . 0.0 110.926 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.09 -19.54 64.07 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 120.947 0.403 . . . . 0.0 111.55 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.6 tptm 56.64 55.51 6.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.53 1.932 . . . . 0.0 112.306 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 164.0 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -90.27 -21.31 22.16 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.6 m -72.03 -53.03 14.18 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.47 -32.09 73.44 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.917 0.487 . . . . 0.0 110.679 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -62.3 -46.47 88.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.77 0.828 . . . . 0.0 110.155 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -60.56 -50.79 72.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.01 0.924 . . . . 0.0 109.794 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -59.72 -49.47 77.62 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.991 0.516 . . . . 0.0 110.562 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.08 90.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.943 0.497 . . . . 0.0 110.456 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.99 -33.87 76.51 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.214 0.606 . . . . 0.0 110.466 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -77.38 -30.07 54.75 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.614 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 t -88.42 41.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 161.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -143.4 -29.15 0.12 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 176.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 19' ' ' LYS . 75.1 mmtt -85.75 -41.53 15.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.4 -18.17 64.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.645 0.778 . . . . 0.0 110.511 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.9 tp -87.68 -43.75 11.7 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.54 -32.85 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 15' ' ' LYS . 64.6 tttm -69.7 -32.11 70.52 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.76 0.424 . . . . 0.0 110.102 175.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.39 -47.2 29.77 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.96 -30.87 71.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.944 0.498 . . . . 0.0 110.917 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.142 0 C-N-CA 122.347 0.259 . . . . 0.0 111.366 -178.587 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 120.423 0.154 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.8 mt -59.08 -39.31 81.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.745 0.818 . . . . 0.0 110.371 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.9 t -67.87 -39.06 83.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.86 0.464 . . . . 0.0 110.733 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.745 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 39.0 m -65.48 -37.6 87.32 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.517 0.327 . . . . 0.0 110.746 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.53 -30.76 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.044 0.537 . . . . 0.0 110.405 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.9 t -81.67 -55.8 4.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.845 0.458 . . . . 0.0 109.896 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.2 t -57.65 -12.37 2.82 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.665 1.186 . . . . 0.0 111.647 175.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.745 ' HB2' ' O ' ' A' ' 28' ' ' THR . 11.9 tppt? -75.72 -42.73 49.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.13 0.972 . . . . 0.0 109.737 -175.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.7 mt -44.88 -55.15 5.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.415 1.086 . . . . 0.0 110.903 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.75 -28.41 36.51 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.276 0.56 . . . . 0.0 111.454 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 tptt 64.97 79.79 0.25 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.339 1.856 . . . . 0.0 111.104 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.452 -0.349 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.843 162.639 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -90.19 -12.68 37.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.684 0.793 . . . . 0.0 110.146 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 97.9 m -61.27 -52.95 62.57 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.5 -37.21 86.76 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.305 0.642 . . . . 0.0 110.651 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -60.36 -39.31 86.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.199 0.6 . . . . 0.0 110.568 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.08 -55.94 28.16 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.836 0.854 . . . . 0.0 110.259 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -68.41 -34.41 75.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.922 0.489 . . . . 0.0 111.378 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.69 98.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.85 53.39 2.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.55 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -170.95 -46.21 0.04 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 124.656 1.122 . . . . 0.0 113.02 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.4 t -78.99 28.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 143.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -126.26 -27.02 1.14 Allowed Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 167.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.721 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 45.5 mmtm -81.13 -29.85 34.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.08 0.952 . . . . 0.0 110.111 173.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.4 -27.29 63.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.17 -43.19 10.6 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.308 1.043 . . . . 0.0 108.264 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -66.36 -27.64 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 119.356 -0.938 . . . . 0.0 108.718 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.721 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 57.6 tptt -72.62 -36.85 68.15 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.11 0.564 . . . . 0.0 109.711 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.5 -41.93 56.82 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.55 80.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 122.875 0.47 . . . . 0.0 111.555 179.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 N--CA 1.455 -0.215 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.9 mt -54.7 -31.77 58.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.999 0.92 . . . . 0.0 111.115 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.2 t -82.19 -46.25 14.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.228 0.611 . . . . 0.0 110.476 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.1 m -63.53 -56.61 14.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.309 0.643 . . . . 0.0 110.57 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.6 p -49.66 -35.16 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.088 0.955 . . . . 0.0 111.876 -176.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.4 t -69.44 -60.91 2.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.116 0.567 . . . . 0.0 111.134 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 12.3 p -66.46 1.63 1.59 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 119.116 -0.469 . . . . 0.0 112.068 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 1.35 ' HD3' ' CD ' ' A' ' 35' ' ' LYS . 26.5 mmtm -90.04 52.46 2.28 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.642 0.655 . . . . 0.0 109.286 175.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.1 tp -76.44 -61.04 2.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.99 44.65 2.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 1.35 ' CD ' ' HD3' ' A' ' 32' ' ' LYS . 46.5 mmtm 49.28 61.15 3.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.968 1.307 . . . . 0.0 110.879 -171.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.055 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.15 -21.28 22.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.1 m -71.73 -45.04 63.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.08 -39.97 96.29 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.592 0.757 . . . . 0.0 110.038 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.662 ' HE3' ' HD2' ' A' ' 11' ' ' LYS . 56.7 tptt -59.01 -47.15 86.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.714 0.806 . . . . 0.0 110.559 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -61.12 -47.48 86.08 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.696 0.798 . . . . 0.0 110.022 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -62.5 -42.95 99.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.307 0.643 . . . . 0.0 110.586 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.02 96.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.666 0.386 . . . . 0.0 110.105 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.662 ' HD2' ' HE3' ' A' ' 7' ' ' LYS . 63.6 mtpt -81.71 43.36 0.75 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 171.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.21 -36.46 0.02 OUTLIER Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.98 41.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 153.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.24 -32.77 0.48 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.929 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 22.7 pttp -90.06 -25.17 20.92 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.363 0.665 . . . . 0.0 110.328 173.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.7 -26.42 63.41 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 167.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -89.98 -51.68 5.35 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.127 1.371 . . . . 0.0 108.223 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.6 t -65.42 -29.99 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.929 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 13.3 tmtt? -66.61 -39.66 88.44 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 173.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.32 -44.04 60.7 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.81 77.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 171.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.503 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.8 mt -56.97 -43.51 81.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.853 0.861 . . . . 0.0 110.473 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 m -65.3 -47.26 77.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.759 0.423 . . . . 0.0 110.075 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.847 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 2.3 m -82.49 36.26 0.47 Allowed 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.978 0.174 . . . . 0.0 110.804 178.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.55 -43.17 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 148.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.7 m -74.4 -58.79 3.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.469 0.708 . . . . 0.0 110.203 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.5 p -78.91 39.14 0.36 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.321 -0.371 . . . . 0.0 111.189 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.847 ' HD3' ' O ' ' A' ' 28' ' ' THR . 13.6 mmmm -81.37 -64.07 1.26 Allowed 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.268 0.486 . . . . 0.0 112.05 165.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 32.4 tp -29.89 71.45 0.0 OUTLIER 'General case' 0 C--N 1.339 0.148 0 C-N-CA 128.352 2.661 . . . . 0.0 113.306 -163.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 32' ' ' LYS . . . 67.62 57.54 0.54 Allowed 'General case' 0 C--O 1.23 0.055 0 C-N-CA 125.716 1.606 . . . . 0.0 110.087 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -144.31 -57.43 0.37 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.739 1.616 . . . . 0.0 109.605 -170.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 124.657 1.183 . . . . 0.0 109.914 -155.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -90.25 -18.82 24.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.489 0.716 . . . . 0.0 109.758 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -64.06 -47.46 80.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.3 -39.93 94.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.243 0.617 . . . . 0.0 110.532 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -63.04 -44.34 96.17 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.47 0.708 . . . . 0.0 110.377 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -56.84 -45.33 82.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.585 1.154 . . . . 0.0 110.222 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -76.98 -29.56 55.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.116 0.566 . . . . 0.0 111.282 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.68 94.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.745 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.576 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 9.1 ptpp? -83.72 44.33 0.98 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.936 0.494 . . . . 0.0 109.867 172.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.588 ' N ' ' H ' ' A' ' 14' ' ' GLY . . . -161.83 -49.12 0.02 OUTLIER Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.77 1.176 . . . . 0.0 112.862 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 91.9 t -68.34 4.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 148.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' N ' ' A' ' 12' ' ' GLY . . . -112.72 -15.36 9.45 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.935 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 98.8 mttt -89.97 -29.76 18.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.803 0.841 . . . . 0.0 109.327 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.02 -26.94 64.29 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 167.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -89.45 -46.98 8.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.797 1.239 . . . . 0.0 108.591 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.6 t -65.83 -26.78 39.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.97 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.935 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 40.5 ttmt -71.84 -38.21 70.16 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.771 0.429 . . . . 0.0 109.848 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.82 -41.78 55.0 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.87 -33.63 75.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 170.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.271 0 C-N-CA 122.89 0.476 . . . . 0.0 111.638 -179.623 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.37 -32.98 70.62 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.76 0.824 . . . . 0.0 110.763 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 t -70.57 -39.33 73.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.75 0.42 . . . . 0.0 110.766 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.731 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 87.4 m -65.63 -35.12 79.88 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.678 0.217 . . . . 0.0 111.288 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.9 t -51.11 -30.8 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 122.788 0.435 . . . . 0.0 110.459 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.2 t -73.98 -62.1 1.62 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.928 0.491 . . . . 0.0 112.276 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 1.349 ' HB2' ' CD ' ' A' ' 35' ' ' LYS . 10.5 p -52.54 -27.29 15.98 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.731 ' HB2' ' O ' ' A' ' 28' ' ' THR . 62.2 tttp -79.06 65.78 4.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.666 1.222 . . . . 0.0 110.386 -158.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.3 mt -87.67 -53.15 4.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.078 -1.874 . . . . 0.0 108.495 166.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.09 0.19 0.32 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.594 0.757 . . . . 0.0 112.081 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 1.349 ' CD ' ' HB2' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -88.57 -46.64 8.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.886 1.274 . . . . 0.0 111.908 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 CA--C 1.535 0.395 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -159.761 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.158 ' O ' ' HD3' ' A' ' 7' ' ' LYS . 3.9 mm? . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 119.531 -0.271 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.17 -19.84 23.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.4 m -75.49 -45.41 38.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.5 -40.23 86.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.393 0.677 . . . . 0.0 110.092 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 1.158 ' HD3' ' O ' ' A' ' 3' ' ' LEU . 4.3 mptp? -64.87 -47.17 78.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.51 0.724 . . . . 0.0 109.955 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -61.83 -46.22 90.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.654 0.782 . . . . 0.0 110.152 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -60.86 -50.79 72.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.956 0.502 . . . . 0.0 110.221 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.79 -28.62 69.7 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.142 0.577 . . . . 0.0 111.291 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -72.09 -41.21 67.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.151 0.58 . . . . 0.0 110.26 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.85 -30.63 34.83 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.3 t -90.01 45.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 159.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.38 -30.16 0.13 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.92 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 20.5 ptmt -88.46 -20.12 25.6 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.741 0.416 . . . . 0.0 110.189 173.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.4 -27.64 61.57 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.01 -48.43 7.21 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.855 1.262 . . . . 0.0 108.314 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.1 t -67.16 -28.9 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.92 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 29.4 tptp -69.95 -34.06 72.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.4 -45.32 48.01 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.74 -30.2 70.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.708 0.403 . . . . 0.0 110.709 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.649 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.656 0.265 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.2 mt -56.67 -37.47 70.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.576 1.151 . . . . 0.0 111.512 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.2 p -90.12 -44.36 9.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.119 0.567 . . . . 0.0 111.255 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.437 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 99.1 m -49.2 -54.19 17.73 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.512 0.725 . . . . 0.0 110.889 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 p -48.86 -32.59 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.671 0.788 . . . . 0.0 111.131 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 t -87.44 -60.07 2.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.539 0.736 . . . . 0.0 111.288 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.826 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 35.2 m -59.36 -8.81 1.9 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.993 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -78.24 29.38 0.18 Allowed 'General case' 0 C--N 1.342 0.241 0 C-N-CA 118.61 -1.236 . . . . 0.0 113.023 -163.319 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.56 -41.3 89.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 166.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.56 44.99 1.62 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.875 0.87 . . . . 0.0 109.534 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? 48.91 46.06 22.24 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.847 1.259 . . . . 0.0 110.788 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.826 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 57.6 m . . . . . 0 N--CA 1.454 -0.24 0 C-N-CA 123.063 0.545 . . . . 0.0 112.146 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 70.8 mt . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 111.416 0.154 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.1 -11.49 41.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.803 0.841 . . . . 0.0 109.156 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 88.1 m -74.36 -59.32 2.78 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -172.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.0 mt -57.24 -40.0 76.71 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.714 0.405 . . . . 0.0 110.123 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -57.53 -45.47 85.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.227 1.011 . . . . 0.0 111.182 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -58.96 -51.57 69.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.165 0.586 . . . . 0.0 110.225 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -66.18 -39.66 89.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.894 0.478 . . . . 0.0 111.085 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.72 -37.52 84.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 175.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.0 mtpt -81.81 43.38 0.76 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 171.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -164.57 -36.86 0.02 OUTLIER Glycine 0 C--N 1.337 0.617 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.2 46.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 154.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -152.21 -29.34 0.04 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 19' ' ' LYS . 62.1 mtpt -79.85 -41.1 26.99 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.2 -22.49 66.9 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.033 0.933 . . . . 0.0 110.73 173.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.2 mt -90.09 -41.05 11.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.12 0.968 . . . . 0.0 108.586 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.5 -32.38 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 170.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 15' ' ' LYS . 23.4 tptm -70.21 -36.59 74.68 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.6 -41.56 50.5 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.05 82.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 170.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.345 0 C-N-CA 123.111 0.564 . . . . 0.0 111.047 179.487 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.456 -0.131 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.8 mt -53.57 -19.27 3.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.855 1.262 . . . . 0.0 112.575 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.9 m -87.75 -48.95 7.45 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.155 0.582 . . . . 0.0 110.749 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.562 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 94.1 m -48.21 -51.83 23.59 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.528 0.731 . . . . 0.0 111.229 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 m -49.48 -39.94 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 124.327 1.051 . . . . 0.0 112.263 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.5 p -72.6 -56.13 5.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.307 0.243 . . . . 0.0 110.661 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.7 p -81.91 27.16 0.47 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.516 0.726 . . . . 0.0 111.256 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 28' ' ' THR . 13.5 tmtt? -88.37 -41.7 12.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.978 0.511 . . . . 0.0 111.92 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 tp -48.53 -65.6 0.54 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.534 1.134 . . . . 0.0 111.528 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.22 -11.0 60.36 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.573 0.349 . . . . 0.0 111.524 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 16.4 tptm 48.49 51.74 14.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.824 2.049 . . . . 0.0 112.725 176.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 159.804 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.27 -28.98 18.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 168.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -74.86 -55.88 5.34 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.927 0.491 . . . . 0.0 111.646 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.42 -35.26 78.68 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.662 0.385 . . . . 0.0 110.091 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' N ' ' CD ' ' A' ' 7' ' ' LYS . 11.6 mptt -67.14 -39.76 86.63 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.776 1.23 . . . . 0.0 110.607 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -63.67 -47.5 80.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.551 0.741 . . . . 0.0 109.694 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -66.26 -45.49 80.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.045 0.538 . . . . 0.0 110.388 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.96 88.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 173.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -81.02 41.7 0.6 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.564 0.746 . . . . 0.0 109.245 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -162.88 -38.49 0.02 OUTLIER Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.68 45.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 155.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -146.56 -31.52 0.07 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.6 -41.26 27.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 170.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -65.99 -17.53 64.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.087 0.955 . . . . 0.0 111.08 173.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 mt -90.1 -41.74 11.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -65.42 -32.31 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' C ' ' HD3' ' A' ' 19' ' ' LYS . 1.4 tmtp? -69.28 -34.74 75.19 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.204 0.601 . . . . 0.0 109.874 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.02 -47.94 50.96 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.75 -30.17 70.78 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.078 0.551 . . . . 0.0 110.982 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.085 0 CA-C-N 117.493 0.133 . . . . 0.0 111.014 -179.238 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.38 -39.18 69.81 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.638 0.775 . . . . 0.0 110.661 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 t -63.96 -51.48 64.16 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.922 0.489 . . . . 0.0 110.432 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.854 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 62.4 m -60.72 -49.2 78.47 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.617 0.367 . . . . 0.0 110.246 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.87 -34.58 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.449 0.699 . . . . 0.0 110.607 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.2 t -72.37 -62.0 1.6 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.5 p -75.51 20.12 0.17 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.778 0.431 . . . . 0.0 111.55 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.854 ' HB2' ' O ' ' A' ' 28' ' ' THR . 41.1 ttmt -90.07 -34.17 16.03 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.605 0.762 . . . . 0.0 111.332 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.3 tp -57.15 -53.62 56.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 36' ' ' THR . . . -80.69 78.58 7.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 160.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -63.39 22.75 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 126.561 1.944 . . . . 0.0 112.106 -171.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 34' ' ' ALA . 15.2 t . . . . . 0 CA--C 1.532 0.281 0 O-C-N 121.947 -0.47 . . . . 0.0 109.82 169.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -90.21 -20.78 22.62 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.0 m -73.3 -50.61 21.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.52 -33.67 76.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 173.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.33 -45.03 96.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.963 0.905 . . . . 0.0 110.499 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -51.05 -52.21 45.49 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.453 1.101 . . . . 0.0 110.509 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -79.67 -30.54 41.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.563 0.745 . . . . 0.0 111.711 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.53 91.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.64 0.376 . . . . 0.0 110.82 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -64.86 -30.07 71.05 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.228 0.611 . . . . 0.0 110.654 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -76.24 -30.34 57.15 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 t -87.38 36.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 162.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -127.96 -33.77 0.58 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.245 -2.342 . . . . 0.0 107.245 170.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 19' ' ' LYS . 70.5 mmtt -73.97 -45.8 47.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.57 0.748 . . . . 0.0 109.421 172.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.19 -18.42 65.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.376 0.67 . . . . 0.0 110.472 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.99 -43.39 10.57 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.089 1.355 . . . . 0.0 107.897 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.0 t -63.3 -33.93 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -70.58 -32.49 69.89 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.753 0.421 . . . . 0.0 109.893 175.349 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.46 -45.85 44.23 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.02 -29.45 69.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.917 0.487 . . . . 0.0 110.921 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.13 0 CA-C-N 117.534 0.152 . . . . 0.0 111.005 -179.405 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -54.53 -36.8 64.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.065 0.946 . . . . 0.0 111.353 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 80.4 p -67.64 -48.47 66.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.414 0.285 . . . . 0.0 110.646 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.61 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 66.0 m -57.7 -46.87 83.76 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.068 0.547 . . . . 0.0 110.47 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.8 t -54.23 -31.78 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.573 0.749 . . . . 0.0 110.721 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.8 m -89.98 -48.37 7.25 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.995 0.518 . . . . 0.0 111.412 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 74.7 m -57.18 -19.07 18.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.65 0.38 . . . . 0.0 111.75 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.612 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -76.32 24.39 0.14 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -158.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.5 tp -60.33 -49.07 79.07 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.29 45.4 1.85 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.872 0.869 . . . . 0.0 108.9 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 45.52 57.94 4.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.3 1.44 . . . . 0.0 111.057 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 59.0 m . . . . . 0 N--CA 1.453 -0.321 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.057 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.105 ' O ' ' HD2' ' A' ' 7' ' ' LYS . 89.8 mt . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -90.1 -25.37 20.77 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.4 m -75.04 -48.59 23.26 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 123.375 0.422 . . . . 0.0 110.342 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.72 -38.52 91.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 1.105 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 0.6 OUTLIER -62.7 -41.07 98.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.92 0.888 . . . . 0.0 110.529 178.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -52.32 -43.41 64.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.93 0.892 . . . . 0.0 110.709 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -90.05 -39.36 12.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.605 0.762 . . . . 0.0 111.59 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.76 -38.88 76.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.204 0.602 . . . . 0.0 111.857 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -67.7 -35.16 78.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 119.473 -0.299 . . . . 0.0 110.748 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -71.53 -24.85 76.31 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.58 49.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 160.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -148.43 -33.97 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 174.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -72.29 -43.6 63.99 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.66 -23.48 67.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.514 0.726 . . . . 0.0 111.045 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.4 mt -88.46 -37.59 15.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 t -66.65 -29.94 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -79.89 1.69 26.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.127 0.571 . . . . 0.0 110.585 174.46 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.03 -68.38 0.35 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.42 -63.91 1.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.643 0.777 . . . . 0.0 110.891 177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.396 0 C-N-CA 123.803 0.841 . . . . 0.0 110.767 -177.763 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 30' ' ' SER . 87.8 mt -50.89 -39.44 54.23 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.486 1.114 . . . . 0.0 111.81 -177.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.9 p -80.8 -42.05 22.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.761 0.424 . . . . 0.0 110.896 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.5 m -62.53 -52.35 63.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.302 0.641 . . . . 0.0 110.486 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.11 -36.75 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 122.946 0.499 . . . . 0.0 110.595 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 35.6 t -67.29 -55.53 13.52 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.511 0.725 . . . . 0.0 110.964 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.1 p -70.92 7.42 1.17 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.649 0.38 . . . . 0.0 111.837 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.705 ' HD2' ' HE3' ' A' ' 35' ' ' LYS . 22.9 ttpp -80.81 59.03 3.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.631 0.729 . . . . 0.0 109.871 -172.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.01 72.27 7.41 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 168.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.17 50.05 3.15 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.617 1.167 . . . . 0.0 110.189 -170.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.705 ' HE3' ' HD2' ' A' ' 32' ' ' LYS . 35.6 mmtp 53.79 67.7 0.96 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.024 1.33 . . . . 0.0 111.425 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.6 m . . . . . 0 N--CA 1.454 -0.255 0 C-N-CA 122.621 0.368 . . . . 0.0 110.206 176.533 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 111.422 0.156 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -90.01 -16.65 29.36 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.873 0.869 . . . . 0.0 108.967 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.0 m -73.26 -51.65 16.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.997 -173.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.3 mt -66.41 -36.29 82.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.946 0.499 . . . . 0.0 109.959 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -57.08 -46.94 82.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.905 0.882 . . . . 0.0 110.554 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -57.79 -49.32 77.0 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.127 0.971 . . . . 0.0 110.209 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -65.99 -43.02 89.03 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.238 0.615 . . . . 0.0 110.927 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.54 95.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.074 0.55 . . . . 0.0 111.74 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -82.05 -18.62 42.56 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 117.923 0.328 . . . . 0.0 111.151 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.18 -28.85 47.84 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 170.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.02 47.22 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 158.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.26 -28.35 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.926 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 3.0 pptp? -89.07 -22.66 22.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.895 0.478 . . . . 0.0 109.923 173.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.75 -27.0 62.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.147 0.579 . . . . 0.0 109.549 167.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.1 mt -90.16 -48.09 7.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.324 1.049 . . . . 0.0 108.964 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 t -65.96 -31.95 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.926 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 1.2 tmtp? -67.4 -39.63 85.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.195 0.598 . . . . 0.0 109.72 173.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.17 -41.87 59.19 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.42 -35.06 79.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 170.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.277 0 C-N-CA 122.821 0.449 . . . . 0.0 111.648 179.515 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.21 -36.05 82.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.56 0.744 . . . . 0.0 110.228 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.4 m -64.62 -47.1 79.8 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.118 0.567 . . . . 0.0 110.403 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.756 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 98.0 m -57.25 -50.38 73.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.076 0.55 . . . . 0.0 110.367 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.7 t -54.56 -33.22 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.815 0.846 . . . . 0.0 110.948 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.4 t -73.16 -62.63 1.4 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.192 0.197 . . . . 0.0 110.611 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -75.78 16.41 0.4 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.448 0.299 . . . . 0.0 111.621 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.756 ' HB2' ' O ' ' A' ' 28' ' ' THR . 68.5 tttt -90.2 -31.93 16.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.059 0.543 . . . . 0.0 111.49 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.2 tp -51.23 -64.13 0.91 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.794 0.838 . . . . 0.0 110.995 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.69 -7.47 59.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.811 0.444 . . . . 0.0 111.352 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 19.1 tptm 46.46 58.7 4.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.271 1.828 . . . . 0.0 112.167 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 161.352 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -90.23 -15.62 31.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.8 m -68.51 -47.0 68.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -59.58 -38.72 81.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.663 0.785 . . . . 0.0 110.567 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -63.83 -51.06 66.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -57.62 -48.9 78.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.086 0.955 . . . . 0.0 109.805 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -60.67 -44.72 96.14 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.412 0.685 . . . . 0.0 110.756 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.48 96.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.589 0.356 . . . . 0.0 110.238 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -82.83 42.71 0.8 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.573 ' O ' ' OD2' ' A' ' 16' ' ' ASP . . . -157.28 -37.74 0.02 OUTLIER Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 t -87.24 47.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 152.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -136.97 -36.32 0.18 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 174.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 19' ' ' LYS . 5.0 mmpt? -66.54 -39.85 88.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.705 0.802 . . . . 0.0 109.194 169.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.573 ' OD2' ' O ' ' A' ' 12' ' ' GLY . 3.5 m-20 -65.26 -25.98 67.9 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.431 1.093 . . . . 0.0 111.07 175.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.3 mt -90.1 -39.89 12.6 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.63 -30.84 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 15' ' ' LYS . 64.7 tttp -71.71 -36.87 70.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.052 0.541 . . . . 0.0 109.843 174.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.51 -41.93 56.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.58 80.88 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.309 0 C-N-CA 122.92 0.488 . . . . 0.0 111.633 -179.72 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.416 0.15 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.23 -37.66 72.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.25 1.02 . . . . 0.0 110.813 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -80.06 -41.64 25.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.135 0.574 . . . . 0.0 110.727 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 90.6 m -65.5 -50.35 65.63 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.27 0.628 . . . . 0.0 111.113 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.21 -41.25 86.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 122.784 0.433 . . . . 0.0 110.73 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.1 m -71.46 -46.82 58.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.197 0.599 . . . . 0.0 110.165 176.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.2 t -65.35 -12.01 47.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.214 0.606 . . . . 0.0 111.199 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 1.364 ' CD ' ' HD3' ' A' ' 35' ' ' LYS . 19.7 ttpp -87.27 63.49 7.81 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.799 0.809 . . . . 0.0 109.452 -172.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.56 -57.99 4.51 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 168.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.02 47.92 1.71 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.991 0.917 . . . . 0.0 108.699 171.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 1.364 ' HD3' ' CD ' ' A' ' 32' ' ' LYS . 3.0 mmmp? 49.11 56.6 7.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.942 1.297 . . . . 0.0 111.016 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.891 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -90.12 -27.3 19.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 173.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.7 m -68.41 -44.41 75.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 123.346 0.404 . . . . 0.0 110.19 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.3 mt -58.11 -45.24 87.6 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.713 0.805 . . . . 0.0 110.322 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.83 -48.07 82.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.807 0.843 . . . . 0.0 110.71 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.46 -51.35 69.82 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.805 0.842 . . . . 0.0 109.762 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -57.91 -50.89 71.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.164 0.586 . . . . 0.0 110.51 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.75 -33.68 74.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.029 0.532 . . . . 0.0 110.744 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -73.99 -30.93 62.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.968 0.507 . . . . 0.0 110.16 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -76.19 -31.01 56.26 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 173.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -86.16 43.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 160.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -141.33 -32.69 0.13 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 107.343 -2.303 . . . . 0.0 107.343 172.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 19' ' ' LYS . 70.7 mmtt -68.73 -40.93 79.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.376 0.67 . . . . 0.0 109.416 169.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -64.05 -26.19 68.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.714 0.806 . . . . 0.0 110.664 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.4 mt -90.04 -41.34 11.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.237 1.015 . . . . 0.0 108.869 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.9 t -65.31 -29.02 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 171.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 15' ' ' LYS . 23.4 tptm -72.58 -37.06 68.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.869 0.467 . . . . 0.0 109.772 175.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.85 -42.55 52.8 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.85 80.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.287 0 C-N-CA 122.825 0.45 . . . . 0.0 111.645 179.579 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.8 mt -59.87 -40.42 88.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.047 0.939 . . . . 0.0 110.36 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.6 m -70.2 -40.84 74.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.988 0.515 . . . . 0.0 110.642 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.982 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 26.1 m -69.88 -7.09 37.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.13 -39.21 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 166.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -76.3 -64.17 1.16 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.057 0.543 . . . . 0.0 110.198 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 6.8 p -77.67 43.33 0.4 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 119.435 -0.317 . . . . 0.0 110.393 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.982 ' HB2' ' O ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -90.11 -56.13 3.34 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 178.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 tt -29.88 -75.0 0.03 OUTLIER 'General case' 0 C--N 1.343 0.29 0 C-N-CA 126.021 1.728 . . . . 0.0 113.264 -148.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.35 59.23 1.35 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -141.76 -65.52 0.42 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.032 0.933 . . . . 0.0 110.815 -162.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.536 0.442 0 C-N-CA 123.63 0.772 . . . . 0.0 109.472 -159.369 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.038 0 N-CA-C 112.271 -0.332 . . . . 0.0 112.271 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -35.54 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 123.98 0.912 . . . . 0.0 110.867 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.964 ' O ' ' HD2' ' A' ' 7' ' ' LYS . 82.6 mt -72.48 -18.27 61.69 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.974 0.51 . . . . 0.0 112.186 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -90.08 -26.76 20.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.2 m -68.78 -56.88 6.61 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.293 -172.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.5 mt -59.99 -36.55 77.42 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.106 0.562 . . . . 0.0 110.546 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.964 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 0.4 OUTLIER -62.61 -41.96 99.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.362 0.665 . . . . 0.0 110.286 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.16 -57.67 11.21 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.447 0.699 . . . . 0.0 110.387 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -65.16 -38.62 91.14 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.962 0.505 . . . . 0.0 111.174 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.44 96.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -81.25 47.55 1.04 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -166.15 -34.59 0.02 OUTLIER Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.1 t -87.6 46.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 154.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -154.08 -30.31 0.03 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 19' ' ' LYS . 48.1 tptt -74.79 -39.24 61.83 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 123.87 0.868 . . . . 0.0 109.061 170.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.41 -24.02 67.66 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.089 0.955 . . . . 0.0 110.834 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -89.98 -42.3 11.24 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.8 t -63.2 -31.58 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 170.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 15' ' ' LYS . 87.1 tttt -71.71 -36.2 70.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.891 0.476 . . . . 0.0 109.938 175.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.0 -40.75 56.42 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.34 -37.59 88.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 170.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.07 36.54 0.87 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.942 0.497 . . . . 0.0 111.485 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -90.03 -56.79 3.09 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.218 0.607 . . . . 0.0 111.262 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.72 -72.05 1.27 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -171.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.3 t -86.37 -53.12 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 126.857 2.063 . . . . 0.0 110.551 0.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.579 ' O ' ' HB3' ' A' ' 30' ' ' SER . 86.0 mt -56.84 -33.42 66.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.839 0.855 . . . . 0.0 111.664 -175.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.873 ' O ' ' CB ' ' A' ' 31' ' ' CYS . 78.1 p -67.42 -40.33 85.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.788 0.435 . . . . 0.0 110.925 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.578 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 94.5 m -77.64 -51.88 9.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.352 0.661 . . . . 0.0 110.274 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.63 -49.07 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 123.388 0.675 . . . . 0.0 110.351 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 26' ' ' LEU . 34.8 t -66.38 -45.92 78.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.873 ' CB ' ' O ' ' A' ' 27' ' ' SER . 50.2 t -60.31 -15.61 26.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.7 0.8 . . . . 0.0 111.492 174.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 28' ' ' THR . 9.1 ttmm -80.43 56.96 2.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.191 0.52 . . . . 0.0 110.997 -171.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.3 mp -67.27 -57.11 7.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.09 43.13 2.55 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.057 0.943 . . . . 0.0 108.521 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.787 ' HE2' ' O ' ' A' ' 37' ' ' CYS . 22.2 tptm 48.59 61.74 2.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.06 1.344 . . . . 0.0 110.901 -175.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.3 p -89.51 10.27 23.44 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.092 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.787 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 87.4 m . . . . . 0 C--N 1.342 0.253 0 C-N-CA 123.935 0.894 . . . . 0.0 109.289 169.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.039 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.5 tp -59.48 -31.0 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 123.839 0.856 . . . . 0.0 110.65 178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.659 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 81.4 mt -74.28 -21.38 59.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.121 0.568 . . . . 0.0 111.842 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -90.14 -23.52 21.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -69.86 -55.8 8.81 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 pp -63.31 -32.79 74.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.851 0.46 . . . . 0.0 110.576 174.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 1.5 tppp? -58.05 -47.46 83.05 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.263 1.025 . . . . 0.0 110.717 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -49.37 -54.02 19.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.782 1.233 . . . . 0.0 110.791 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -66.62 -42.64 86.47 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.071 0.549 . . . . 0.0 111.014 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.9 91.98 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.884 0.473 . . . . 0.0 110.978 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -69.26 -28.76 66.6 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.688 0.395 . . . . 0.0 110.505 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -74.52 -28.16 64.03 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.1 t -86.73 42.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 162.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -142.5 -32.19 0.11 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 172.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 7.2 mtpm? -77.31 -36.69 53.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.561 0.744 . . . . 0.0 109.3 172.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.55 -24.23 66.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.548 0.739 . . . . 0.0 110.371 173.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.1 mt -90.05 -45.74 8.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.002 0.921 . . . . 0.0 109.138 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.5 t -66.32 -27.89 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 65.2 tttm -74.51 -38.58 62.78 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.159 0.584 . . . . 0.0 110.186 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.79 -46.05 40.3 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -34.63 71.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 122.624 0.37 . . . . 0.0 110.039 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.16 -17.24 40.67 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -76.39 -41.88 46.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.051 0.54 . . . . 0.0 111.018 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -129.95 72.03 0.49 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 t -60.15 -52.2 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 123.005 0.522 . . . . 0.0 110.698 -166.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.41 -40.09 85.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.684 0.794 . . . . 0.0 111.364 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.6 p -67.41 -42.55 83.08 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.421 0.289 . . . . 0.0 111.393 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 1.075 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 66.1 m -54.31 -29.5 47.82 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.712 0.805 . . . . 0.0 111.341 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.51 -41.31 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 122.61 0.364 . . . . 0.0 110.056 176.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.0 t -76.24 -61.98 1.76 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.514 0.326 . . . . 0.0 110.319 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.6 p -77.61 31.13 0.16 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.314 0.246 . . . . 0.0 111.32 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 1.075 ' HB3' ' O ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -89.84 -25.65 20.93 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 117.658 0.208 . . . . 0.0 111.434 175.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.22 2.29 0.6 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.04 2.05 1.15 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.705 0.802 . . . . 0.0 111.007 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 48.4 33.49 3.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.055 1.342 . . . . 0.0 112.205 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.5 p -69.1 -27.8 65.92 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 166.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.9 m . . . . . 0 N--CA 1.45 -0.444 0 C-N-CA 124.719 1.208 . . . . 0.0 109.272 178.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.052 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -84.29 37.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.634 0.774 . . . . 0.0 110.652 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.24 -34.27 25.88 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.007 0.923 . . . . 0.0 111.594 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -90.13 -17.81 26.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 91.8 m -69.76 -54.13 15.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -174.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 pp -59.63 -34.71 73.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.642 0.377 . . . . 0.0 110.852 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.23 -42.77 96.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.784 0.833 . . . . 0.0 110.832 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -56.73 -56.11 25.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.622 0.769 . . . . 0.0 110.458 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -69.15 -31.89 70.86 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.88 0.472 . . . . 0.0 111.462 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.56 86.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -83.76 54.21 2.81 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 169.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.696 ' H ' ' H ' ' A' ' 14' ' ' GLY . . . -166.42 -52.83 0.03 OUTLIER Glycine 0 C--N 1.337 0.616 0 C-N-CA 124.574 1.083 . . . . 0.0 113.058 -170.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.46 0.35 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 150.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.696 ' H ' ' H ' ' A' ' 12' ' ' GLY . . . -107.8 -18.2 10.29 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.944 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 35.4 mmtp -89.13 -19.95 24.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.403 1.081 . . . . 0.0 109.797 168.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.43 -30.55 61.95 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 167.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.8 mt -90.22 -43.86 10.13 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.137 0.975 . . . . 0.0 108.614 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -67.81 -27.54 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.949 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.944 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 13.4 tmtt? -68.43 -39.98 81.34 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.065 0.546 . . . . 0.0 109.665 172.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.15 -40.99 60.93 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.91 73.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.03 37.45 0.89 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.742 0.417 . . . . 0.0 110.929 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -90.05 -59.95 2.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.389 0.675 . . . . 0.0 109.482 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -171.29 56.46 0.18 Allowed Glycine 0 C--N 1.338 0.658 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 p -85.56 -42.99 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 123.113 0.565 . . . . 0.0 110.49 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.4 mt -56.47 -38.95 72.41 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.0 0.92 . . . . 0.0 110.828 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.8 p -68.97 -45.11 71.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.107 0.563 . . . . 0.0 110.662 177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.61 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 89.7 m -54.82 -43.28 72.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.162 0.585 . . . . 0.0 111.139 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.29 -39.1 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.504 0.722 . . . . 0.0 110.798 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.7 t -72.54 -60.69 2.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.536 0.335 . . . . 0.0 110.484 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 6.0 p -78.46 29.18 0.19 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.897 0.479 . . . . 0.0 111.411 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 28' ' ' THR . 5.7 tmtt? -90.11 -52.43 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.38 1.072 . . . . 0.0 110.083 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.5 tp -50.2 -59.3 4.07 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.141 0.976 . . . . 0.0 110.926 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.09 -19.54 64.07 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 120.947 0.403 . . . . 0.0 111.55 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.6 tptm 56.64 55.51 6.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.53 1.932 . . . . 0.0 112.306 173.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.3 p -97.51 14.06 27.78 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 164.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 77.6 m . . . . . 0 N--CA 1.453 -0.293 0 C-N-CA 123.827 0.851 . . . . 0.0 109.969 -178.709 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.016 0 N-CA-C 111.931 -0.468 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.34 -34.95 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 123.692 0.797 . . . . 0.0 109.866 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.67 -22.91 63.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.098 0.559 . . . . 0.0 111.876 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -90.27 -21.31 22.16 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.6 m -72.03 -53.03 14.18 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.47 -32.09 73.44 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.917 0.487 . . . . 0.0 110.679 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -62.3 -46.47 88.62 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.77 0.828 . . . . 0.0 110.155 176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -60.56 -50.79 72.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.01 0.924 . . . . 0.0 109.794 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -59.72 -49.47 77.62 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 122.991 0.516 . . . . 0.0 110.562 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.08 90.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.943 0.497 . . . . 0.0 110.456 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.99 -33.87 76.51 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.214 0.606 . . . . 0.0 110.466 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -77.38 -30.07 54.75 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.614 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.6 t -88.42 41.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 161.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -143.4 -29.15 0.12 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 176.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 19' ' ' LYS . 75.1 mmtt -85.75 -41.53 15.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 169.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.4 -18.17 64.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.645 0.778 . . . . 0.0 110.511 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.9 tp -87.68 -43.75 11.7 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.54 -32.85 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 15' ' ' LYS . 64.6 tttm -69.7 -32.11 70.52 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.76 0.424 . . . . 0.0 110.102 175.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.39 -47.2 29.77 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 176.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.96 -30.87 71.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.944 0.498 . . . . 0.0 110.917 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.13 -29.25 67.26 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.347 0.259 . . . . 0.0 111.366 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -55.71 -37.88 68.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.767 0.827 . . . . 0.0 111.071 177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.22 80.72 0.11 Allowed Glycine 0 C--N 1.339 0.716 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.2 m -60.45 -47.51 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 122.991 0.517 . . . . 0.0 110.629 -175.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.8 mt -59.08 -39.31 81.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.745 0.818 . . . . 0.0 110.371 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.9 t -67.87 -39.06 83.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.86 0.464 . . . . 0.0 110.733 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.745 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 39.0 m -65.48 -37.6 87.32 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.517 0.327 . . . . 0.0 110.746 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.53 -30.76 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.044 0.537 . . . . 0.0 110.405 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.9 t -81.67 -55.8 4.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 122.845 0.458 . . . . 0.0 109.896 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.2 t -57.65 -12.37 2.82 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.665 1.186 . . . . 0.0 111.647 175.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.745 ' HB2' ' O ' ' A' ' 28' ' ' THR . 11.9 tppt? -75.72 -42.73 49.96 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.13 0.972 . . . . 0.0 109.737 -175.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.7 mt -44.88 -55.15 5.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.415 1.086 . . . . 0.0 110.903 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.75 -28.41 36.51 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.276 0.56 . . . . 0.0 111.454 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.0 tptt 64.97 79.79 0.25 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.339 1.856 . . . . 0.0 111.104 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.3 t -129.65 16.12 5.9 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.843 162.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 56.6 m . . . . . 0 C--N 1.344 0.329 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 172.602 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.056 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.29 -26.4 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.733 1.613 . . . . 0.0 110.156 -0.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.23 -28.15 69.16 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.827 0.851 . . . . 0.0 112.378 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -90.19 -12.68 37.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.684 0.793 . . . . 0.0 110.146 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 97.9 m -61.27 -52.95 62.57 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.5 -37.21 86.76 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.305 0.642 . . . . 0.0 110.651 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -60.36 -39.31 86.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.199 0.6 . . . . 0.0 110.568 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.08 -55.94 28.16 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.836 0.854 . . . . 0.0 110.259 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -68.41 -34.41 75.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.922 0.489 . . . . 0.0 111.378 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.69 98.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.85 53.39 2.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.55 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -170.95 -46.21 0.04 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 124.656 1.122 . . . . 0.0 113.02 -173.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.4 t -78.99 28.27 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 143.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -126.26 -27.02 1.14 Allowed Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 167.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.721 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 45.5 mmtm -81.13 -29.85 34.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.08 0.952 . . . . 0.0 110.111 173.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.4 -27.29 63.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.17 -43.19 10.6 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.308 1.043 . . . . 0.0 108.264 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -66.36 -27.64 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 119.356 -0.938 . . . . 0.0 108.718 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.721 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 57.6 tptt -72.62 -36.85 68.15 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.11 0.564 . . . . 0.0 109.711 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.5 -41.93 56.82 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.55 80.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.05 28.48 1.38 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.875 0.47 . . . . 0.0 111.555 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -88.6 -60.58 1.92 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.108 0.563 . . . . 0.0 109.617 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.45 81.25 0.08 OUTLIER Glycine 0 C--N 1.337 0.603 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.95 -52.09 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.564 0.746 . . . . 0.0 110.236 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.9 mt -54.7 -31.77 58.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.999 0.92 . . . . 0.0 111.115 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.2 t -82.19 -46.25 14.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.228 0.611 . . . . 0.0 110.476 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.1 m -63.53 -56.61 14.65 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.309 0.643 . . . . 0.0 110.57 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.6 p -49.66 -35.16 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.088 0.955 . . . . 0.0 111.876 -176.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.4 t -69.44 -60.91 2.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.116 0.567 . . . . 0.0 111.134 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 12.3 p -66.46 1.63 1.59 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 119.116 -0.469 . . . . 0.0 112.068 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 1.35 ' HD3' ' CD ' ' A' ' 35' ' ' LYS . 26.5 mmtm -90.04 52.46 2.28 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.642 0.655 . . . . 0.0 109.286 175.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.1 tp -76.44 -61.04 2.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.99 44.65 2.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 1.35 ' CD ' ' HD3' ' A' ' 32' ' ' LYS . 46.5 mmtm 49.28 61.15 3.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.968 1.307 . . . . 0.0 110.879 -171.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.7 m -61.28 -41.68 97.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 169.678 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.067 0 N-CA-C 112.391 -0.284 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.8 -34.46 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.696 0.799 . . . . 0.0 109.914 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.52 -23.59 62.67 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.388 0.675 . . . . 0.0 112.01 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.15 -21.28 22.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.1 m -71.73 -45.04 63.03 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.08 -39.97 96.29 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.592 0.757 . . . . 0.0 110.038 172.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.662 ' HE3' ' HD2' ' A' ' 11' ' ' LYS . 56.7 tptt -59.01 -47.15 86.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.714 0.806 . . . . 0.0 110.559 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -61.12 -47.48 86.08 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.696 0.798 . . . . 0.0 110.022 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -62.5 -42.95 99.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.307 0.643 . . . . 0.0 110.586 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.02 96.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.666 0.386 . . . . 0.0 110.105 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.662 ' HD2' ' HE3' ' A' ' 7' ' ' LYS . 63.6 mtpt -81.71 43.36 0.75 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 171.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.21 -36.46 0.02 OUTLIER Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.98 41.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 153.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.24 -32.77 0.48 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.929 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 22.7 pttp -90.06 -25.17 20.92 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.363 0.665 . . . . 0.0 110.328 173.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.7 -26.42 63.41 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 167.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -89.98 -51.68 5.35 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.127 1.371 . . . . 0.0 108.223 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.6 t -65.42 -29.99 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.929 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 13.3 tmtt? -66.61 -39.66 88.44 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 173.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -70.32 -44.04 60.7 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.81 77.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 171.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.47 -18.69 44.35 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -58.76 -42.63 89.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.294 0.638 . . . . 0.0 110.715 -177.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -157.46 79.17 0.18 Allowed Glycine 0 C--N 1.338 0.641 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.95 -51.27 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 122.973 0.509 . . . . 0.0 109.82 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.8 mt -56.97 -43.51 81.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.853 0.861 . . . . 0.0 110.473 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 m -65.3 -47.26 77.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.759 0.423 . . . . 0.0 110.075 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.847 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 2.3 m -82.49 36.26 0.47 Allowed 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.978 0.174 . . . . 0.0 110.804 178.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.55 -43.17 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 148.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.7 m -74.4 -58.79 3.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.469 0.708 . . . . 0.0 110.203 178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.5 p -78.91 39.14 0.36 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.321 -0.371 . . . . 0.0 111.189 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.847 ' HD3' ' O ' ' A' ' 28' ' ' THR . 13.6 mmmm -81.37 -64.07 1.26 Allowed 'General case' 0 C--N 1.344 0.345 0 CA-C-N 118.268 0.486 . . . . 0.0 112.05 165.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 32.4 tp -29.89 71.45 0.0 OUTLIER 'General case' 0 C--N 1.339 0.148 0 C-N-CA 128.352 2.661 . . . . 0.0 113.306 -163.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 32' ' ' LYS . . . 67.62 57.54 0.54 Allowed 'General case' 0 C--O 1.23 0.055 0 C-N-CA 125.716 1.606 . . . . 0.0 110.087 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.506 ' CB ' ' H ' ' A' ' 37' ' ' CYS . 82.2 mttt -144.31 -57.43 0.37 Allowed 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 125.739 1.616 . . . . 0.0 109.605 -170.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.3 p 56.49 16.89 2.7 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.657 1.183 . . . . 0.0 109.914 -155.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.506 ' H ' ' CB ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 C-N-CA 125.021 1.328 . . . . 0.0 111.189 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.083 0 N-CA-C 112.121 -0.392 . . . . 0.0 112.121 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.8 tp -83.17 -27.42 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 125.607 1.563 . . . . 0.0 110.636 -1.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.1 mt -67.34 -20.87 65.64 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.176 0.59 . . . . 0.0 112.443 -176.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -90.25 -18.82 24.98 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.489 0.716 . . . . 0.0 109.758 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -64.06 -47.46 80.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.3 -39.93 94.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.243 0.617 . . . . 0.0 110.532 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -63.04 -44.34 96.17 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.47 0.708 . . . . 0.0 110.377 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -56.84 -45.33 82.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.585 1.154 . . . . 0.0 110.222 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -76.98 -29.56 55.56 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.116 0.566 . . . . 0.0 111.282 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.68 94.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.745 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.576 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 9.1 ptpp? -83.72 44.33 0.98 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.936 0.494 . . . . 0.0 109.867 172.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.588 ' N ' ' H ' ' A' ' 14' ' ' GLY . . . -161.83 -49.12 0.02 OUTLIER Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.77 1.176 . . . . 0.0 112.862 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 91.9 t -68.34 4.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 148.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.588 ' H ' ' N ' ' A' ' 12' ' ' GLY . . . -112.72 -15.36 9.45 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 175.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.935 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 98.8 mttt -89.97 -29.76 18.25 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.803 0.841 . . . . 0.0 109.327 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.02 -26.94 64.29 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 167.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -89.45 -46.98 8.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.797 1.239 . . . . 0.0 108.591 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.6 t -65.83 -26.78 39.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 119.179 -1.008 . . . . 0.0 108.97 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.935 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 40.5 ttmt -71.84 -38.21 70.16 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.771 0.429 . . . . 0.0 109.848 174.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.82 -41.78 55.0 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.87 -33.63 75.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 170.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.07 26.03 1.98 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.89 0.476 . . . . 0.0 111.638 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -79.47 -53.25 7.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.93 78.4 0.13 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.58 -57.69 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 123.199 0.599 . . . . 0.0 109.945 -175.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.37 -32.98 70.62 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.76 0.824 . . . . 0.0 110.763 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 t -70.57 -39.33 73.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.75 0.42 . . . . 0.0 110.766 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.731 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 87.4 m -65.63 -35.12 79.88 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.678 0.217 . . . . 0.0 111.288 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.9 t -51.11 -30.8 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 122.788 0.435 . . . . 0.0 110.459 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.2 t -73.98 -62.1 1.62 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.928 0.491 . . . . 0.0 112.276 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 1.349 ' HB2' ' CD ' ' A' ' 35' ' ' LYS . 10.5 p -52.54 -27.29 15.98 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.731 ' HB2' ' O ' ' A' ' 28' ' ' THR . 62.2 tttp -79.06 65.78 4.33 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 122.666 1.222 . . . . 0.0 110.386 -158.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.3 mt -87.67 -53.15 4.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.078 -1.874 . . . . 0.0 108.495 166.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.09 0.19 0.32 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.594 0.757 . . . . 0.0 112.081 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 1.349 ' CD ' ' HB2' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -88.57 -46.64 8.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.886 1.274 . . . . 0.0 111.908 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 37' ' ' CYS . 4.8 m 61.7 13.26 5.19 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -159.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 36' ' ' THR . 1.7 m . . . . . 0 C--N 1.345 0.385 0 C-N-CA 123.928 0.891 . . . . 0.0 110.131 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.047 0 N-CA-C 112.385 -0.286 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.86 -30.01 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.168 0.587 . . . . 0.0 109.738 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.158 ' O ' ' HD3' ' A' ' 7' ' ' LYS . 3.9 mm? -64.51 -26.54 68.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.266 0.626 . . . . 0.0 111.662 174.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.17 -19.84 23.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.4 m -75.49 -45.41 38.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.5 -40.23 86.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.393 0.677 . . . . 0.0 110.092 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 1.158 ' HD3' ' O ' ' A' ' 3' ' ' LEU . 4.3 mptp? -64.87 -47.17 78.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.51 0.724 . . . . 0.0 109.955 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -61.83 -46.22 90.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.654 0.782 . . . . 0.0 110.152 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -60.86 -50.79 72.02 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.956 0.502 . . . . 0.0 110.221 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.79 -28.62 69.7 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.142 0.577 . . . . 0.0 111.291 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -72.09 -41.21 67.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.151 0.58 . . . . 0.0 110.26 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.85 -30.63 34.83 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.3 t -90.01 45.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 159.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.38 -30.16 0.13 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.92 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 20.5 ptmt -88.46 -20.12 25.6 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.741 0.416 . . . . 0.0 110.189 173.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.4 -27.64 61.57 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -90.01 -48.43 7.21 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.855 1.262 . . . . 0.0 108.314 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.1 t -67.16 -28.9 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.92 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 29.4 tptp -69.95 -34.06 72.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 173.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.4 -45.32 48.01 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.74 -30.2 70.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.708 0.403 . . . . 0.0 110.709 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.98 -17.48 64.7 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -55.57 -41.3 73.1 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.617 0.767 . . . . 0.0 110.937 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -169.84 77.61 0.1 Allowed Glycine 0 C--N 1.337 0.631 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -53.82 -42.41 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 123.468 0.707 . . . . 0.0 111.057 -177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.2 mt -56.67 -37.47 70.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.576 1.151 . . . . 0.0 111.512 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.2 p -90.12 -44.36 9.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.119 0.567 . . . . 0.0 111.255 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.437 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 99.1 m -49.2 -54.19 17.73 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.512 0.725 . . . . 0.0 110.889 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 p -48.86 -32.59 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.671 0.788 . . . . 0.0 111.131 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 t -87.44 -60.07 2.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.539 0.736 . . . . 0.0 111.288 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.826 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 35.2 m -59.36 -8.81 1.9 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.936 -0.554 . . . . 0.0 111.993 -176.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -78.24 29.38 0.18 Allowed 'General case' 0 C--N 1.342 0.241 0 C-N-CA 118.61 -1.236 . . . . 0.0 113.023 -163.319 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.56 -41.3 89.83 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 166.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.56 44.99 1.62 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.875 0.87 . . . . 0.0 109.534 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? 48.91 46.06 22.24 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.847 1.259 . . . . 0.0 110.788 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.826 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 57.6 m -73.06 -18.42 61.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.063 0.545 . . . . 0.0 112.146 -169.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 C--N 1.341 0.212 0 C-N-CA 122.779 0.432 . . . . 0.0 110.074 177.036 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.079 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.0 pt -80.5 53.43 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 123.73 0.812 . . . . 0.0 110.278 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 70.8 mt -84.13 -46.13 12.26 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.655 0.782 . . . . 0.0 111.416 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.1 -11.49 41.14 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.803 0.841 . . . . 0.0 109.156 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 88.1 m -74.36 -59.32 2.78 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -172.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.0 mt -57.24 -40.0 76.71 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.714 0.405 . . . . 0.0 110.123 174.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -57.53 -45.47 85.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.227 1.011 . . . . 0.0 111.182 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -58.96 -51.57 69.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.165 0.586 . . . . 0.0 110.225 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -66.18 -39.66 89.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.894 0.478 . . . . 0.0 111.085 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.72 -37.52 84.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 175.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.0 mtpt -81.81 43.38 0.76 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 171.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -164.57 -36.86 0.02 OUTLIER Glycine 0 C--N 1.337 0.617 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.2 46.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 154.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -152.21 -29.34 0.04 OUTLIER Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.264 -1.934 . . . . 0.0 108.264 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 19' ' ' LYS . 62.1 mtpt -79.85 -41.1 26.99 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.2 -22.49 66.9 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.033 0.933 . . . . 0.0 110.73 173.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.2 mt -90.09 -41.05 11.89 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.12 0.968 . . . . 0.0 108.586 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.5 -32.38 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 170.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 15' ' ' LYS . 23.4 tptm -70.21 -36.59 74.68 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.6 -41.56 50.5 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.24 -36.05 82.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 170.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.06 41.54 1.05 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.111 0.564 . . . . 0.0 111.047 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -90.01 -58.86 2.36 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.375 0.67 . . . . 0.0 110.196 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.58 -79.23 1.21 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.3 t -84.29 -44.19 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 126.132 1.773 . . . . 0.0 109.76 -1.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.8 mt -53.57 -19.27 3.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.855 1.262 . . . . 0.0 112.575 -177.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.9 m -87.75 -48.95 7.45 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.155 0.582 . . . . 0.0 110.749 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.562 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 94.1 m -48.21 -51.83 23.59 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.528 0.731 . . . . 0.0 111.229 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 m -49.48 -39.94 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 124.327 1.051 . . . . 0.0 112.263 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.5 p -72.6 -56.13 5.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.307 0.243 . . . . 0.0 110.661 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.7 p -81.91 27.16 0.47 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.516 0.726 . . . . 0.0 111.256 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 28' ' ' THR . 13.5 tmtt? -88.37 -41.7 12.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.978 0.511 . . . . 0.0 111.92 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 tp -48.53 -65.6 0.54 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.534 1.134 . . . . 0.0 111.528 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.22 -11.0 60.36 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.573 0.349 . . . . 0.0 111.524 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 16.4 tptm 48.49 51.74 14.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.824 2.049 . . . . 0.0 112.725 176.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.3 t -72.97 -16.04 61.53 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 159.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.451 -0.4 0 C-N-CA 124.576 1.15 . . . . 0.0 108.74 177.511 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 N-CA-C 112.308 -0.317 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 pp -90.05 15.32 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 125.368 1.467 . . . . 0.0 111.732 -1.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.9 mt -78.49 -17.38 56.35 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.206 0.602 . . . . 0.0 111.8 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -90.27 -28.98 18.44 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 168.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -74.86 -55.88 5.34 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.927 0.491 . . . . 0.0 111.646 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.42 -35.26 78.68 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.662 0.385 . . . . 0.0 110.091 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' N ' ' CD ' ' A' ' 7' ' ' LYS . 11.6 mptt -67.14 -39.76 86.63 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.776 1.23 . . . . 0.0 110.607 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -63.67 -47.5 80.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.551 0.741 . . . . 0.0 109.694 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -66.26 -45.49 80.34 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.045 0.538 . . . . 0.0 110.388 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.96 88.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 173.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -81.02 41.7 0.6 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.564 0.746 . . . . 0.0 109.245 173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.445 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -162.88 -38.49 0.02 OUTLIER Glycine 0 C--N 1.336 0.576 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.68 45.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 155.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -146.56 -31.52 0.07 OUTLIER Glycine 0 CA--C 1.525 0.671 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -79.6 -41.26 27.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 170.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -65.99 -17.53 64.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.087 0.955 . . . . 0.0 111.08 173.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 mt -90.1 -41.74 11.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -65.42 -32.31 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 172.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' C ' ' HD3' ' A' ' 19' ' ' LYS . 1.4 tmtp? -69.28 -34.74 75.19 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.204 0.601 . . . . 0.0 109.874 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.02 -47.94 50.96 Favored Glycine 0 C--N 1.336 0.536 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.75 -30.17 70.78 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.078 0.551 . . . . 0.0 110.982 175.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.81 -33.18 73.67 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 117.493 0.133 . . . . 0.0 111.014 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -59.76 -47.49 85.48 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.538 0.735 . . . . 0.0 110.479 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.52 99.01 0.13 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.8 t -58.67 -60.13 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -171.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.38 -39.18 69.81 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.638 0.775 . . . . 0.0 110.661 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 t -63.96 -51.48 64.16 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.922 0.489 . . . . 0.0 110.432 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.854 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 62.4 m -60.72 -49.2 78.47 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.617 0.367 . . . . 0.0 110.246 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.87 -34.58 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.449 0.699 . . . . 0.0 110.607 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.2 t -72.37 -62.0 1.6 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.5 p -75.51 20.12 0.17 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.778 0.431 . . . . 0.0 111.55 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.854 ' HB2' ' O ' ' A' ' 28' ' ' THR . 41.1 ttmt -90.07 -34.17 16.03 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.605 0.762 . . . . 0.0 111.332 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.3 tp -57.15 -53.62 56.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 175.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.476 ' C ' ' H ' ' A' ' 36' ' ' THR . . . -80.69 78.58 7.44 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 160.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -63.39 22.75 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 126.561 1.944 . . . . 0.0 112.106 -171.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 34' ' ' ALA . 15.2 t -81.05 18.59 1.01 Allowed 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.947 -0.47 . . . . 0.0 109.82 169.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 119.123 -0.465 . . . . 0.0 110.091 -172.244 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.019 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -33.76 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 123.795 0.838 . . . . 0.0 109.999 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.2 mt -69.11 -25.55 64.46 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.54 0.736 . . . . 0.0 112.065 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -90.21 -20.78 22.62 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.0 m -73.3 -50.61 21.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 pp -64.52 -33.67 76.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 173.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.33 -45.03 96.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.963 0.905 . . . . 0.0 110.499 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -51.05 -52.21 45.49 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.453 1.101 . . . . 0.0 110.509 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -79.67 -30.54 41.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.563 0.745 . . . . 0.0 111.711 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.53 91.64 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.64 0.376 . . . . 0.0 110.82 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -64.86 -30.07 71.05 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.228 0.611 . . . . 0.0 110.654 174.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -76.24 -30.34 57.15 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.5 t -87.38 36.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 162.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -127.96 -33.77 0.58 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 107.245 -2.342 . . . . 0.0 107.245 170.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 19' ' ' LYS . 70.5 mmtt -73.97 -45.8 47.91 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.57 0.748 . . . . 0.0 109.421 172.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -65.19 -18.42 65.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.376 0.67 . . . . 0.0 110.472 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.99 -43.39 10.57 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.089 1.355 . . . . 0.0 107.897 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.0 t -63.3 -33.93 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' LYS . 0.9 OUTLIER -70.58 -32.49 69.89 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.753 0.421 . . . . 0.0 109.893 175.349 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.46 -45.85 44.23 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.02 -29.45 69.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.917 0.487 . . . . 0.0 110.921 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.53 -34.95 76.43 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 117.534 0.152 . . . . 0.0 111.005 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -60.54 -30.67 69.91 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.742 0.817 . . . . 0.0 111.227 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -161.41 85.89 0.11 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.16 -61.55 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -172.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -54.53 -36.8 64.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.065 0.946 . . . . 0.0 111.353 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 80.4 p -67.64 -48.47 66.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.414 0.285 . . . . 0.0 110.646 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.61 ' O ' ' HB3' ' A' ' 32' ' ' LYS . 66.0 m -57.7 -46.87 83.76 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.068 0.547 . . . . 0.0 110.47 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.8 t -54.23 -31.78 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.573 0.749 . . . . 0.0 110.721 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.8 m -89.98 -48.37 7.25 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.995 0.518 . . . . 0.0 111.412 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 36' ' ' THR . 74.7 m -57.18 -19.07 18.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.65 0.38 . . . . 0.0 111.75 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.612 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -76.32 24.39 0.14 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -158.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.5 tp -60.33 -49.07 79.07 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.29 45.4 1.85 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.872 0.869 . . . . 0.0 108.9 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.9 tptp 45.52 57.94 4.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.3 1.44 . . . . 0.0 111.057 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 31' ' ' CYS . 59.0 m -69.35 -21.08 63.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.057 176.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.452 -0.365 0 C-N-CA 122.552 0.341 . . . . 0.0 110.665 175.522 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.019 0 N-CA-C 112.272 -0.331 . . . . 0.0 112.272 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.8 tp -58.22 -31.69 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 123.717 0.807 . . . . 0.0 110.617 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.105 ' O ' ' HD2' ' A' ' 7' ' ' LYS . 89.8 mt -72.15 -21.59 61.43 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.55 0.74 . . . . 0.0 112.2 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -90.1 -25.37 20.77 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.4 m -75.04 -48.59 23.26 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 123.375 0.422 . . . . 0.0 110.342 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.72 -38.52 91.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 1.105 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 0.6 OUTLIER -62.7 -41.07 98.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.92 0.888 . . . . 0.0 110.529 178.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -52.32 -43.41 64.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.93 0.892 . . . . 0.0 110.709 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -90.05 -39.36 12.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.605 0.762 . . . . 0.0 111.59 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.76 -38.88 76.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.204 0.602 . . . . 0.0 111.857 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -67.7 -35.16 78.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 119.473 -0.299 . . . . 0.0 110.748 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -71.53 -24.85 76.31 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.58 49.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 160.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -148.43 -33.97 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 174.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.566 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -72.29 -43.6 63.99 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.66 -23.48 67.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.514 0.726 . . . . 0.0 111.045 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.4 mt -88.46 -37.59 15.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.3 t -66.65 -29.94 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 168.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -79.89 1.69 26.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.127 0.571 . . . . 0.0 110.585 174.46 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.03 -68.38 0.35 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.42 -63.91 1.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.643 0.777 . . . . 0.0 110.891 177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.02 40.81 1.02 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.803 0.841 . . . . 0.0 110.767 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.94 -60.04 2.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -165.58 74.47 0.16 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.06 -49.97 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 123.295 0.638 . . . . 0.0 110.175 -175.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 30' ' ' SER . 87.8 mt -50.89 -39.44 54.23 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.486 1.114 . . . . 0.0 111.81 -177.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.9 p -80.8 -42.05 22.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.761 0.424 . . . . 0.0 110.896 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.5 m -62.53 -52.35 63.78 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.302 0.641 . . . . 0.0 110.486 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.11 -36.75 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 122.946 0.499 . . . . 0.0 110.595 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 35.6 t -67.29 -55.53 13.52 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.511 0.725 . . . . 0.0 110.964 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 17.1 p -70.92 7.42 1.17 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.649 0.38 . . . . 0.0 111.837 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.705 ' HD2' ' HE3' ' A' ' 35' ' ' LYS . 22.9 ttpp -80.81 59.03 3.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.631 0.729 . . . . 0.0 109.871 -172.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.01 72.27 7.41 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 168.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.17 50.05 3.15 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.617 1.167 . . . . 0.0 110.189 -170.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.705 ' HE3' ' HD2' ' A' ' 32' ' ' LYS . 35.6 mmtp 53.79 67.7 0.96 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.024 1.33 . . . . 0.0 111.425 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.6 m -76.7 -37.63 55.79 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.621 0.368 . . . . 0.0 110.206 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.341 0.206 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.987 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.037 0 N-CA-C 112.32 -0.312 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.5 pp -82.29 38.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.678 0.791 . . . . 0.0 110.638 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.4 mt -82.23 -37.09 26.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.89 0.876 . . . . 0.0 111.422 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -90.01 -16.65 29.36 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.873 0.869 . . . . 0.0 108.967 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.0 m -73.26 -51.65 16.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.997 -173.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.3 mt -66.41 -36.29 82.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.946 0.499 . . . . 0.0 109.959 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -57.08 -46.94 82.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.905 0.882 . . . . 0.0 110.554 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -57.79 -49.32 77.0 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.127 0.971 . . . . 0.0 110.209 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -65.99 -43.02 89.03 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.238 0.615 . . . . 0.0 110.927 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.78 -40.54 95.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.074 0.55 . . . . 0.0 111.74 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -82.05 -18.62 42.56 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 117.923 0.328 . . . . 0.0 111.151 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.18 -28.85 47.84 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 170.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.02 47.22 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 158.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.26 -28.35 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.926 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 3.0 pptp? -89.07 -22.66 22.82 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.895 0.478 . . . . 0.0 109.923 173.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.75 -27.0 62.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.147 0.579 . . . . 0.0 109.549 167.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.1 mt -90.16 -48.09 7.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.324 1.049 . . . . 0.0 108.964 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 t -65.96 -31.95 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 174.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.926 ' HB2' ' O ' ' A' ' 15' ' ' LYS . 1.2 tmtp? -67.4 -39.63 85.56 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.195 0.598 . . . . 0.0 109.72 173.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.17 -41.87 59.19 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.42 -35.06 79.18 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 170.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.1 27.02 1.71 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.821 0.449 . . . . 0.0 111.648 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -78.87 -62.01 1.83 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.94 52.39 0.16 Allowed Glycine 0 C--N 1.336 0.557 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 p -73.55 -46.02 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.21 -36.05 82.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.56 0.744 . . . . 0.0 110.228 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.4 m -64.62 -47.1 79.8 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.118 0.567 . . . . 0.0 110.403 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.756 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 98.0 m -57.25 -50.38 73.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.076 0.55 . . . . 0.0 110.367 178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.7 t -54.56 -33.22 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.815 0.846 . . . . 0.0 110.948 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.4 t -73.16 -62.63 1.4 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.192 0.197 . . . . 0.0 110.611 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 19.7 p -75.78 16.41 0.4 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.448 0.299 . . . . 0.0 111.621 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.756 ' HB2' ' O ' ' A' ' 28' ' ' THR . 68.5 tttt -90.2 -31.93 16.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.059 0.543 . . . . 0.0 111.49 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.2 tp -51.23 -64.13 0.91 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.794 0.838 . . . . 0.0 110.995 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.69 -7.47 59.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.811 0.444 . . . . 0.0 111.352 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.627 ' HE2' ' O ' ' A' ' 37' ' ' CYS . 19.1 tptm 46.46 58.7 4.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.271 1.828 . . . . 0.0 112.167 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.3 t -76.22 -18.24 59.14 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 161.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.627 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 63.1 m . . . . . 0 N--CA 1.452 -0.333 0 C-N-CA 124.015 0.926 . . . . 0.0 109.875 176.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.005 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -82.4 39.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.626 0.77 . . . . 0.0 110.522 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.3 mt -82.81 -35.68 26.21 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.505 0.722 . . . . 0.0 111.577 -172.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -90.23 -15.62 31.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.8 m -68.51 -47.0 68.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.4 mt -59.58 -38.72 81.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.663 0.785 . . . . 0.0 110.567 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -63.83 -51.06 66.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.07 0.548 . . . . 0.0 109.912 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -57.62 -48.9 78.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.086 0.955 . . . . 0.0 109.805 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -60.67 -44.72 96.14 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.412 0.685 . . . . 0.0 110.756 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.48 96.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.589 0.356 . . . . 0.0 110.238 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -82.83 42.71 0.8 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.573 ' O ' ' OD2' ' A' ' 16' ' ' ASP . . . -157.28 -37.74 0.02 OUTLIER Glycine 0 C--N 1.336 0.555 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 t -87.24 47.78 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 152.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -136.97 -36.32 0.18 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 174.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 19' ' ' LYS . 5.0 mmpt? -66.54 -39.85 88.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.705 0.802 . . . . 0.0 109.194 169.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.573 ' OD2' ' O ' ' A' ' 12' ' ' GLY . 3.5 m-20 -65.26 -25.98 67.9 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.431 1.093 . . . . 0.0 111.07 175.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.3 mt -90.1 -39.89 12.6 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.63 -30.84 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 15' ' ' LYS . 64.7 tttp -71.71 -36.87 70.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.052 0.541 . . . . 0.0 109.843 174.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.51 -41.93 56.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.58 80.88 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.01 28.77 1.31 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.92 0.488 . . . . 0.0 111.633 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? -78.81 -55.23 5.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -168.94 76.3 0.11 Allowed Glycine 0 C--N 1.337 0.596 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m -56.41 -44.67 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.592 0.757 . . . . 0.0 110.843 -176.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.23 -37.66 72.61 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.25 1.02 . . . . 0.0 110.813 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -80.06 -41.64 25.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.135 0.574 . . . . 0.0 110.727 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 90.6 m -65.5 -50.35 65.63 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.27 0.628 . . . . 0.0 111.113 -177.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.21 -41.25 86.15 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 C-N-CA 122.784 0.433 . . . . 0.0 110.73 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.1 m -71.46 -46.82 58.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.197 0.599 . . . . 0.0 110.165 176.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.2 t -65.35 -12.01 47.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.214 0.606 . . . . 0.0 111.199 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 1.364 ' CD ' ' HD3' ' A' ' 35' ' ' LYS . 19.7 ttpp -87.27 63.49 7.81 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.799 0.809 . . . . 0.0 109.452 -172.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.56 -57.99 4.51 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 168.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.02 47.92 1.71 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.991 0.917 . . . . 0.0 108.699 171.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 1.364 ' HD3' ' CD ' ' A' ' 32' ' ' LYS . 3.0 mmmp? 49.11 56.6 7.54 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.942 1.297 . . . . 0.0 111.016 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -71.61 -35.76 70.59 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 91.5 m . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 170.444 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.002 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.61 -36.52 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.384 0.674 . . . . 0.0 109.599 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.9 mt -73.65 -15.44 61.25 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.907 0.483 . . . . 0.0 112.104 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -90.12 -27.3 19.72 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 173.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.7 m -68.41 -44.41 75.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 123.346 0.404 . . . . 0.0 110.19 -176.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.3 mt -58.11 -45.24 87.6 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.713 0.805 . . . . 0.0 110.322 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.83 -48.07 82.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.807 0.843 . . . . 0.0 110.71 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.46 -51.35 69.82 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.805 0.842 . . . . 0.0 109.762 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -57.91 -50.89 71.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.164 0.586 . . . . 0.0 110.51 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.75 -33.68 74.5 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.029 0.532 . . . . 0.0 110.744 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -73.99 -30.93 62.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.968 0.507 . . . . 0.0 110.16 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -76.19 -31.01 56.26 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 173.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -86.16 43.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 160.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 12' ' ' GLY . . . -141.33 -32.69 0.13 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 107.343 -2.303 . . . . 0.0 107.343 172.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 19' ' ' LYS . 70.7 mmtt -68.73 -40.93 79.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.376 0.67 . . . . 0.0 109.416 169.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -64.05 -26.19 68.45 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.714 0.806 . . . . 0.0 110.664 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.4 mt -90.04 -41.34 11.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.237 1.015 . . . . 0.0 108.869 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.9 t -65.31 -29.02 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 171.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 15' ' ' LYS . 23.4 tptm -72.58 -37.06 68.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.869 0.467 . . . . 0.0 109.772 175.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.85 -42.55 52.8 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.971 -1.251 . . . . 0.0 109.971 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.85 80.56 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.08 27.38 1.63 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.825 0.45 . . . . 0.0 111.645 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -78.65 -62.55 1.65 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.35 46.7 0.17 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 177.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.0 p -64.0 -41.91 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 122.916 0.486 . . . . 0.0 110.061 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.8 mt -59.87 -40.42 88.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.047 0.939 . . . . 0.0 110.36 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.6 m -70.2 -40.84 74.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.988 0.515 . . . . 0.0 110.642 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.982 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 26.1 m -69.88 -7.09 37.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.13 -39.21 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 166.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.5 t -76.3 -64.17 1.16 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.057 0.543 . . . . 0.0 110.198 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 6.8 p -77.67 43.33 0.4 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 119.435 -0.317 . . . . 0.0 110.393 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.982 ' HB2' ' O ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -90.11 -56.13 3.34 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 178.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 tt -29.88 -75.0 0.03 OUTLIER 'General case' 0 C--N 1.343 0.29 0 C-N-CA 126.021 1.728 . . . . 0.0 113.264 -148.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.35 59.23 1.35 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.411 ' CB ' ' H ' ' A' ' 37' ' ' CYS . 45.2 mtpt -141.76 -65.52 0.42 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.032 0.933 . . . . 0.0 110.815 -162.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.9 m 63.37 11.92 5.86 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.63 0.772 . . . . 0.0 109.472 -159.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.411 ' H ' ' CB ' ' A' ' 35' ' ' LYS . 1.2 t . . . . . 0 N--CA 1.452 -0.373 0 C-N-CA 124.642 1.177 . . . . 0.0 111.569 177.339 . . . . . . . . 1 1 . 1 stop_ save_